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Intracytoplasmic sperm injection (ICSI) has developed as a radical form of male 
fertility treatment (Palermo et al., 1992), with remarkable high success rates. Even the 
use of non-ejaculated sperm and sperm that has not completed the maturation 
process is no obstacle for fertilization (Silber et al., 1995a; Tesarik et al., 1998). Hence, 
ICSI bypasses natural barriers of sperm selection at the moment of fertilization and 
therefore, there is a potential danger of increasing the transmission of genetic 
disorders and inducting genetic anomalies into the offspring. Although questions 
concerning the possible risks for the offspring and future generations are partially 
answered (requiring more genetic, biological and clinical research), ICSI has become 
the treatment of choice for severe male infertility and in its first decade of existence it 
is a routine procedure in almost every IVF centre. Therefore, it is highly desirable to 
increase our knowledge and understanding of the causes of severe male infertility 
and short and long-term consequences for the children conceived with ICSI.  
Since the introduction of ICSI, the study of sperm quality has gained an 
essential place in the biology of artificial reproduction. The routine semen analysis 
currently used in most laboratories is generally considered not sufficient for the 
assessment of sperm quality. With the development of molecular biological 
techniques, a rapid increase in knowledge of genetics, function and characteristics of 
human spermatozoa has been obtained. A major concern is the DNA integrity of 
sperm in male infertility. It has already been extensively demonstrated that sperm of 
infertile males show an increase in DNA anomalies, i.e. breaks and aneuploidy (Sun 
et al., 1997; Evenson et al., 1999; Bernardini et al., 2000; Martin et al., 2000; Morris et al., 
2002). Moreover, in non-ejaculated sperm retrieved from the epididymis or from the 
testis, additional threads such as imperfect spermiation, incomplete nuclear 
compaction, DNA damage, immaturity, aging due to a long stay in the efferent duct 
(in case of obstruction) and incomplete maturation come into play. This thesis has 
focused on the quality of epididymal spermatozoa in men suffering from obstructive 
azoospermia in order to predict and anticipate possible genetic anomalies to the 
offspring following ICSI with the use of epididymal sperm. 
In order to better comprehend the different aspects and results described in this 
thesis, a general description of male infertility and azoospermia, characteristics and 
regulation of the spermatogenesis, nuclear characteristics of the spermatozoon and 
the treatment of azoospermic patients are addressed in this chapter.   
 
 
1. MALE INFERTILITY AND AZOOPSERMIA  
 
1.1  Incidence 
The incidence of couples seeking fertility treatment in the western world is 
estimated 15 percent (WHO 1999). Male factors account for approximately 50% of all 
cases of infertility, while azoospermia, defined as the absence of spermatozoa in the 
ejaculate is present in about 5% of infertile couples (Irvine 1998). The incidence of 
azoospermia caused by an obstruction in the efferent tract varies per study, but it is 
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estimated to occur in about 30-40% of cases, while impaired spermatogenesis 
accounts for the majority of the azoospermias (Matsumiya et al., 1994; Ezeh 2000). 
The sole therapeutic option for these patients is ICSI with the use of surgically 
retrieved sperm at the site of the epididymis or testis, a technology that has opened a 
complete new chapter in the treatment of azoospermia. 
As the use of ICSI for the treatment of azoospermia increases irrespective its 
aetiology, a better understanding of the causes and clinical characteristics of 
azoospermia is becoming relevant to predict complications and (genetic) risks that 
are involved in the use of non-ejaculated sperm (Dohle et al., 2002; Oates et al., 2002). 
Moreover, evolutionary questions about the long term safety and the consequences 
for future generations need to be adequately addressed (Meschede et al., 1995; De 
Jonge et al., 1995; Patrizio 1995; Silber et al., 1995b).  
To understand the clinical impact of cellular characteristics of non-ejaculated 
spermatozoa, a complete and detailed classification of azoospermia is essential.  With 
the systematic and careful characterization of each type and cause of azoospermia, it 
may become possible to predict the risk for the offspring of an individual 
azoospermic man. 
 
 
1.2  Classification 
In clinical practice, it is sometimes difficult to predict a completed 
spermatogenesis based on clinical parameters. The current parameters used to 
classify azoospermia are the medical history, hormone levels (such as FSH, inhibin B, 
etc.) and the testicular volume among others. However, the most accurate parameter 
to predict a normal and completed spermatogenesis is the testicular histology. The 
importance of a correct diagnosis relies on the chance for a successful sperm recovery 
and identification of patients at higher risk for genetic anomalies. Because in the 
literature different classifications are used in azoospermia, the most commonly used 
ones are listed below: 
 
¾ Obstructive versus non-obstructive 
Traditionally, azoospermia is classified as “obstructive” or “non-obstructive”. 
Sporadically an obstruction may be accompanied by a spermatogenetic disorder. 
Worldwide, this classification implies that in the first group, an obstruction in the 
Wolffian system is the cause of infertility. In the second group, there is a deficient (or 
absent) spermatogenesis. Despite the fact that the clinical diagnosis of an obstruction 
especially in the epididymis is not possible, almost all current clinical research papers 
adopt this classification based on the indirect prove of normal spermatogenesis. 
However, there is no general consensus about the definition of “normal 
spermatogenesis”. Following the classification (score) proposed by Johnsen (Johnsen 
1970), only a few men would be included in this category. According to the Johnsen 
score “normal spermatogenesis” is considered for scores above nine and therefore, 
restricted to testis with high rates of sperm production (see below “Testicular 
histology”).  
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¾ Clinical diagnosis 
A clinically orientated classification of azoospermia (Sharif 2000) places the 
different causes of azoospermia into categories with a common aetiology, 
presentation, prognosis or treatment (adapted from the publication of Sharif, 2000):  
1. Pre-testicular azoospermia: this includes all cases of hypogonadotrophic 
hypogonadism, whether congenital (e.g. Kallmann’s syndrome), acquired 
(trauma, tumour, irradiation or infiltrations in the endocrine-neural system, etc.) 
or idiopathic.  
2. Testicular azoospermia: this includes testicular disorders and may be congenital 
(e.g. chromosomal anomalies among which Klinefelter syndrome, Sertoli Cell 
Only Syndrome (SCO), Y-deletions, etc.), acquired (radiotherapy, 
chemotherapy, torsion, cryptorchidism, etc.) or idiopathic.  
3. Post-testicular azoospermia: this category includes either ductal obstruction or 
dysfunction. Obstruction can be congenital such as congenital bilateral absence 
of the vas deferens (CBAVD), Young’s syndrome, etc. or acquired such as post-
vasectomy, post-surgery, trauma, infection, etc. 
 
¾ Location of sperm retrieval  
This classification is based on the anatomical location sperm can be retrieved 
(Ezeh et al., 2001): “ejaculated” (in cases of anejaculation, disturbed ejaculation, etc.),  
“epididymal” or “testicular”. We do not consider the first type of azoospermia as 
such because it concerns a functional instead of mechanical obstruction. Here we will 
focus on disorders of non-ejaculated sperm.  
1. Epididymal sperm can be recovered via a percutaneous epididymal sperm 
aspiration (PESA, see figure 1) or microsurgical sperm aspiration (MESA) 
from the caput (head) or cauda (tail) of the epididymis.  
2. Testicular sperm can be retrieved by an open biopsy (TESE), fine needle 
aspiration (FNA) with or without the use of a biopsy gun.  
 
¾ Aetiology  
This classification counts for the origin and cause of azoospermia. This is of 
clinical relevance in the treatment prognosis, as different success rates with ICSI and 
different genetic risks for the offspring are related to the aetiology of the disorder. 
1. Idiopathic: In at least 50% of the cases of azoospermia the cause is still unknown. 
Recent studies suggest that many cases in this large group of azoospermic 
males may have a genetic basis (Lilford et al., 1994; Meschede et al., 2000), as 
more and more genes related to spermatogenesis are discovered. Although 
idiopathic azoospermia is considered to be non-obstructive, some patients 
may still produce sufficient sperm for retrieval at PESA. 
 
 
   Introduction 
 15 
Figure 1: PESA procedure (courtesy Dr. G. Dohle) 
 
 
2. Acquired: as above mentioned, azoospermia may be caused by an obstruction at 
different levels of the efferent duct, presenting normal testicular 
spermatogenesis. Other acquired causes of azoospermia are cryptorchidism, 
testicular torsion, viral infection (mumps), cytotoxic therapy (drugs or 
chemotherapy), varicocele, testicular atrophy, etc. (Ezeh 2000). The rate of 
sperm production in these males can vary from severely to moderately 
impaired spermatogenesis. 
3. Genetic: Genetic anomalies can cause severe male factor infertility, most of 
which present either as oligoasthenoteratozoospermia (OAT) or azoospermia 
(Dohle et al., 2002; Oates et al., 2002). Mutations in some genes not related to 
spermatogenesis, such as in CBAVD cases, are responsible for 1-2% of cases of 
male infertility (~9% of azoospermic males).  Although this aetiology is 
obstructive, absence of epididymal sperm and impaired spermatogenesis has 
been reported in this group (Meng et al., 2001), suggesting additional genetic 
factors.  
Structural and numerical chromosomal abnormalities are estimated to be 
present in 10-15% of azoospermic patients (De Braekeleer et al., 1991; Van 
Assche et al., 1996). The prime example of a numerical abnormality is the 
Klinefelter syndrome (XXY), which incidence in azoospermic males is ~2.7%. 
Structural chromosomal anomalies mainly concern translocations and 
deletions of the Y-chromosome, which are present in 5-25% of azoospermic 
males. These patients present with a wide histological variation from Sertoli 
cell only to hypospermatogenesis (Fujisawa et al., 2001; Oates et al., 2002). 
 
 
 
Chapter 1 
 16 
 
2. SPERMATOGENESIS: regulation and sperm production 
(Adapted from Andrology, ed. Nieschlag and Behre, 2001)  
 
The testis fulfils two essential functions: production and maturation of male 
gametes and synthesis and secretion of sexual hormones. The term spermatogenesis 
describes and includes all cellular processes involved in the production of gametes. 
This process, which is probably one of the most complicated mammalian cellular 
differentiation processes, occurs within the seminiferous tubules of the testis. For the 
normal production of sperm, the endocrine regulation system, the testicular tubular 
compartment and the testicular interstitial compartment are necessary.  
   
2.1  The endocrine regulation  
The hormonal regulation of testicular function is a complex system controlled by 
the hypothalamus-gonadal axis. The gonadotropins luteinizing hormone (LH) and 
follicle-stimulating hormone (FSH) are produced and secreted by the gonadotropic 
cells of the anterior pituitary gland. The secretion of the pituitary gland is regulated 
by the hypothalamic gonadotropin-releasing hormone (GnRH), and its function is in 
turn under the control of gonadal steroids and peptides that influence its activity (see 
Fig. 2). LH and FSH exercise their tasks via specific receptors located in the Leydig 
cells and Sertoli cells respectively. LH stimulates testosterone synthesis of the Leydig 
cells, whereas FSH controls spermatogenesis via the Sertoli cells and is regulated 
through a negative feedback by inhibin B, produced by the Sertoli cells. The 
intertesticular effect of testosterone (which also has a autocrine and paracrine action 
in the testis) is important for spermatogenesis and control of the secretion of LH. 
Besides the primary control of the testicular function by the molecules described 
above, there is a complex (local) intratesticular control by regulatory mechanisms. 
These mechanisms will not be further discussed.    
 
¾ Reference values of the hormones 
Normal hormone values ranges in peripheral serum vary per laboratory. The 
reference normal values ranges in our hospital are: 
FSH: 2.0 – 7.5 IU/l 
LH: 1.8 – 9.5 IU/l 
Testosterone: 11 – 45 nmol/l 
Inhibin B: 100 – 400 pg/ml  
2.2  Spermatogenesis 
A number of cell types are involved in the production, support, differentiation 
and maturation of the spermatozoa. This brief presentation of the cells involved in 
this process is only intended for a better interpretation of the histology of the 
testicular biopsy. 
Sertoli cells: are diploid cells, which do extend from the periphery of the tubule 
to the lumen. Their main function is to create a favourable environment for cell 
differentiation. Sertoli cells have a complicated morphology; they are connected to 
   Introduction 
 17 
one other by tight junctions, forming the blood-testis barrier. These cells are 
stimulated by FSH, and are responsible for the production of inhibin B. 
Spermatogonia are situated in the basal compartment of the seminiferous tubules 
between the Sertoli cells and the peripheral myeloid cells.  
Leydig cells: form clusters around the blood vessels and produce steroids 
(testosterone). 
Germ cells: Spermatogonia are undifferentiated diploid cells. They undergo two 
proliferation waves: the prespermatogenic wave, which occurs during foetal life and 
the second one following puberty.  The second proliferation wave takes place in 
undifferentiated spermatogonia that form a pool of flexibly reacting cells that 
regulate the output of gametes and differentiated spermatogonia. They proliferate 
exponentially in a fixed number of generations thereby increasing the number of 
germ cells enormously (Hilscher 1991). 
Spermatocytes: divide by two meiotic divisions to form four haploid 
spermatids. During this process, the random separation of homologous 
chromosomes and crossing over of genetic material occurs, which is an important 
step for genetic variation. Each primary spermatocyte gives rise to two secondary 
spermatocytes.  
Spermatids: are haploid cells that develop to spermatozoa in a process called 
spermiogenesis. During this process, the cell changes into a highly specialised 
spermatozoon. Somatic and testicular histones are replaced by transition proteins 
and subsequently by protamines. By this process, the nuclear chromatin becomes six 
times more condensed than somatic cells. When spermatogenesis is complete, the 
cytoplasmic connections with the Sertoli cells are broken and spermatozoa are 
released into the lumen of the tubules (testicular spermatozoa). 
 
2.3  Testicular histology   
The testicular histology is considered the golden standard for the evaluation 
of spermatogenesis, as the clinical and endocrinological parameters fail in the 
distinction of the different types of spermatogenetic anomalies. In 1970 Johnsen 
developed a score system in order to enable a quantitative evaluation of 
spermatogenesis (Johnsen 1970) (see Table1). The status of spermatogenesis is 
evaluated in at least 25 tubular cross-sections in a scale from zero to ten: the average 
of the individual scores represents the biopsy score (see Figure 3, Table 1). According 
to the so called Johnsen score (Johnsen 1970), a normal spermatogenesis is 
represented by at least 60% of tubules with score of 10 (based on the testicular biopsy 
of 17 normospermic fertile men). The mean score and SD of normal fertile men was 
calculated to be 9.38 ± 0.24 (normal limit are 8.90 - 9.86). The mean Johnsen score 
calculated for men with severe idiopathic hypospermatogenesis (< 20 million sperm 
cells in the ejaculate) was 5.32 ± 2.13, while in moderate idiopathic 
hypospermatogenesis (> 20 million sperm cells in the total ejaculate), the mean score 
was 7.8 ± 1.26. The Johnsen score correlates with sperm count (r=0.82) and testicular 
volume but not with sperm morphology. 
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Table 1: Assessment of the spermatogenic status (score based upon Johnsen, 1970 
and de Kretser, 1976) 
 
Score Histology Diagnosis 
10 > 20 mature spermatids/tubule, germinal epithelium 
organizes in a regular thickness leaving an open lumen. 
Complete/ normal 
spermatogenesis 
9 > 20 mature spermatids/tubule but germinal epithelium 
disorganised with sloughing or obliteration of lumen 
Reduced spermatogenesis 
(hypospermatogenesis) 
8 Only few mature spermatids (<5-10)/tubule Reduced spermatogenesis 
(hypospermatogenesis) 
7 No mature spermatids, but many immature spermatids Disturbed differentiation of 
spermatids 
6 No mature spermatids and only few round immature 
spermatids (<5) 
Disturbed differentiation of 
spermatids 
5 No spermatids but several or many primary spermatocytes Primary spermatocyte 
maturation arrest 
4 No spermatids, few primary spermatocytes (<5) Primary spermatocyte 
maturation arrest 
3 No spermatids, no primary spermatocytes, only 
spermatogonia (germ cells) 
Spermatogonial arrest 
2 No germ cells, only Sertoli cells Sertoli-cell Only 
 
1 Degenerating Sertoli cells, no cells at tubular section Tubular atrophy 
 
 
 
2.4  The spermatozoon: nuclear characteristics, maturation and transport 
 
¾ Nuclear characteristics: chromatin reorganization during spermatogenesis  
(Adapted from (Dadoune 1995) 
The nuclear status of sperm cells is determined by two major events that take 
place during spermatogenesis: a) the acquisition of the final nuclear shape, and b) the 
replacement of somatic testicular type histones by the protamines (sperm-specific 
basic nuclear proteins). Most of the morphological abnormalities of human 
spermatozoa are thought to occur at the last stages of the spermatogenesis (also 
called spermiogenesis). The knowledge of the structure and composition of human 
ejaculated sperm requires the understanding of the events involved in the 
reorganisation of the nucleus during spermiogenesis and the epididymal maturation. 
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Figure 2: Hormonal regulation of spermatogenesis  
(Courtesy of Prof. Dr.E. Nieslag, University of Munster, Germany) 
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Ad. a) During spermiogenesis, haploid round spermatids undergo complex 
morphological, biochemical and physiological changes. The shaping of the nucleus, 
changes in the compaction state of chromatin, the development of the acrosome and 
the formation of the tail are some of the events that enable the spermatozoon to reach 
his goal: fertilization of the oocyte.  The spermatid nucleus is completely reorganized 
during mid-spermiogenesis. The shape and size of the nucleus and the compactation 
state of the chromatin change dramatically as the histones/nucleosomes are replaced 
by transition proteins and protamines. At the end of the spermatid acrosome phase, 
the chromatin is first condensed in coarse granules, and homogeneous and dense in 
the mature spermatids. The decrease in nuclear area and width occurs concomitantly 
with an increase in chromatin condensation. There is some degree of heterogeneity in 
the condensation in the cell as well. The degree of condensation and shape differs 
between species. While in round spermatids the nucleolus organising region is still 
transcriptionally active (Dadoune 1995), the arrest of transcription in the spermatid 
elongation phase is concomitant with the loss of the DNase-I hypersensitive regions 
that are normally located in transcriptionally active or potentionally active genes. 
Ad b) During elongation of the spermatid nucleus, histones and non-histone 
chromosomal proteins are replaced by new basic proteins. In intermediate 
spermatids, histones are replaced by spermatid-specific transition proteins (TPs). 
Transition proteins exhibit physical and chemical properties intermediate between 
histones and protamines. They are characterized by a high basicity due to their large 
amount of histidine and lysine residues. Two transition proteins TP1 and TP2 have 
been identified in man (TP2 is also rich in cysteine). These proteins are removed from 
the condensing chromatin at later stages of spermiogenesis and are replaced by 
protamines. Protamines are the principal basic nuclear proteins of mature sperm. 
Two different types of mammalian protamines have been identified (P1 and P2). P1 
protamines are present in all mammalian spermatozoa, while P2 protamines have 
been found in sperm nuclei of only a few mammalian species, including mouse and 
man. In the human, the proportion of P1 is almost equal to P2, although, in infertile 
men a decrease in the P2 has been found (de Yebra et al., 1993; de Yebra et al., 1998; 
Carrell et al., 2001). Protamines are rich in arginine and cysteine (which are also rich 
in thiol groups, SH), but differ in their relative amounts of histidine and tyrosine. In 
addition to DNA binding to neutralise the negative charge of the phosphate groups 
of the DNA backbone, protamine molecules interact with themselves and with other 
protamine molecules by forming disulfide bonds between cysteine residues (S-S), 
thereby facilitating DNA compaction and stabilization.  
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Figure 3: Tubular cross-sections of testicular biopsies: a) Testicular atrophy (J-Score1); b) Sertoli Cell 
Only (J-Score 2); c) Spermatogonia arrest (J-Score 3); d) Spermatocyte arrest (J-Score 5); e) Disturbed 
differentiation of spermatids (J-Score 7); f) Normal spermatogenesis (J-Score 10). Magnification 40x. 
(Courtesy of Dr. Hulsbergen-vd Kaa, Department of Pathology, UMCN).   
 
 
¾ Sperm maturation and epididymal transit 
The stability of the chromatin, depending on the amount of S-S crosslinks within 
and between thiol groups of protamines, increases during epididymal transit. 
Evaluation of the number of disulfide bonds in protamines isolated from human 
immature and mature spermatozoa originating from the three epididymal segments 
has indicated that the stabilization of the chromatin starts in the testis and then 
develops with the passage from the caput epididymis to the cauda epididymis 
(Saowaros et al., 1979). Transit through the epididymis varies per species; in human 
sperm transport takes 2 to 19 days. 
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3. ICSI WITH NON-EJACULATED SPERM  
3.1  The Dutch situation 
1. The moratorium 
Shortly after the introduction of ICSI the Netherlands in 1994, the use of non-
ejaculated sperm for ICSI was unrestricted. In the period 1995 until may 1996, 
fertilization and pregnancies were achieved using epididymal and testicular sperm 
of patients with obstructive azoospermia. However, due to concerns about the 
unknown risks of the use of non-ejaculated sperm (Hollanders et al., 1996; Tuerlings 
et al., 1997), the Dutch association of obstetricians and gynaecologists (NVOG) and 
the association of Dutch embryologists (KLEM) decided to stop the use of non-
ejaculated sperm until a better estimation of the risks of this fertilization method was 
possible (Meuleman et al., 1998a). In 1998, the voluntary moratorium was changed 
into a national prohibition of the use of surgically retrieved sperm for fertility 
purposes by the ministry of Health, Welfare and Sport (VWS). The prerequisite for 
resuming ICSI with non-ejaculated sperm was to have data available about the risks 
for the offspring. The research that was set out to obtain these data can be 
summarised as follows:  
- Research in an animal model in order to explore the possible risks of the use of 
DNA damaged sperm in the fertilization process; 
- Research to assess the quality of human epididymal sperm and to estimate the 
extend of DNA damage in these cells. 
 
¾ The research 
In the period following the institution of the moratorium, a multicentre study 
regarding animal and human epididymal spermatozoa was granted by the Dutch 
Organisation for Scientific Research (NWO). The animal research was performed at 
the Wageningen University using a mouse ICSI model. The human research was split 
in three levels: 
a) Study of the external nuclear features of human sperm using a computerised 
karyometric image analysis (CKIA); 
b) Study of sperm chromosome damage and translocations using karyograms 
obtained after fertilization of (damaged) sperm in a heterologous oocyte-system; 
c) Study of DNA damage of human spermatozoa using the TdT-UTP-nick end 
labelling (TUNEL) and the Comet assay.  
The above-mentioned parameters were proposed to be studied in correlation to 
physiological parameters of sperm: morphology and motility. 
Human epididymal sperm studies were confined to the University Medical Centre 
(UMC) Utrecht  (“b” and the Comet assay of “c”) and the UMC St Radboud 
Nijmegen (item “a” and TUNEL of “c”).  
 
¾ The restart of ICSI 
Because internationally more and more data became available regarding the 
safety for the offspring following ICSI with non-ejaculated sperm (Bonduelle et al., 
1999; Wennerholm et al., 2000; Palermo et al., 1999; Bonduelle et al., 2002b) and it was 
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supposed to be unethical to perform a epididymal sperm aspiration only for research 
purposes, a multicentre protocol concerning the ICSI procedure using epididymal 
sperm from azoospermic men was submitted and approved by the Central 
Committee on Research involving Human Subjects (CCMO). The clinical research 
entitled “Intracytoplasmic sperm injection with surgical retrieved sperm from men 
with obstructive azoospermia: a observational study with follow up of the children” 
implied not only the evaluation of fertilization rates, pregnancy rates and pregnancy 
outcome but also the psychomotor development of the children at the age of two and 
six years.  
At the end of 2000, the Ministry of VWS approved the request of the scientific 
boards of the associations of gynaecology (NVOG), embryology (KLEM) and urology 
(NVU) to restart the ICSI programme with the use of epididymal sperm for ICSI in 
the above-mentioned multicentre pilot study. 
 
 
3.2  Treatment of azoospermia: ICSI results around the world 
The introduction of the ICSI has changed the perspective of the treatment of 
azoospermic males. While in the past donor insemination and in a few cases IVF 
were the only treatment modalities offered to couples with this severe type of 
infertility, nowadays azoospermia does not have to be a barrier to conceive own 
progeny (Silber et al., 1995; Tournaye et al., 1997a). The encouraging results obtained 
with ICSI are one of the most important breakthroughs in the artificial fertilization 
and reproduction era. The extensive number of publications from fertility centres 
worldwide concerning the results of fertilization, pregnancy rates and children born 
from azoospermic males, has proven the efficiency of this technique (Patrizio et al., 
1995; Silber et al., 1995a; Rosenlund et al., 1997; Friedler et al., 1998; Dohle et al., 1998; 
Tournaye et al., 1999; Palermo et al., 1999; Cayan et al., 2001).  
However, the success rate is dependent on the cause of infertility. A recently 
published paper from the Brussels’ group (Vernaeve et al., 2003) report differences in 
the sperm retrieval and success rates of ICSI using testicular sperm from 
azoospermic men with severe spermatogenetic defects compared to sperm recovered 
from patients suffering from obstructive azoospermia. Testicular or epididymal 
sperm of obstructive azoospermic patients yield comparable results, testicular sperm 
of males suffering from impaired spermatogenesis result in significantly lower 
pregnancies rates (Schwarzer et al., 2003). Therefore, the underlying cause of 
azoospermia is an important predictor of the outcome of ICSI. 
Another point of consideration when talking about non-ejaculated sperm is the 
worldwide tendency of the use of testicular sperm irrespective the cause of 
azoospermia. Because a higher rate of DNA damage was found in epididymal sperm 
compared to testicular sperm (O'Connell et al., 2002), some authors, in spite of good 
fertilization and pregnancy rates with epididymal sperm, recommend the use of 
testicular sperm in all cases of azoospermia. 
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4. SCOPE OF THE THESIS 
 
4.1     Aim of the study 
The aim of the thesis is to characterize epididymal sperm of azoospermic 
patients retrieved by PESA in comparison with ejaculated spermatozoa of fertile men 
in order to make a statement about the safety of the use of epididymal sperm in ICSI. 
The validity of the clinical classification of different aetiologies of azoospermia, in 
particular of obstructive azoospermia, is evaluated in terms of spermatogenesis, 
sperm retrieval rates and other clinical characteristics. The risks for the offspring of 
injecting immature, aged, damaged or dead spermatozoa is analysed by studying 
external cellular characteristics such as sperm morphology and nuclear 
characteristics such as chromatin condensation and DNA damage. In order to 
estimate the potential risks for children conceived through ICSI with epididymal 
sperm, these observations were controlled by selecting under the ICSI microscope 
only epididymal sperm that fulfils the selection criteria of motility and morphology 
used for standard ICSI.  
 
 
4.2    Outline of the thesis 
This study consists of three main parts:  
 
¾ PART I  
Azoospermia: characterization of the study population 
It is difficult to define completed spermatogenesis on basis of clinical 
parameters in azoospermic males. In Chapter 2 the clinical characteristics of 
azoospermic patients included in our study are given. The presence of sperm in the 
epididymis as well as the clinical and biochemical parameters were evaluated in 
relation to the aetiology of azoospermia. Epididymal sperm samples from these 
patients were used for other studies described in this thesis. 
 
 
¾ PART II 
The pre-clinical studies  
To study different sperm parameters, techniques have been adapted or set up in 
ejaculated spermatozoa. This section includes the evaluation, adaptation and 
validation of the techniques later used for the study of epididymal spermatozoa.  
Chapter 3: The external features of sperm cells after staining the cells with Feulgen are 
evaluated with the computerized karyometric image analysis (CKIA). The 
evaluation of this method for the objective characterization of spermatozoa is 
presented. 
Chapter 4: Chromatin of human spermatozoa shows high rates of heterogeneity. This 
section analyses whether this finding is due to the incomplete protamination 
and/or deficiency in the condensation of spermatozoa. Evaluation of both 
abnormalities is carried out with specific fluorochromes and flow cytometry 
(FACS). Sorted sperm populations are evaluated for the DNA damage rates with 
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TdT-UTP nick end labelling (TUNEL) and for chromatin condensation 
characteristics with a monoclonal antibody against double-strand DNA. 
Chapter 5: Nuclear damage and DNA breaks are probably induced by the presence of 
reactive oxygen species (ROS) in the epididymis, produced by cell breakdown. 
Effects of ROS in spermatozoa are studied in vitro to mimic the situation in the 
obstructed epididymis. DNA damage rates are determined with TUNEL.  
 
¾ PART III 
The clinical studies  
This section evaluates epididymal sperm of azoospermic patients with the 
techniques used in the Part II of the thesis and the clinical results of the ICSI with 
non-ejaculated sperm. 
Chapter 6: Morphology as selection criteria for the identification of normal 
spermatozoa is evaluated with the CKIA. Epididymal sperm of azoospermic 
patients is compared to ejaculated sperm from fertile donors. After selecting 
sperm from both patients and donors following the ICSI criteria (motile sperm 
and normal morphology at 400 x magnification), the difference between the cell 
populations is analysed.  
Chapter 7: Chromatin condensation and DNA damage of epididymal spermatozoa is 
studied regarding the different aetiologies of obstructive azoospermia and it is 
compared to ejaculated sperm of normospermic donors. 
Chapter 8: The motility of spermatozoa as a selection criterion for identification of 
intact DNA is evaluated with the TUNEL assay. DNA damage of epididymal and 
ejaculated sperm is measured in the total cell population as well as after following 
selection of motile sperm using the ICSI criteria.  
Chapter 9: The results of the ICSI procedures (fertilization, pregnancy rates and birth 
outcome) carried out with epididymal (and testicular) sperm of patients with 
obstructive azoospermia in the period before the moratorium are presented.  
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ABSTRACT 
Objective: The diagnosis of obstructive azoospermia (OA) is mostly based on 
medical history, physical examination and biochemical markers. However, the most 
accurate parameter is testicular histology. To avoid such an invasive procedure, the 
predictive value of the percutaneous-epididymal-sperm-aspiration (PESA) was 
investigated for the identification of a completed spermatogenesis (Johnsen Score 
≥8). Furthermore, we assessed the accuracy of FSH, inhibin-B and testicular volume 
to predict completed spermatogenesis in OA. 
Methods: Specificity and sensitivity of FSH, inhibin-B, LH, testosterone, testicular 
volume, testicular histology and a epididymal outcome was evaluated in 147 
azoospermic males with clinical suspicion of obstruction.  
Results: PESA showed the highest sensitivity and specificity to predict a Johnsen 
score ≥8 (93% and 94% respectively) compared with FSH (90% and 19%), inhibin-B 
(88% and 57%) and testicular volume (95% and 45%). Clinical and biochemical 
parameters presented different patterns per aetiology group of obstruction.  
Conclusions: The presence of sperm in the epididymis correlates with the clinical 
diagnosis of obstructive azoospermia. It is the most accurate parameter to predict a 
completed spermatogenesis (Johnsen score ≥8) compared with clinical or biochemical 
parameters. Between OA patients, large variation and differences in the clinical 
presentations and biochemical parameters were observed.  
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INTRODUCTION 
  
 Azoospermia is no longer an obstacle for men to father their own genetic 
progeny. Using the intracytoplasmic sperm injection (ICSI) technology, surgically 
retrieved sperm from the epididymis or testicle can successfully fertilize oocytes and 
achieve pregnancies (Silber et al., 1995a). However, it is still uncertain which risks are 
implicated for the offspring when non-ejaculated sperm is used for fertilization 
(Dohle et al., 2002). Therefore, in the period between 1996 and 2001, the Dutch 
healthcare authorities imposed a moratorium for all fertility treatments using non-
ejaculated sperm until more knowledge was available about the implications for the 
offspring. Supported by the results of the follow up studies of children born after 
using non-ejaculated spermatozoa for ICSI (Bonduelle et al., 1999), together with the 
results obtained from our previous research on DNA damage (Ramos et al., 2002b), 
ICSI in combination with epididymal sperm is again allowed in the Netherlands. The 
inclusion criteria for the treatment of azoospermic males in this ICSI programme are: 
1) the use of epididymal sperm, 2) obstructive azoospermia and 3) long-term follow-
up of children born after this procedure.  
Traditionally, azoospermia is classified as “obstructive” or “non-obstructive” 
(Foresta et al., 1995a; Silber et al., 1995b; Sharif 2000; Ezeh et al., 2001). Obstructive 
azoospermia (OA) is characterised by an obstruction of the efferent tract (the 
Wolffian system) and normal spermatogenesis; differentiated spermatozoa can be 
found in the lumen of the testicular tubules and in the epididymis. The aetiology of 
the obstruction may have a primary (e.g. unknown), a genetic (e.g. congenital 
bilateral absence of the vas deferens, CBAVD) or an acquired origin (e.g. post-
vasectomy). Non-obstructive azoospermia (NOA) is characterized by different 
degrees of impaired spermatogenesis on histopathologic examination. Depending on 
the relative and absolute numbers of the different cell types, the lesion can be further 
classified. Typical for this condition is the heterogeneous spermatogenesis with foci 
showing different histological patterns in the different tubules (Turek et al., 2000). 
Spermatozoa may sporadically be observed in the ejaculates of these patients. The 
aetiology of NOA is often unclear, though, a higher prevalence of genetic 
abnormalities (other than mutations in the CFTR gene) is found in these patients 
(Van Assche et al., 1996; Bernardini et al., 2000; Yogev et al., 2000; Levron et al., 2001; 
Dohle et al., 2002). Based on the evidence that NOA has higher genetic risks to the 
offspring, we restricted our patient treatment population to the obstructed cases and 
sought to find parameters to predict obstruction. 
In most fertility centres, the differentiation between OA and NOA is based on 
clinical features such as medical history, physical examination, FSH and recently 
inhibin-B. However, their accuracy is relatively poor (Pierik et al., 1998; Foresta et al., 
1999; Ballesca et al., 2000; Brugo-Olmedo et al., 2001; Seo et al., 2001; Vernaeve et al., 
2002) compared with the testicular histology and, its use is limited due to the 
invasiveness of the biopsy, inconsistency of histopathologic classifications and the 
heterogeneity of spermatogenesis in the testis.  
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We assessed the accuracy of current clinical parameters to diagnose a completed 
spermatogenesis (Johnsen Score ≥8) and evaluated the relation between the presence 
of epididymal sperm to testicular histology. Furthermore, the variation of clinical 
parameters in the different aetiologies of obstruction is presented.  
 
 
MATERIALS and METHODS  
 
Patients  
Between June 1999 and September 2002, 147 azoospermic males attending the 
Urology department with clinical suspicion of obstructive azoospermia, were 
included in this retrospective study. Patients with an obvious pattern of defective 
spermatogenesis (testes < 12ml and/or elevated FSH) were excluded from the 
percutaneous epididymal sperm aspiration (PESA). In our protocol, obstructive 
azoospermia (defined as a Johnsen Score [J-Score] ≥8 in the testicular biopsy) and the 
presence of (motile) spermatozoa in the epididymis (PESA +) were requisites for the 
inclusion of azoospermic patients in the ICSI programme.  
From all men, a medical history, a physiological examination, a testicular biopsy 
and an epididymal aspiration sample were obtained. Testicular volume was 
determined by one person (E.M.) with the method of the Prader chain (Behre et al., 
1989). Moreover, FSH, LH, testosterone and inhibin-B were measured. Patients with 
CBAVD were screened for mutations in the cystic fibrosis transmembrane 
conductance receptor (CFTR) and repeats of intron 8. 
According to the aetiology, patients were grouped as follows: post-vasectomy 
or failed vaso-vasostomy (FVV, n=47), CBAVD (n=38), azoospermia of unknown 
origin (n= 41) and other causes such as trauma, infection, genital surgery, testis 
tumour and chemotherapy, etc. (“other causes” n= 21).  
All patients signed an informed consent for participation in the study. The 
project was approved by the Ethic Committee of the University Medical Centre 
Nijmegen (UMCN, CMO) and the Dutch Central Committee for Research Involving 
Human Subjects (CCMO, The Hague).  
 
Hormone measurement 
Blood samples were centrifuged at 500 g for 10 minutes and serum was 
separated and stored at – 20 °C until processing. Follicular stimulating hormone 
(FSH) and luteinizing hormone (LH) were determined with the Fluorescence 
Immuno Enzymatic Assay (Abbott, USA) using the Random Access Analyser (Type 
AxSYM, Abbott) (reference range in our laboratory for FSH 1.5 – 11.0 IU/l and LH 
1.4 - 8.5 IU/l).  Testosterone was measured after extraction using the direct 
Radioimmuno Assay (reference value 11 – 45 nmol/l (Swinkels et al., 1988).  
Dimeric Inhibin-B was quantified using a solid phase sandwich enzyme-linked 
immunosorbent assay (ELISA) specific for the measurement of inhibin-B in human 
serum (Oxford Bio-Innovation Ltd, Oxford,UK). The assay was performed according 
to the manufacterer’s instructions. Sensitivity of the assay is estimated <15 pg/ml 
with high specificity (about 1% cross reaction with inhibin-A). 
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Epididymal samples  
Epididymal sperm samples were obtained by PESA (129 cases) or microsurgical 
epididymal sperm aspiration (MESA, 18 cases) together with a testicular biopsy. 
PESA was performed at the outpatient clinic of the Urology department under local 
anaesthesia (Tsirigotis et al., 1995).  In short, after a funiculus’s block and local scrotal 
anaesthesia, a 21 Gauge butterfly needle connected to a 5 ml syringe is inserted into 
the caput epididymis. By aspirating the syringe, vacuum is applied and the butterfly 
needle is slowly retracted until fluid is aspirated. The aspirate is transferred into a 
tube with 1 ml human tubal fluid medium complemented with 10% plasma proteins 
(GPO) (HTF, Cambrex, Bio Whittaker Europe, Belgium) and immediately examined 
for the presence of spermatozoa. Up to four aspirates per epididymis were obtained. 
After concentration of the epididymal samples, sperm count, motility and 
morphology (when possible) were assessed according the WHO criteria (WHO 1999). 
Whenever sufficient motile epididymal sperm was retrieved, samples were 
cryopreserved for later use for ICSI.  
 
Testicular biopsies 
From all patients, a testicular biopsy of the size of a grain of rice was obtained 
from the site where epididymal sperm was found or from the largest testicle when no 
sperm was observed at PESA. In practice, the biopsy was divided over two aliquots: 
one aliquot was fixed in Bouin’s fluid and processed for routine histology at the 
Pathology department. Tissue sections of 5 µm were stained with Haematoxylin-
eosin and an elastine stain according to van Gieson. The evaluation of the following 
criteria were included in the histopathologic examination: 1) number and mean 
seminiferous tubular diameter; 2) distribution of the lesion (focal or diffuse); and 3) 
quantitative score according to Johnsen (Johnsen 1970). The histopathology 
evaluation was performed by one experienced pathologist (HvdK) without previous 
knowledge of the patient’s history.  
The other aliquot was conserved in HTF-GPO medium and processed at the 
Fertility laboratory: the testicular tissue was minced between a pair of glass slides 
into fine tubular fragments with single (loose) cells and checked in a wet preparation 
(wet-prep) for the presence/absence of spermatozoa at a 200x magnification. 
 
Statistical Methods 
For the purpose of the statistical analysis, categorical variables were constructed 
from the clinical measurements. One was based on the Johnsen Score, one was based 
on the PESA outcome and location where spermatozoa were retrieved and one was 
based on the aetiology of azoospermia. We considered a J-Score ≥ 8 as indicative for 
the presence of a completed/ normal spermatogenesis (i.e. presence of maturated 
testicular spermatozoa); abnormal spermatogenesis was defined for a mean J-Score 
<8. For the evaluation of PESA as a diagnostic tool to replace the testicular biopsy, 
only the presence or absence of spermatozoa in epididymis was recorded in the 
statistical analysis. Furthermore, patients were categorised by the location where 
sperm was recovered in three groups: (1) presence of sperm in epididymis (PESA +), 
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(2) the presence of testicular sperm in cases of a negative PESA (PESA (-)/ testis (+)) 
and (3) complete absence of sperm (no sperm, testis -). Finally, patients were 
categorised by the clinical diagnosis of azoospermia: post vasectomy/FVV, CBAVD, 
unknown and other causes.  
Prior to statistical analysis, age, clinical and biochemical parameters were 
logarithmic transformed in order to stabilize variances. The T-test was used to test 
differences between two groups for statistical significance. The median and range of 
untransformed data in each group are presented. In case of more than two groups, 
one-way analysis of variance (ANOVA) was used with the corresponding Tukey 
contrast test. The dependent variable was each parameter, separately. The 
independent class variable was one of the specific categorical variables in question 
(PESA outcome and aetiology of azoospermia, respectively). P values <0.05 were 
considered statistical significant. Data was analysed using the SPSS 11.1 software 
package (SPSS Inc., Chicago IL, USA).  
  
 
RESULTS 
 
Johnsen Score vs. Percutaneous Epididymal Sperm Aspiration  
Analysis of sensitivity and specificity of PESA and clinical parameters for 
predicting a J-Score≥8 is presented in Table 1. For PESA, sensitivity (93%) is 
calculated as the percentage of [JS ≥8 and PESA(+)] patients relative to total patients 
with completed spermatogenesis [JS≥8]. Specificity (94%) is the percentage [JS<8 and 
PESA (-)] patients, based on the total number of patients with abnormal 
spermatogenesis of [JS<8]. Furthermore, the positive predictive value calculated for 
PESA was 99.1% (120 out of 121), while the negative predictive value calculated was 
65.4% (17 out of 26). The high positive predictive value of PESA(+) is indicative for a 
high discriminatory power for completed spermatogenesis.  
 
Table 1: Specificity and sensitivity of a positive PESA, FSH, Inhibin-B and testicular 
volume to predict completed spermatogenesis (Johnsen score >8) 
 
Parameter Sensitivity Specificity 
PESA(+) 93% 94% 
FSH (< 11IU/ml)* 90% 19% 
Inhibin-B (>80 pg/ml)* 88% 57% 
Volume of testis (>15ml)* 95% 45% 
* Cut-off values used for the calculation 
 
The box plot in Figure 1 presents the J-Score related to PESA and location where 
sperm was obtained. In 11 out of 26 negative PESA’s, testicular sperm was found in 
the wet-prep (testis +). No statistical difference was found between FSH and inhibin-
B level of PESA(+) vs. PESA (-)/testis(+) patients. However, the mean J-Score in the 
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PESA(-)/testis (+) group was statistically lower than in PESA(+) biopsies (8.44 ± 0.78 
vs. 9.15 ± 0.39, P=0.01). The distribution of the 11 patients with only testicular sperm 
was: one post- vasectomy patient (FSH = 21.9 IU/ml, inhibin-B = 32 pg/ml, J-Score= 
7.6), three CBAVD patients, five idiopathic and two patients with the aetiology 
“other causes”.   
 
 
 
Figure 1: The box-plots of the Johnsen Score by the location of retrieved sperm [PESA(+),  sperm in the 
epididymis; PESA (-)/testis(+), sperm only in the testis; no sperm, total absence of sperm in the wet-
prep] 
 
 
PESA vs. clinical and biochemical parameters 
The median values of the clinical and biochemical parameters as well as the 
number of patients per aetiology, related to the PESA outcome, are presented in 
Table 2a and 2b. The difference found for patient age is a consequence of the 
distribution of post-vasectomy patients (all but one in the PESA(+) category). 
Inhibin-B and testicular volume were strongly related to the PESA(+) (P<0.001 for 
inhibin-B and P=0.002 for testicular volume). FSH, LH and testosterone have no 
discriminatory prognostic value in prognosis to find sperm at PESA. The aetiology of 
azoospermia was also highly related to the PESA outcome, especially for post-
vasectomy and CBAVD patients (97.9% and 92.1% of these men had a PESA(+), 
respectively, Table 2b). Also in these groups, sporadic cases of PESA(-) and J-Score < 
8 were observed. Classifications such as “unknown” or “other causes” hide a 
heterogeneous group of patients, but still in more than 58% of these cases a positive 
PESA was assessed. In these two groups, inhibin-B and testicular volume was found 
to have a good predictive value for PESA(+) in the “other causes” patients, (P=0.03 
and P=0.003 for inhibin-B and testicular volume respectively, data not shown) but 
not for the unknown aetiology.   
1511121 
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no spermPESA (-)/testis(+)PESA (+) 
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Table 2a: The median (range) of the clinical and biochemical parameters in 
azoospermic patients with positive and negative percutaneous epididymal sperm 
aspiration (PESA) 
 PESA(+) 
N=121 
PESA(-) 
N=26 
N P 
 
FSH (IU/l) 
 
4.8 
(1.3-18.4) 
7.2 
(0.2-37.4) 141 0.127 
Inhibin-B (pg/ml) 128 (15-287) 
99 
(<15-205) 132 < 0.001 
 
LH (IU/l) 
 
3.0 
(0.8-17.0) 
 
3.1 
(0.2-15.2) 138 0.769 
Testosteron (nmol/l) 
15.0 
(3.3-60.0) 
 
16.0 
(6.4-36.0) 140 0.919 
Volume of testis* (ml) 20.0 (12-28) 
 
18.0 
(12-25) 
138 0.002 
*Volume of the testis where the testis biopsy was taken. 
P value for the difference between patient with a PESA(+) and PESA(-) using the T-test of logarithmic 
transformed parameters 
 
 
 
Table 2b: Number and percentages of positive and negative PESA by the aetiology of 
azoospermia  
Aetiology of azoospermia N PESA(+) PESA(-) P 
Post vasectomy 47 98% 2% 
CBAVD* 38 92% 8% 
Unknown 41 58% 42% 
Other causes: 21 76% 24% 
 
 
 <0.001 
Genital surgery 5 60% 40% 
Trauma/infection 5 100% - 
Tumour-chemotherapy 4 75% 25% 
Varicocele, others, etc. 7 71% 28% 
 
 0.498 
P value for the difference between patients with a PESA(+) and PESA(-) using the χ2-test 
*CBAVD: congenital bilateral absence of the vas deferens  
 
 
Characteristics of the different aetiologies of obstructive azoospermia 
After selecting those patients with a J-Score ≥8, the clinical and biochemical 
parameters were evaluated in relation to the aetiology of the obstruction (Table 3). 
Although all these patients showed a completed spermatogenesis, statistical 
differences were found for FSH, inhibin-B, LH and testicular volume between the 
aetiologies of azoospermia. The highest FSH with the lowest inhibin-B levels were 
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found in the “other causes”, in spite of a positive PESA in all but two cases. Although 
not significant, statistical analysis showed a tendency for a lower testicular volume in 
CBAVD men (P= 0.08) compared with other categories. 
 
Table 3: Median (range) of clinical and biochemical parameters related to a positive 
finding of sperm in the epididymis per aetiology of obstruction 
 Post-vasectomy 
n=46 
CBAVD 
n=35 
Unknown 
n=24 
Other causes 
n=16 
Age (years) 45.7
 a 
(35-60) 
33.6 b 
(25-46) 
35.1 b 
(30-49) 
36.3 b 
(28-43) 
 
FSH (IU/l) 5.0
 b 
(1.5-18.4) 
5.0 b 
(1.3-15.0) 
3.3 b 
(1.6-12.0) 
7.2 a 
(2.7-18.1) 
 
Inhibin-B (pg/ml) 130
 b 
(40-281) 
133 b 
(60-222) 
143 b 
(33-287) 
106 a 
(15-167) 
 
LH (IU/l) 3.1
 a 
(0.8-11.6) 
3.1 a 
(1.5-17.0) 
2.9 a 
(1.0-5.3) 
4.9 a 
(1.3-9.4) 
 
Testosteron (nmol/l) 15.0
 a 
6.6-27.0) 
14.0 a 
(3.3-60.0) 
15.0 a 
(8.1-27.0) 
15.0 a 
(9.3-27.6) 
 
Volume testis (ml) 20
 a,b 
(15-28) 
20 a 
(12-25) 
20 b 
(18-25) 
20 a,b 
(15-22) 
 
a, b different letter indicate statistically significant differences between the aetiology groups. 
Interpretation of the significances is as follows: e.g. for FSH concentrations, the group “other causes” 
is significant different from the rest of the groups; post-vasectomy, CBAVD and unknown are not 
different between each other. 
 P<0.05, ANOVA-Tukey contrast test after logarithmic transformation of the parameter.  
 
 
DISCUSSION 
 
In an attempt to simplify the differential diagnosis of azoospermia, we assessed 
the predictive value of the presence of sperm in the epididymis (PESA+) for 
completed spermatogenesis (J-Score ≥ 8). We found that the presence of sperm in the 
epididymis is an accurate predictor of a completed spermatogenesis at testicular 
level (J-Score≥ 8). This finding did not come as a surprise, since on the one hand, the 
presence of mature spermatozoa in the testicular tubules automatically results in 
their presence in the head of the epididymis, unless an obstruction at the level of the 
rete testis or tubuli efferent blocks their transport towards the epididymis. On the 
other hand, the testis may show foci with normal completed spermatogenesis site-to-
site to foci with incomplete maturation or Sertoli cells only (Johnsen 1970; Turek et 
al., 2000a). This may have been the case in patients labelled in this study as 
“unknown” or “other causes” such as testicular cancer, chemotherapy, varicocele, 
cryptorchidism etc. (Table 2b) who on clinical features would have been classified as 
non-obstructive. In these cases, the presence of mature sperm in the epididymis may 
be accompanied by a J-Score< 8. A similar phenomenon was observed in men with 
Chapter 2 
 36 
CBAVD, in whom testicular biopsies could show completed spermatogenesis and 
spermatogenetic defects site by site (Meng et al., 2001). 
Based on these findings we have abandoned the routine use of a testicular 
biopsy as a diagnostic procedure to select OA patients for ICSI and consider the 
presence of mature sperm in the epididymis sufficient prove of completed 
spermatogenesis. In our setting, PESA has several advantages over a testicular 
biopsy. Firstly, it is less invasive and less time consuming. Patients have less pain 
and discomfort during and following PESA. Another advantage is that 
cryopreservation of epididymal sperm yields better survival rates (about 60%, data 
not shown), reducing the need for repetitive procedures. Finally, in contrast to 
testicular sperm extraction, PESA is not dependent on the area of the puncture 
(Tournaye et al., 1997b; Schulze et al., 1999), avoiding multiple punctures and 
diagnostic errors due to variation in sampling site. A possible disadvantage of PESA 
is epididymal fibrosis, reducing the chance of successful sperm retrieval in 
subsequent aspirations. This, however, is not our experience.  
In an attempt to improve the selection of men for the ICSI protocol we assessed 
the value of current clinical and biochemical parameters to predict the presence of 
mature sperm in the epididymis.  Table 2a shows that inhibin-B is a better predictor 
of the presence of mature sperm in the epididymis than FSH. This finding is 
confirmed in the literature in several subfertile male subpopulations (Pierik et al., 
2001; Gouveia-Brazao et al., 2003). Additionally, testicular volume appeared to be an 
accurate clinical marker for completed spermatogenesis, a fact that has already been 
described by Nieschlag et al. who showed an linear relationship between testicular 
volume and total sperm count in the ejaculate (Nieschlag et al., 2001). The aetiology 
of azoospermia emerged to be an important prognostic factor for the occurrence of 
sperm in the epididymis. However, in men with proven obstruction and presumable 
normal spermatogenesis such as following vasectomy with proven fertility, a 
negative PESA and impaired spermatogenesis might be sporadically encountered 
(Table 2b).  This finding may have several causes, the most important being the 
potential negative impact of vasectomy on spermatogenesis or fibrosis following 
epididymal blow-out (Jarow et al., 1994; Matsuda et al., 1996; Inaba et al., 1998). Also 
to consider is the possibility that men who fathered children in a previous 
relationship were subfertile already at the time of conception or the unknowledge 
whether the offspring in the previous relationship was their own progeny. 
We observed a tendency towards a lower testicular volume in the CBAVD men 
as compared to men post-vasectomy (P = 0.08), giving way to the speculation that, in 
analogy with animal experiments, an obstruction that occurs before maturation of the 
gonads results in a higher chance of impairment of spermatogenesis than following 
obstruction at adult age (Jegou et al., 1983; Aydos et al., 1998; Inaba et al., 1998).  
In conclusion, it is difficult to predict a completed spermatogenesis in 
azoospermic males based on the results of the clinical and biochemical parameters. 
The presence of sperm in the epididymis (PESA+) correlates with a completed 
spermatogenesis and is a reliable clinical marker for the diagnosis of obstruction in 
men with azoospermia. The current policy at our centre is to restrict the diagnostic 
testicular biopsy to those men with a negative sperm recovery with PESA.  
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ABSTRACT 
The objective of this study is to evaluate a computer image system for its ability 
to determine morphological and nuclear semen characteristics in an integral and 
reproducible way. Semen samples of 19 normospermic fertile donors were used to 
estimate preliminary cut-off values for spermatozoa and test the reproducibility of 
the system. Ten aliquots of one sample were used to investigate the sensitivity of the 
system for experimental conditions by exposure to different laboratory variables. 
Human spermatozoa were stained with Feulgen dye and analyzed under a 
magnification of 1000x. A panel of 21 parameters was measured for each sperm 
nucleus using the computerized karyometric image analysis system (CKIA). Eight 
parameters were found to be sensitive for the differentiating normal or abnormal 
human spermatozoa and cut-off values for each parameter were defined for the 
quantitative analysis. These 8 parameters were grouped into 3 categories, depending 
on their descriptive value: morphometry, DNA-condensation (stainability) and 
chromatin texture. Intrapatient and interpatient variabilities were tested by 
calculating the reliability coefficient of each of the eight parameters as well as for 
each category. The reliability coefficients were all > 70% (indicative of the suitability 
of the system to identify differences between spermatozoa). Intrapatient variability 
(SD) was 5%. Although it was not statistically significant, a variation of 10.9% in the 
measurements was found when the effects of experimental conditions were tested. 
We conclude that an objective description of the human sperm nucleus can be 
achieved with the CKIA, yielding high interpatient and intrapatient reliability 
coefficients (reproducibility), thereby adding a new tool for the quantification of 
normal sperm.  
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INTRODUCTION 
 
Determination of the male fertility status in the laboratory is mainly based on 
the routine semen analysis (ie, sperm count, motility and morphology). Except for 
morphology, this historic heritage has poor predictive value for male fertility status 
and fertilization outcome in in vitro fertilization (IVF) programs (Liu et al., 1992; 
Oehninger et al., 1995; Barratt et al., 1995; Menkveld et al., 2001). Determination of 
sperm morphology requires high standardization to reduce interlaboratory and 
intralaboratory results (Cooper et al., 1992; Cooper et al., 1999). However, great 
variability in morphology assessment occurs despite the many quality control 
programs in use around the world (Neuwinger et al., 1990). The development of a 
system, that can eliminate bias and subjectivity and increase reproducibility between 
observers has been a matter of interest in human andrology as well as in animal 
breeding programs for a long time (Moruzzi et al., 1988; Sailer et al., 1996). In an 
attempt to reduce the subjectivity in assessing human sperm head morphology, a 
number of semiautomated computer analysis systems have been developed in the 
last decades (Moruzzi et al., 1988; Kruger et al., 1995; Garrett et al., 1995; Sailer et al., 
1996). These systems have not gained great use in routine analysis of semen samples 
in fertility centres. This lack of success is probably due to the high degree of 
standardization and investment of labour needed. 
In our centre, computerized karyometric image analysis (CKIA) has been 
successfully applied in pathology for many years, especially in the field of urological 
oncology (van der Poel et al., 1990; van der Poel et al., 1991; van der Poel et al., 1992). 
We have adapted this system for characterizing (qualitative evaluation) and 
quantifying human spermatozoa. For this purpose, we first defined the normal 
karyometric values, then evaluated the reproducibility of CKIA and, finally, we 
determined the influence of laboratory variables (experimental factors) on the results. 
 
 
MATERIALS and METHODS 
 
Semen samples and controls 
A total of 19 cryopreserved samples of normospermic fertile donors evaluated 
by World Health Organization (WHO, 1999) criteria were used in this study, except 
for one fresh sample, which was used to test experimental conditions. Semen 
samples were washed twice in human tubal fluid medium (HTF, Bio Whittaker 
Europe, Belgium) supplemented with 10% (v/v) human plasma solution (CLB, 
Amsterdam, The Netherlands(Quinn et al., 1985)) in order to remove seminal plasma 
and reduce background staining. Cryopreserved bull spermatozoa (from a fertile 
specimen) were used as controls and to calibration the system (see below). Fixation 
and staining of human samples and bull controls were carried out simultaneously. 
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Fixation and Feulgen stain 
All chemicals were provided by Merck (Darmstadt, Germany) unless otherwise 
indicated. One droplet of washed semen sample was placed on a glass slide and left 
to dry. The cells were pre-fixed with standard methods in one part of 100% 
Carbowax (2% polyethylenglycol, molecular weight 1500 in 50% ethanol) and one 
part of physiological saline solution (0.9% NaCl) at 4ºC during 3 days. Thereafter, the 
samples were fixed one additional day with 100% Carbowax at 4ºC. Before staining, 
slides were immersed in Böhm solution (10% formaldehyde [37%], 5% glacial acetic 
acid, 85% absolute ethanol). The fixed slides were stained with Feulgen-Schiff stain 
(hydrolysis in 5 N HCl for 60 minutes and 30 minutes in Schiff-reagent at room 
temperature). Cells were mounted in Permount (Fischer Scientific, Fairlawn, NJ, 
USA). At least 100 spermatozoa per sample were recorded for analysis. 
 
Study design 
To study the reproducibility and accuracy of CKIA for determining of semen 
characteristics, duplicates of 19 samples were stained and evaluated at different 
moments. CKIA was performed on 100 to 120 cells per slide.  
To study the influence of experimental conditions (laboratory variables) on the 
measurements, different aliquots of 1 sample (fresh and cryopreserved) were used. 
Four experimental conditions were analysed against a standard condition. We 
defined the standard condition for fresh semen as pre-fixation in freshly made 
fixative at 4 °C during 3 days. While keeping the rest of the variables unchanged, we 
tested the effect of the following conditions in the CKIA: 1) cryopreserved semen, 2) 
prefixation at room temperature, 3) prefixation in 6-month-old fixative, or 4) 
extended prefixation for 10 days. As a result 5 x 2 (= duplicates) = 10 aliquots were 
used for the analysis.  
 
Calibration of the system 
Control of the stain intensity and calibration of the microscope light is crucial 
for CKIA. Therefore, light calibration of the system with a nucleus with constant 
staining intensity before measurements is required. For this purpose, bull 
spermatozoa were used and stained together with the rest of the samples. The 
advantage of bull spermatozoa is the low rate of variation in the DNA condensation 
in the fertile animals (more than 90% shows normal condensation, (Dobrinski et al., 
1994). 
 
Computerized Karyometric Image Analysis  
This technique, which is routinely used at the Nijmegen Urology Department 
for karyometric analysis of bladder tumours (van der Poel et al., 1990), has been 
applied to sperm head morphology. Cytomorphological measurements were made 
using a microscope connected to a CCD-video camera  (Vision Technology, 
Eindhoven, The Netherlands). The system consists of a frame grabber board  (VFG 
frame grabber, Image Technology, Woburn, Mass) connected to a personal computer 
(van der Poel et al., 1992). Using a 1000x magnification, images of 512 x 512 pixels 
were captured, digitized and stored in the computer before analysis. The images 
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were corrected for background and shading and filtered before applying local 
segmentation. Each cell image is then processed independently from the images of 
other cells. The nuclear boundary is delineated and separated from the background. 
The nuclei were automatically analyzed and numbered, enabling “post-analysis” 
verification of the objects. After computer analysis, each detected nucleus was 
visually screened and artifacts or faulty segmented nuclei were eliminated. The time 
required to perform the analysis is about 1 minute per field; the complete procedure 
takes no more than 15 to 30 minutes per sample, depending on the sperm 
concentration. 
The karyometric parameters recorded for each cell were grouped into three 
categories: 1) morphometric parameters that describe size and shape of the nucleus; 
2) densitometric parameters that are related to staining intensity (DNA 
condensation), and 3) chromatin texture parameters that quantify stain distribution 
patterns. The code and description of all karyometric parameters measured are 
presented in Table 1.  
 
Determination of cut-off values and definition of normal karyometry 
In the first phase of the study, preliminary cut-off ranges for each nuclear 
parameter were calculated. These were based on the means ± 2SD values of a total of 
483 randomly selected sperm cells from 10 fertile normospermic donors. Comparing 
these values to those of other cell types (data not shown), we found that 14 out of 21 
parameters were appropriate for the identification of human spermatozoa (the + and 
++ categories in Table 1). We choose only 8 parameters (++) grouped in the 
aforementioned 3 categories, for further CKIA evaluation.  
In a second phase of the study, the determination of the cut-off ranges for 
“normal” head morphology was carried out by analyzing 160 spermatozoa that were 
visually selected according to their conformation to WHO (1999) criteria. The mean ± 
SD values derived from this population were used as cut-off values to define the 
normal human sperm nucleus. Also, 430 visually selected abnormal sperm were 
analyzed and evaluated for differences compared to the normal or unselected sperm 
population. For the quantification of normal forms, we applied the following 
criterion: whenever the measured value of a parameter suits the defined normal 
range of that parameter, the cell is classified as normal for that specific parameter. 
Thus, the classification of normal sperm heads (for each category) is based on the 
combination of normal ranges for all parameters in that category. The combination of 
normal values for the 3 categories results in a quantitative value for that sample (total 
normal karyometry). 
 
 
Statistical methods 
Reproducibility of each CKIA parameters was evaluated using a one-way 
analysis of variance (ANOVA) with patients considered as a random effect. The 
validity of the parameters is measured by the reliability coefficient and computed for 
interpatient and intrapatient variability. Reliability coefficients ≥70% are considered 
suitable for the characterization of human spermatozoa and discrimination between 
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samples. Also, differences between experimental factors in measurements were 
tested for statistical significance using one-way ANOVA. The experimental 
conditions were analyzed as independent variables and the mean of each parameter 
were analyzed separately as a dependent variable. The estimated mean square error 
(MSE) between slides (samples) and standard errors are presented.  P< 0.05 was 
considered statistically significant. Calculations were performed using the Statistical 
Analysis System computer program (SAS, SAS Institute Inc, Cary, NC, USA). 
 
 
RESULTS 
 
Selection of parameters, definition of normal values for human spermatozoa, and 
evaluation of suitability for differentiation between samples  
 The total panel of karyometric parameters and its suitability for analysis of 
human sperm is presented in Table 1. The mean and SD values of the selected 
parameters (++, except nuclear roundness factor, or fpe) were evaluated by 
comparing unselected, and visually selected normal and abnormal sperm heads 
(Table 2). Also, two examples of other cell types (bull sperm and human cumulus 
cells) are presented. When the quantitative analysis (percentage normal cells in each 
sample) was carried out, statistically significant differences were found for all groups 
(P< 0.01; Table 3). Differences between the unselected sperm cells (phase 1, see 
“Materials and Methods”) and abnormal sperm cells (phase 2) were found for the 
morphometry (57% vs. 17%, P<0.01). Also in these cell populations, the percentage of 
cells with total normal karyometry was statistically different (26% vs. 5% P <0.01). 
From the visually selected normal sperm heads, 76% were classified as normal by 
karyometry with CKIA (P<0.01 compared to unselected and abnormal sperm 
populations).  
 
Reproducibility of the karyometric measurements (quantitative analysis) 
An average of 127 randomly selected spermatozoa were analyzed in duplicates 
for each of the 19 semen samples. The relationship between the duplicates is 
presented in Figure 1. The intrapatient variability was calculated in order to validate 
the discrimination capacity of CKIA between normal and abnormal cells. The SD 
within donors was 5% for the percentage of sperm with normal karyometry as 
determined by CKIA (see Table 4) whereas the interpatient variability (SD between 
donors) was 10.7%. The reliability coefficients for each parameter are also presented 
in Table 4.Reliability coefficients >70% are by definition considered good (suitable) 
for differentiation between spermatozoa (normal/abnormal) and between samples 
(patients).  
 
Assessment of the influence of experimental conditions on CKIA 
Evaluation of the influence of some laboratory variables in CKIA measurements 
is shown in Table 5. MSE values indicate that the differences in the qualitative 
analysis are within the range of clinical relevance. The differences found cannot be 
related to one specific experimental condition. Although not significant for the 
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quantitative analysis, a MSE= 10.9% for the influence of experimental factors 
suggests that some conditions are likely to influence the determination.  
 
Table 1: Suitability of nuclear measurements of CKIA for sperm head analysis, 
grouped by category. 
Category Code Description of the parameter Suitable 
area* Nuclear area in µm2 ++♦ 
perimeter Nuclear perimeter (in µm) + 
fpe Nuclear roundness factor =(4π x area)/ perimeter2 ++ 
maxd Maximal diameter of the nucleus +/- 
fell* Elliptic factor (minimum/maximum diameter) ++ 
posX / Y Position of the nucleus in the screen - 
ben* Bending energy (difference between highest and lowest value in the smooth Freeman difference chain code (SFDC)) ++ 
nmac* Nominal mean curvature; factor derived from the SFDC ++ 
thre Threshold value from the form factors, derived from the SFDC + 
diss Distance between the values of the threshold limits - 
pass Number of times the threshold values has been passed +/- 
Morphometric 
parameters 
(size and shape 
of cells) 
form1 Total bending energy of the SFDC - 
od* Optical density (stainability of the cell) ++ 
iod Integrated optical density (area x od) + 
varod* Mean variation of the od of the nucleus ++ 
Densitometric 
parameters  
(DNA 
condensation) 
cvod Mean coefficient of variation of the od + 
meanhis* Mean grey value of the line of the maximal diameter ++ 
sdhis Mean standard deviation of the grey values of the line of maximal diameter + 
cvhis* Mean coefficient of variation of sdhis ++ 
scathis Mean scatter of grey values in the line of the diameter +/- 
Chromatin 
texture 
parameters  
(quantification 
of the DNA 
distribution 
patterns) 
edghis Mean gray value of the nuclear edge +/- 
Note: * parameters used later for the quantitative analysis. ♦ - indicates not suitable; +/-, poor 
suitable; ++, very suitable. 
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Table 2: CKIA measurements for different cell populations (mean ± SD)  
  Categories / mean (± SD) 
  Morphometry DNA-condensation Chromatin texture 
Cell type* n area fell ben nmac od varod meanhis cvhis 
Unselected  483 6.43   
(0.77) 
0.61  
(0.09) 
1522 
(314) 
32.4  
(7.8) 
0.78  
(0.07) 
0.24  
(0.04) 
115   
(19) 
0.37  
(0.10) 
Selected 
normal  
160 6.87  
(0.65) 
0.63  
(0.05) 
1394 
(183) 
28.9  
(5.2) 
0.83  
(0.04) 
0.22  
(0.04) 
111  
(11) 
0.39   
(0.06) 
Selected 
abnorm.  
430 6.82  
(1.65) 
0.53  
(0.13) 
1914 
(499) 
39.3  
(8.9) 
0.79 
(0.08) 
0.25  
(0.05) 
 113  
(19) 
0.40   
(0.11) 
Bull sperm 487 18.0  
(1.7) 
0.44  
(0.03) 
1978 
(200) 
28.9  
(2.2) 
0.26  
(0.15) 
0.052  
(0.014) 
  190  
(8) 
0.051 
(0.01) 
Human 
cumulus cells 
140 25.6  
(7.1) 
0.75  
(0.09) 
1463 
(346) 
14.1   
(3.8) 
0.79  
(0.06) 
0.21  
(0.04) 
101  
(26) 
0.37  
(0.12) 
* Human spermatozoa unless mentioned otherwise. 
 
Table 3: Percentage of normal cells per category and total normal spermatozoa 
analysed with CKIA (based on defined cut-off ranges for normal human 
spermatozoa) 
Category /  
Type of sperm 
Morphometry DNA-
condensation 
Chromatin 
texture 
Total normal  
karyometry* 
Unselected (total sample) 57% 60% 53% 26% 
Selected normal 91% 91% 93% 76% 
Selected abnormal 17% 57% 52% 5% 
* To consider a cell “normal”, the same cell has to score normal after a combination of all three 
categories. All groups are significant different (P<0.01) 
 
Table 4:  Intra- and interpatient variability and reliability coefficients for 19 donors 
calculated for each individual parameter and per category 
Parameter/ category Mean SD within donors 
SD between 
donors 
Reliability 
coefficient 
area 7.01 0.299 0.502 73.7 % 
fell 0.62 0.007 0.043 97.6 % 
ben 1512 25.1 135.9 96.7 % 
nmac 30.6 0.86 2.35 88.3 % 
od 0.84 0.012 0.020 72.4% 
varod 0.21 0.011 0.018 68.5 % 
meanhis 103.4 3.95 6.24 71.4% 
cvhis 0.42 0.024 0.030 60.1% 
Normal morphometry (%) 51.9 4.2 9.8 84.1 
Normal DNA-condensation (%) 72.6 7.2 13.0 76.5 
Normal chromatin texture (%) 64.4 5.6 12.9 84.2 
Total normal karyometry (%) 31.4 5.0 10.7 82.2 
Reliability coefficients ≥70% are considered good for discrimination between normal and abnormal 
sperm cells and discrimination between samples. 
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Table 5: Mean CKIA values and percentage normal forms (quantitative CKIA) after 
exposing cells to different experimental factors  
Morphometry DNA-condensation 
Chromatin 
texture 
Categories/ 
Experimental 
factors* area fell ben nmac od var-od meanhis cvhis 
CKIA§
standard† 7.50 0.612 1481 29.01 0.823 0.23 110.0 0.400 49.2% 
cryo sperm 7.60 0.600 1512 29.92 0.838 0.22 106.8 0.402 42.0% 
old fixative 6.89 0.600 1506 31.19 0.836 0.22 105.4 0.406 61.0% 
room temp. 6.86 0.615 1439 30.38 0.814 0.23 116.8 0.358 41.3% 
long fixing 7.42 0.620 1446 28.69 0.821 0.23 112.0 0.379 52.0% 
MSE‡ 0.30 0.007 20 0.96 0.015 0.01 4.8 0.028 10.9% 
*All other conditions were kept standard; † Standard conditions: fresh washed semen, 3 days at 4 °C in 
50% freshly made Carbowax; ‡MSE: Mean Square Error (SD between slides); § Total normal 
karyometry per sample. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Repeatability of the CKIA measurements per category obtained from 19 samples analysed in 
duplicates (a vs. b). Repeatability of the duplicates for each category were r= 0.84, 0.76, 0.87 and 0.82 
for morphometry, DNA-condensation, chromatin texture and total normal karyometry respectively. 
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DISCUSSION 
 
The present study describes the application of CKIA for objective 
characterization of human sperm heads and quantification of normal forms. After 
staining semen samples with the Feulgen stain, the cells were digitized and each 
image was analyzed individually. For each nucleus a panel of morphometric, 
densitometric and chromatin texture parameters was determined. An important 
advantage of CKIA relies on recording imperceptible differences by the human eye 
in the distribution and intensity of the stain, and by identifying other differences in 
spermatozoa rather than morphology alone. Therefore, the present assumption that 
morphological normal spermatozoa are fertile may be not always be correct because 
other characteristics in the sperm nucleus may contribute to the fertility potential of 
human spermatozoa. Another benefit of CKIA is that objectivity and high 
reproducibility can be achieved. 
The need for assessing the fertility potential of spermatozoa has been a long-
term issue for andrologists. Until now, the percentage of sperm with normal 
morphology and the percentage of spermatozoa with a normal reaction to acid 
induced denaturation of DNA (using green/red acridine orange fluorescence) seem 
to be the most important predictive factors for fertilization rates in vitro (Liu et al., 
1992; Oehninger et al., 1995; Evenson et al., 1999). However, the accuracy of 
morphology determination in predicting fertilization failures in IVF programs is still 
poor. The deficiencies of morphology determination can be summarized as follows: 
1) the subjectivity of the determination of normal forms; 2) the reproducibility of the 
results and 3) little information about the DNA/chromatin condensation.  
Subjectivity by technicians in determining of normal forms is one of the most 
important biases in morphology determination in routine analysis; quality control 
programs still show large differences in results (Neuwinger et al., 1990; Kruger et al., 
1995; Cooper et al., 1999). In this respect, CKIA leads to an objective determination, 
although some items have to be kept in mind for its interpretation and use.  Selection 
of sperm cells for determination of normal cut-off ranges may carry some 
subjectivity. Selection of normal cells is mainly based on the shape (morphology), 
whereas differences in DNA stain or chromatin condensation are mostly 
imperceptible by the human eye, but can be detected by a computer. These features 
may explain the fact that, when manually selected normal spermatozoa are analyzed 
with CKIA, 76% rather 100% of sperm heads are classified as “normal”. This 
difference gives evidence that CKIA measurements are an integral analysis of the cell 
nucleus. Evaluation and verification of the defined normal karyometry for fertility 
must be performed in a larger population of fertile and infertile men (in study). 
We found that the reproducibility of the results within donors has a correlation 
of r=0.82, explaining r2= 68% of the variance, probably because the intradonor 
repeatability was evaluated by selecting independent samples and not the 
reproducibility of each individual cell. Still, high reliability coefficients were found 
for almost all parameters, indicating that the system can effectively discriminate 
between patients  (SD between donors = 10.7%) and is constant for each patient (inter 
patient SD = 5%). Only the parameter “cvhis” (Table 1) was found to be not very 
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relevant for our system and will probably be replaced in the future by “sdhis” 
(reliability coefficient 73%, data not shown).  
Although only 10 aliquots of one sample were used to study the influence of 
some experimental factors in the CKIA, we found that no factor by itself was critical 
for determining differences in measurements. In particular, the use of fresh or 
cryopreserved samples for the karyometric measurements did not show significant 
differences. This result was observed previously in a larger group of patients (data 
not shown). Although quantitative analysis for evaluation of experimental conditions 
showed differences in the results (10.9% individual variation among measurements), 
it was found not to be of statistically significance. This finding underlines the 
importance of the standardization of every step in the fixation and staining 
procedure in order to reduce the random effects in the measurements.  
Besides morphology, increasing evidence indicates that the condensation status 
of spermatozoa may play an important role in fertilization outcome in human and 
animal programs (Bito et al., 1999). Therefore it is necessary to assess those sperm 
defects that may explain low fertilization rates in some patients (Dobrinski et al., 
1994; Gravance et al., 1996; Evenson et al., 1999). Abnormal DNA condensation in 
spermatozoa can hardly be detected by the human eye with routine morphology 
stains. DNA-specific dyes such as Feulgen were found to correlate well with the 
chromatin structure assay  (SCSA) and have been used to assess chromatin 
condensation (Dobrinski et al., 1994; Dadoune 1995; Sailer et al., 1996). Feulgen stain 
(a stoichiometric dye) selectively binds to the aldehyde groups of the purines, 
allowing anomalies such as coarse or fine clumping of the nuclear material to be 
determined (Peluso et al., 1992). Also, Feulgen staining has revealed a higher 
percentage of heterogeneous DNA distribution in semen from infertile compared 
with fertile donors (Moruzzi et al., 1988; Sailer et al., 1996). 
One disadvantage of CKIA is the overestimation of some sperm populations by 
rejection of aberrant forms. The program automatically rejects incorrect images 
(which mostly do not correspond to that of spermatozoa). Therefore, very abnormal 
forms or spermatozoa that are too large spermatozoa (probably diploid or multiploid 
cells) are not always recognized as such and are automatically eliminated in analysis. 
This can lead to under-representation of some types of aberrant cells. Also, post 
control of the captured cells before data analysis must be done because the computer 
does not always discriminate unfocused cells or debris. Elimination of these images 
is necessary, although accounting for no more than 2% of the images. Another item 
to consider with CKIA is that when extra condensed, diploid or multiploid sperm 
cells are present in the sample, the optical density does not increase linearly with the 
cellular DNA content. Small increases in optical density may lead to incorrect 
interpretation of DNA content if the area is not taken into account. Therefore, 
monitoring the variability of the stain can be better achieved using cells with a 
constant morphology and stainability characteristics (in our case, bull spermatozoa) 
in order to eliminate stain variances. 
In conclusion, CKIA offers an objective and integral method for sperm head 
characterization with high reproducibility. Image analysis not only describes 
morphometric parameters of the cell but can also detect small differences in stain 
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intensity and distribution, which are related to changes in the DNA/chromatin 
condensation. Differences in DNA condensation may explain differences in 
fertilization potential of some spermatozoa. Still, validation for the diagnostic value 
of CKIA must be carried out before it can be used for clinical proposes. 
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ABSTRACT 
 
An experimental design was developed to reveal the biological significance of 
double strand  (ds)DNA fluorescence in human ejaculated sperm. Spermatozoa from 
a normospermic donor and a pooled sample from two teratospermic patients were 
sorted by FACS for high and low chromomycin A3 (CMA3) fluorescence, high and 
low free and total thiol levels (by monobromobismane (mBBr) fluorescence without 
and with DTT reduction of S-S bridges). Immunofluorescence (IF) with the dsDNA 
specific monoclonal antibody (mAb#36) was performed on sperm sorted fractions. 
From the same fractions, DNA damage was measured using the TUNEL assay. The 
mAb#36 produces a staining pattern in up to 80% and 95% of nuclei form the donor 
and patient phenotypes respectively. On average, nuclei from the patients are more 
heavily labelled. Staining patterns vary from the periphery to the whole nucleus, 
sometimes with distinct features. CMA3(+) selected nuclei show heavier staining 
with mAb#36.  Selection for free and total thiol groups does not have a pronounced 
effect on overall IF in both types of sorted sperm populations. In 67% of donor and 
52% of patient nuclei, a negative fluorescence band (band+) was seen in the post 
acrosomal region above the tail implantation fossa, which is regarded to be a normal 
chromatin condensation landmark. In the donor, occurrence of this band is increased 
in both CMA3(+) and mBBr(+) fractions, an effect not observed in the patient. 
TUNEL positivity increased when sperm were selected for CMA3(+), mBBr(-) and 
DTT-mBBr(-). In about 10% of nuclei, the mAb#36 shows a coiled axial structure 
through the whole malformed nucleus, likely representing the nuclear matrix. 
Combining the data of donor and patient shows sperm differentiation to be  much 
more error prone in infertile men, which leads to the large sperm heterogeneity 
found in teratospermia. Normally differentiated chromatin patterns are found 
however, though at a much smaller frequency.  
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INTRODUCTION 
 
Male sperm heterogeneity can be defined on many levels such as overall 
morphology, motility, nuclear characteristics, capacitation characteristics to name the 
best studied ones. Sperm heterogeneity also has a species-specific component. In the 
comparisons between mouse, bull and man for instance, man stands out as to be 
more variable in overall morphology, before and after exposure to detergents 
(Bedford et al., 1973). Both in man and in mouse, there is an inverse relationship 
between the sperm count and the morphology and motility variation observed. In the 
human the extreme condition is known as oligoastenoteratospermia (OAT 
syndrome). The biological significance of OAT has received more attention in the last 
years due to the application of intracytoplasmic sperm injection (ICSI) in human 
reproduction, which demands visual selection of “normal” looking sperm if available 
(chapter 6 and De Vos et al., (2003). 
When focussing on the nucleus, elongation halfway during spermiogenesis is 
accompanied by the transition of the nuclear chromatin from a nucleosome-based 
structure to a protamine-based structure (for a review, see Dadoune (2003), largely 
reducing the nuclear volume. Before and after this transition, the chromatin is 
organised in looped domains that at their bases are attached to the nuclear matrix 
(Ward et al., 1989a). In human and mouse, two species of protamines (PRM1 and 
PRM2) that effectively neutralize the negative charge of the DNA backbone, 
contribute to the compaction of chromatin. To this purpose, histones are exchanged 
for transition proteins 1 and 2 (TP1 and TP2), which are replaced by PRM 1 and 2. 
During this process, DNA nicking occurs (McPherson et al., 1993). When sperm is 
passing from the testis to the epididymis, a further compaction of nuclear structure is 
achieved by oxidation of the cysteine rich protamines. In mouse cauda epididymis, 
about 95% of SH groups are converted into -S-S- bridges (Pellicciari et al., 1983). In 
man an identical scenario is followed (Seligman et al., 1994), and most of the 
crosslinking occurs in the cauda as well (Saowaros et al., 1979). Protamine thiol 
oxidation has been linked to the stability of the DNA, yielding a shift from red to 
green Acridine Orange (AO) fluorescence in rodents and man after acetic 
acid/alcohol fixation (Kosower et al., 1992). A higher susceptibility to a shift from 
green to red AO fluorescence is indicative for a lower sperm quality, leading to 
correlations with in vivo fertility and fertility after ART (for a review, see Evenson et 
al., (2002). The replacement of histones by protamines is less complete in the human 
(85%, (Gatewood et al., 1987) compared with other mammals (Bench et al., 1996). 
Also, specific histone types are now found in human sperm (Zalensky et al., 2002), 
although chromatin structure of spermatozoa as a field of research only starts to 
develop.  
As OAT largely occurs in hypospermatogenesis or a combination of this 
condition with incomplete maturation arrest (Johnsen 1970; Levin 1979), there could 
be a cell density related aspect during spermiogenesis, which causes this condition. 
Moreover, epididymal sperm transport could also contribute to functional 
heterogeneity. In the human, epididymal sperm transport is reported to be very 
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variable, taking from 2 – 19 days, the longer periods occurring when sperm output 
form the testis is smaller (Johnson et al., 1988). This phenomenon likely contributes to 
the increase in sperm heterogeneity when the production of gametes decreases.   
In human compromised spermatogenesis, leading to OAT, some recent 
publications focus on incomplete chromatin remodelling as a characteristic of the 
condition. Steger et al., (2001) established that both PRM1 and 2 transcription is 
proportionally lacking in round spermatids, and related to the severity of the 
spermatogenic defect. However, the ratio of the frequencies for the two species per 
patient was on average not affected. In concordance with this finding, the fraction of 
elongating spermatids that were immunofluorescence (IF) positive for 
hyperacetylated histone 4 (H4) was decreased by a factor 0.6 – 0.75 in azoo- to 
oligospermic patients (Sonnack et al., 2002). A decrease in the amount of protamines 
in infertile men, measured by thiol fluorescence before and after treatment with 
dithiotreitol (DTT), was found earlier, but not linked to the genesis of the sperm 
nuclei (Rufas et al., 1991). Furthermore, sperm of infertile men is much more sensitive 
to DNase I, highlighting the role of uncompacted chromatin in infertility (Sakkas et 
al., 2002). 
Another aspect of sperm nuclear stability is the origin of DNA breaks. A 
correlation between the TdT-UTP-nick end labelling (TUNEL) score and the ratio of 
red/green AO fluorescence has been established in oligospermic men (Aravindan et 
al., 1997), whereas (Sun et al., 1997) found a negative correlation between the TUNEL 
outcome and the fertilization and embryo cleavage rate in IVF samples. TUNEL 
positivity in somatic cells is a marker for late apoptosis. It is not clear (see Sakkas et 
al., (2002), whether sperm do show a genuine apoptotic response, comparable to 
somatic cells. However, the finding by Shen et al. (2002) that Annexin V positive 
sperm can be both membrane intact (PI negative) and membrane damaged (PI 
positive), the latter fraction correlating with TUNEL positivity, argues for a genuine 
late apoptotic respons, contrary to incomplete healing of DNA breaks during 
chromatin remodelling as the origin of a TUNEL reaction (see Sakkas et al., (2002). 
Electronmicrographs of “apoptotic” sperm from infertile men show a disruption of 
nuclear structure by the formation of central vacuoles with the denser chromatin to 
the periphery of the nucleus (Baccetti et al., 1996).   
One approach to study sperm chromatin compaction is to measure the 
accessibility of the nucleus for DNA-specific fluorochromes that generally decreases 
during spermiogenesis and deposition in the vas deferens (Evenson et al., 1986). The 
use of Chromomycin A3 (CMA3) fluorescence, which is specific for CG rich DNA, as 
a parameter for sperm quality (Bianchi et al., 1993; Iranpour et al., 2000), originated 
from this principle. By transmission electronmicroscopy, Iranpour and co-workers 
were able to correlate CMA3 positivity with a more open chromatin structure, in 
contrary to the dark staining of the fully differentiated gametes. 
With the assumption that chromatin structure is the main variable, both within 
and between nuclei in the ejaculate, and between ejaculates from normospermic and 
oligospermic males, we focussed on this parameter. To achieve a better insight  into 
the relation between chromatin compaction parameters and TUNEL scores, we have 
sorted by FACS for high and low CMA3 fluorescence and for high and low free and 
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total thiol levels to quantify protamine behaviour. Subsequently, the fractions were 
stained with mouse monoclonal antibody mAb#36 that is specific for double 
stranded DNA. The TUNEL assay was run on the same fractions. 
A signal produced by this antibody would mean access of the antibody to the 
DNA, implicating a more open chromatin structure. In order to prevent any effects 
on the nuclear structure by cell flattening during preparation (drying-down the 
spermatozoa on glass), we made use of the properties of the fibrinogen thrombin 
interaction to embed the spermatozoa in a fibrin clot on glass, preserving their 3-
dimensional characteristics.  
The hierarchy of sperm anti-DNA IF patterns relative to CMA3 stainability, 
protamine status and TUNEL sensitivity will be discussed.  
 
 
MATERIALS and METHODS 
 
Outline of the experimental protocol 
From both donor and patients, sperm was prepared for FACS analysis in five 
different ways: without staining (1), stained with CMA3 (2), stained with mBBr (3), 
double stained with CMA3 and mBBr (4), and stained with mBBr after reduction of 
S-S bridges by dithiotreitol (DTT, 5). Before FACS analysis, and before and after 
staining, samples were characterised for excessive DNA damage by TUNEL analysis. 
This analysis was repeated after passage through the FACS for the unstained sample 
(gated in A, see Fig. 2) and for the CMA3, mBBr and DTT-mBBr samples after 
selection for low and high fluorescence. Sorted fractions will be abbreviated as 
CMA3(+) or (-); mBBr (+) or (-); DTT-mBBr (+) or (-). These fractions have been 
characterised by mAb#36, specific for ds-DNA. The nuclear structure of the mBBr(+) 
and mBBr(-) fractions from the normospermic donor has been confirmed by 
transmission electronmicroscopy (TEM).  
 
Patients 
Semen samples were collected from two patients with teratospermia and one 
normospermic donor. The spermiogram was performed according to the WHO 
criteria (WHO 1999).  Morphology was assessed by the strict criteria (Menkveld, R. et 
al., 2001). The results of the semen analysis were:  
Sample 1 (donor): volume/concentration: 3.8 ml/ 200x 106/ml; motility 80%; 
morphology 33% normal. 
Sample 2 (patient): volume/concentration: 1.5 ml/ 30 x 106/ml; motility 15%; 
morphology 2% normal.  
Sample 3 (patient): volume/concentration: 1.0 ml/ 45 x 106/ml; motility 20%; 
morphology 3% normal.  
Because of the lower sperm numbers in the patient samples, these have been 
pooled, designated “patient” hereafter. Donor and patient samples were 
cryopreserved using a dilution 1/1 with cryoprotectant Freezing Medium (TYB) 
(Irvine Scientific, USA) in liquid nitrogen vapour. The sperm number was 
approximately 10-20 x106 /straw in order to perform pilot experiments on the same 
Chapter 4 
 56 
materials. Cryopreserved sperm samples were thawed at room temperature and 
washed once with human tubal fluid medium (HTF, Cambrex, Belgium) 
supplemented with 10% GPO (CLB, Amsterdam) in order to eliminate the 
cryopreservation medium by spinning for 5 minutes at 500 g. The pellet was 
resuspended in 200 µl phosphate buffered saline (PBS, Sigma, MO, USA), pH 7.4 and 
divided in 5 aliquots.  
 
Source of antibody #36 
Monoclonal antibody (mAb) #36 was obtained from lupus-prone 
(NZWxNZB)F1 mice, which are characterized by anti-chromatin autoantibodies 
(Smeenk et al., 1988) and belongs to the IgG2a subclass. The mAb was produced, 
purified and characterized as described previously (Kramers et al., 1994). After 
purification, no histones or DNA could be detected in the mAb fraction. 
ELISA experiments to determine anti-chromatin, anti-DNA and anti-histone 
reactivity were performed as described previously (Kramers et al., 1994; Licht et al., 
2001). Briefly, for the nucleosome ELISA the S2 fraction (concentration 372.5 ng/ml 
dsDNA) of nucleosomes, isolated according to the protocol previously described 
(Mizzen et al., 1999; Licht et al., 2001) was diluted 1:200 in PBS and 100 µl was coated 
overnight in Maxisorb 96-well plates. In the DNA ELISA, 100 µl of calf thymus 
dsDNA (Roche) or M13 single strand (ss)DNA was coated overnight in Maxisorb 96-
well plates at a concentration of 20 µg/ml in PBS, and in the histone ELISA 100 µl of 
calf thymus (individual) histones (Roche) were coated overnight in a concentration of 
2.5 µg/ml in 0.1 M glycine buffer at pH 9. The wells were washed with PBS/0.05% 
(v/v) Tween-20 (PBS-T) and blocked with 150 µl 5% foetal calf serum (FCS) for 2 
hours at room temperature. After washing with PBS-T, 100 µl of monoclonal 
antibody was added at a concentration of 100 ng/ml in PBS-T and incubated for 2 
hours at room temperature.  After washing with PBS-T, 100 µl horseradish 
peroxidase-conjugated goat anti-mouse Ig(H+L) (Southern Biotechnology Associates, 
Birmingham, USA) diluted 1:7500 in T(tris)BS-T (Sigma, USA), was added and 
incubated for 1 hour at room temperature. The plates were washed again with PBS-T 
and developed for 15 minutes using 100 µl 3,5,3’,5’-tetramethylbenzidine (TMB) 
(SFRI Diagnostics, Saint Jean d’Ilac, France). The reaction was stopped by the 
addition of 100 µl 2M H2SO4 and the optical density at 450 nm was measured in a 
microplate reader (Biorad). 
 
CMA3 staining 
Cells in suspension were fixed during 15 minutes in 1% paraformaldehyde 
(PFA, Sigma, MO, USA) in PBS at room temperature and washed twice in PBS, 
spinning 5 minutes at 500 g. The pellet was resuspended in 100 µl CMA3 solution 
(Sigma-Aldrich, Steinheim, Germany, 0.25 mg/ml in McIlvaine buffer, pH 7.0 
containing 10 mM MgCl2) and stained in the dark for 15 minutes at room 
temperature (Bianchi et al., 1993). Subsequently the sample was washed once more in 
PBS and the pellet was resuspended in 500µl PBS for FACS sorting.  
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mBBr staining 
For the mBBr (Calbiochem, USA) staining of free thiol groups, cells were fixed 
and washed as above. Each fraction was treated with 100 µl 50 µM mBBr in 20 mM 
TBS, pH 7.4 in the dark for 20 minutes at room temperature (Kosower et al., 1987). 
The sample was washed once more in PBS and the pellet was resuspended in 500µl 
PBS for FACS sorting.  
In order to determine the total amount of SH groups (free thiols) in the cells per 
fraction, one aliquot of patient and donor was reduced using DTT. First, samples 
were fixed in 4% PFA in PBS for 10 minutes at room temperature. The cell 
suspension was washed once in PBS and the pellet resuspended in 500 µl 1 mM DTT 
in PBS (15 minutes at room temperature). Reduced cell samples were washed twice 
in PBS (5 minutes, 500 g) before staining with mBBr. For simultaneous staining with 
CMA3 and mBBr, cells were incubated for 15 min in 200 µl of a mixture of the dyes at 
their original concentrations.  
 
FACS parameters and sample collection 
Cells were analysed and sorted on an Altra HyperSort flowcytometer (Beckman 
Coulter, Miami, USA). A 488 nm Argon laser running at 15 mW and a 408 nm 
Vioflame laser running at 25 mW were used for excitation of CMA3 and mBBr 
respectively. The emissions were separated by a 550 nm dichroic mirror and a 525 
nm band-pass filter was used for the mBBr emission. The CMA3 emission was 
measured through a 575 nm band-pass filter. Cells were first gated on forward 
scatter versus side scatter to discriminate cells from debris (Gate A, Fig.2). 
Depending on the final concentration per sample, a minimum of 50,000 up to 500,000 
particles were sorted for high or low fluorescence in the CMA3, mBBr and DTT-
mBBr stained samples. 
Unsorted (gate A, unstained) and sorted fractions (after staining, from the gated 
population) were collected in 500 µl HTF medium and spun for 10 min at 500g. 
Pellets were resuspended in 30 µl HTF for further processing. The sorted fractions 
were divided in 2 aliquots for further characterization of the sperm with mAb#36 
and TUNEL and 3 when electronmicroscopy was performed. 
 
Immunofluorescence with mAb 36# 
After sorting, sperm fractions were sampled by mixing 1 µl of suspension with 3 
µl of fibrin (Calbiochem, USA) on a precleaned coverslip, after which 1 µl of 
thrombin was added (Sigma, USA). A clotting reaction follows within one minute 
and was speeded up by body heath. The clot was washed briefly in PBS. 
Subsequently, the cells were fixed in 0.5% PFA in PBS for 5 min., treated with 1 mM 
DTT for 30 min and refixed for 30 min with ice-cold methanol (modified from 
Zalensky et al., (2002). Subsequently, immunofluorescence was applied according to 
(Baart et al., 2000). The anti dsDNA mAb#36 was diluted 1:200; the secondary Alexa 
488 goat anti mouse antibody (Molecular Probes, Leiden, The Netherlands) was 
diluted 1:500. After staining with 0.33 µg/ml 4,6-diamidino-2-phenylindole (DAPI, 
Sigma, MO, USA; 0.01mg/l in PBS) in PBS, coverslips with clots were mounted 
upside down in 30 µl Vectashield (Vector Lab., CA, USA) on microscope slides and 
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the coverslip was sealed by nailpolish. Observations were made using a Zeiss 
Axiophot fluorescence microscope with DAPI and FITC filters. From each FACS-
sorted fraction, two observers scored 75 flat-orientated nuclei each. No signal from 
the original fluorochromes was detected after staining with mAb#36. Signal patterns 
observed did not differ before and after FACS sorting. 
 The scoring protocol developed for the mAb#36 distinguishes three main 
patterns: intensity of the signal in the body of the nucleus (intensity), extension of the 
signal in the contour of the nucleus (rim) and the presence of a non-fluorescent band 
(band) in the posterior part of the nucleus (see Fig. 1a). Label intensity over the body 
of the nucleus was subjectively valued as (+), (+/-) and (-). Within the latter category, 
a vague overall fluorescence could be present. Nuclei that were overall non-
fluorescent (also lacking signal in the rim) were especially notified. Label in the rim 
was divided in two categories, based on subjective assessment: less than 50% and 
more than 50% of the circumference labelled. In nuclei that could vary from showing 
a dull fluorescence till more heavily labelled, the presence of the band (band+) was 
recorded. The presence of vacuoles was quantified as well. Nuclear morphology was 
scored as normal, round and variable in size, tapered or pyriform shaped (often 
smaller), or of an intermediate shape between round and pyriform (often larger). A 
subset of nuclei, usually of the last morphological type, contained coiled axial 
structures that were highly fluorescent. Fig. 1a gives examples of the patterns found 
in sperm nuclei, and the simultaneous occurrence of these parameters introduced 
above. 
 
TUNEL staining 
The determination of DNA breaks in sperm samples of patients and controls 
was carried out using the TUNEL assay (Cell Death Detection kit, Roche 
Biochemicals, Mannheim, Germany) following the manufacturer’s specifications with 
minor modifications (Ramos et al., 2002b). Briefly, air-dried spermatozoa were fixed 
with 1% PFA in PBS during 10 minutes at room temperature and rinsed twice with 
PBS followed by permeabilization with 0.2% Triton X-100 (Sigma, USA) in PBS for 10 
minutes. The TdT-labelled nucleotide mix was added to each slide and incubated at 
37 °C for 60 minutes. Slides were rinsed twice (5 minutes) in PBS. Subsequently, the 
sperm nuclei were counterstained with DAPI (0.01mg/l in PBS). Nuclei were 
mounted in 25 µl Vectashield. The total number of blue staining sperm nuclei per 
field (DAPI) was first counted. The number of cells with green fluorescence (TUNEL 
positive) was expressed as a percentage of the total cell number. Each sperm sample 
was scored twice by two observers. A minimum of 148 but mostly between 400 and 
700 nuclei per fraction were scored.  
 
Transmission electron microscopy 
Sperm were fixed in 2.5% glutaraldehyde dissolved in 0.1M sodium cacodylate 
buffer, pH 7.4 overnight at 4° C, subsequently washed in the same buffer, postfixed 
in palade buffered 2% OsO4 for 2 hours and pelleted in 15% gelatine, dehydrated and 
embedded in Epon 812 (Merck, Darmstadt, Germany). Ultrathin sections were cut on 
an ultratome (Leica, Reichert Ultracuts, Wien, Austria), and contrasted with 4% 
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uranyl acetate for 45 min and subsequently with lead citrate for 5 min at room 
temperature. Sections were examined in a Jeol 1200 EX2 electron microscope (JEOL, 
Tokyo, Japan). 
 
Statistics 
Chi square analysis was used to test for independency of variables such as 
observers and staining patterns within donor and patient. The Spearman rank 
correlation coefficient was used as an estimate for the congruence between observers. 
P values < 0.05 were considered statistical different. Statistical analysis was carried 
out with the SSPS 11.1 software package (SPSS Inc., Chicago IL, USA). 
 
 
 
RESULTS 
 
 Antibody specificity 
MAb #36 was tested at a concentration of 100 ng/ml in ELISA as described 
previously (Kramers et al., 1994) and optical density (OD) was measured at 450 nm. 
The purified mAb#36 showed a high reactivity with nucleosomes (containing DNA) 
and dsDNA (Table 1). Almost no reactivity with histones or ssDNA was found.  
 
Antigen  OD 
Nucleosomes 2.0 
dsDNA 3.0 
ssDNA 0.0 
Total histones 0.2 
Histone H1 0.0 
Histone H2A 0.0 
Histone H2B 0.1 
Histone H3 0.1 
Histone H4 0.1 
 
  
Table 1: Reactivity of mAb#36 with nucleosomal antigens 
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Figure 1a: Fluorescence patterns obtained with the mAb#36 in human spermatozoa 
 
 
Morphology  Pattern Merge DAPI      mAb#36 
 
Normal Intensity – 
(1.1) Rim <50% 
Band – 
 
 
 
Normal Intensity + 
(1.2) Rim  >50% 
Band + 
 
 
 
Round Intensity +/- 
(1.3) Rim >50% 
Band – 
 
 
Round  Intensity +/- 
(1.4) Rim <50% 
Band – 
 
 
 
Round  Intensity + 
(1.5) Rim >50% 
Band – 
 
 
Tapered Intensity + 
(1.6) Rim >50% 
Band + 
 
 
Round- Intensity + 
pyriform Rim >50% 
(1.7) Band – 
 
 
 
Round- Intensity + 
pyriform Rim <50% 
(1.8)  Band -  
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Figure 2: FACS plot representation for donor and patient of the total unstained sample and of gated 
CMA3, mBBr, DTT-mBBr and CMA3/mBBr stained sperm 
 
Figure 1b: Fluorescence patterns obtained with 
the mAb#36 in mouse spermatozoa 
   Merge DAPI   mAb#36 
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Parameters of nuclear heterogeneity obtained by FACS analysis 
Fig. 2 shows the FACS plots obtained for forward scatter, side scatter, CMA3 
fluorescence, mBBr fluorescence, mBBr fluorescence after DTT reduction and 
combined CMA3-mBBr fluorescence, based on 10.000 particles each. Experiments 
have been repeated several times, yielding essentially the same results epresentative 
plots are shown. The forward-side scatter plot always was more variable in the 
patient than in the donor.  The forward scatter indicates the size of the particle and 
side scatter reflects the smoothness of the surface. The criterion for gating a pure 
sperm population was set such that in the donor, at least 80% of particles would be 
selected. With the same combination of scatter conditions, only 60% of particles were 
selected in the patient (see Fig. 2a and 2f). The sorted fractions are those left and right 
of the bars in Fig. 2. An exception was made for the donor low DTT-mBBR fraction, 
where the two populations at the left (see Fig. 2d) have been pooled. 
Comparing the CMA3 fluorescence in donor and patient, the maximum 
intensity did not differ. In the patient, more particles were in the low fraction (44.6% 
vs. 7.2% in the low and high fractions respectively), which coincided with the smaller 
particles of Fig 2f. For the donor, the bulk of the measurements were in the middle 
“low fluorescing” fraction, contrary to the patient, where a more uniform 
distribution was seen over the middle and high fractions (see Fig. 2b and 2g). 
The scatter plots of the mBBr fluorescence show differences between donor and 
patient as well. For the high fractions, the average fluorescence intensity was higher 
in the patient compared to the donor (14.6 vs 11.0 arbitrary units). The maximum 
fluorescence was higher as well. As for CMA3 fluorescence the distribution was 
more uniform for the patient compared with the donor where the bulk of nuclei were 
in the high fraction (Fig. 2c and 2h). When total SH groups were measured (DTT-
mBBr), this pattern was copied but shifted to the right. Thus for the patient, an 
almost uniform distribution was seen, whereas in the donor the nuclei aggregated in 
the high fraction. 
When a plot was made, relating free thiol fluorescence with CMA3 fluorescence 
(CMA3-mBBr), the two parameters seemed largely unrelated in the patient, but had a 
tendency to cluster in the CMA3 (low) - mBBr (high) range, which could be predicted 
form the single fluorescence plots.    
 
IF patterns of mAb#36 
Nuclei were scored for the presence and distribution of mAb #36 
immunofluorescence in seven FACS-sorted fractions for donor and patient, using the 
criteria outlined in the M & M section. As shown in Fig. 1a (1.2), the lack of 
fluorescence in a zone of the posterior nucleus was recorded as band (+). Fig. 1a(1.6) 
shows the extension and position of this fluorescence-negative zone not to be 
absolutely fixed. The zone was always in the posterior nucleus, however. The 
presence of vacuoles could be detected with this mAb as an extra fluorescent area 
(Fig.1a (1.5) as well. The coiled axial structure of the nucleus is shown in Fig. 1a (1.8), 
occurring most often in the round-pyriform shaped nuclei.  
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Differences between observers 
On inspection of the raw data, both observers agreed on nuclear fluorescence 
intensity, size of the rim and the appearance of the fluorescence free post-acrosomal 
band. Chi square values only occasionally yielded a significant result (data not 
shown). 
When the values for + and +/- intensity for both observers were compared over 
all fractions, a Spearman rank correlation of r=0.88 was found. For size of rim and 
appearance of the “band” identical results were found (r = 0.82 for rim and r = 0.91 
for band). Therefore, for further analysis, data of both observers have been pooled. 
 
Intensity and rim 
Fig. 3 gives the distribution of intensity and rim over the fractions from both 
donor and patient. The results of Chi square analysis within probands are given in 
Table 2. Significant differences follow the same pattern for intensity over the body of 
the nucleus and for nuclear peripheral fluorescence, confirming the visual tendency 
observed in Fig. 3. In donor and patient, the increase of mAb#36 fluorescence 
intensity paralleled CMA3(+) fluorescence as a sorting parameter. The gated A 
population after a FACS run (control) differed from the CMA3(+) fraction, but not for 
the CMA3(-) fraction.  
 
Table 2: P values (significances) of the fluorescence Intensity and extension of the Rim 
for patients and donors in the sorted fractions, based on the Chi2 test 
Donor Patient 
Contrast 
Intensity Rim Intensity Rim 
Control vs CMA3 + <0.001 <0.001 0.001 0.001 
Control vs CMA - 0.614 0.177 0.269 0.131 
CMA3 + vs CMA3 - <0.001 <0.001 0.01 <0.001 
Control vs mBBr + 0.091 0.431 0.395 0.064 
Control vs mBBr -  0.231 0.244 0.439 0.229 
mBBr + vs mBBr - 0.524 0.162 0.981 0.262 
Ctrl vs DTT-mBBr + 0.147 0.114 0.186 0.072 
Ctrl vs DTT-mBBr - 0.020 0.062 0.031 0.333 
DTT-mBBr+ vs. DTT-BBr- 0.579 0.777 0.662 0.292 
 
The only other significant difference was observed between the control and 
DTT-mBBr(-) fraction, for both patient and donor (see Fig. 3 and Table 2). However, 
while in the donor the intensity decreased in the DTT-mBBr(-) fraction, in the patient 
an increased in the intensity was observed. This could be due to an interaction 
between patient sperm and DTT treatment, affecting access for the antibody (patient 
sperm are more reactive to DTT). 
Frequencies of nuclei exhibiting no fluorescence at all (Fig. 1.1) varied from zero 
to 19 percent in donor fractions and between one and 6 percent in patient fractions. 
Chapter 4 
 64 
Two fractions scored higher than 7% for not-fluorescent: the control (19%) and DTT-
mBBr(+) factions of the donor (19%). 
 
Figure 3: Intensity and rim fluorescence patterns of mAb#36 in the different FACS fractions  
 
Band 
Fig. 4 gives the results of band scores for donor and patient. In Table 3 the P 
values for the differences between fractions within probands are given. The relation 
between intensity and presence of a band differed between donor and patient; in the  
Intensity
- 
+/- 
+ 
Rim 
< 50% 
 
> 50% 
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Figure 4: Presence of a non-fluorescent band in the different FACS fractions after immunofluorescence 
staining with mAb#36 
 
Table 3: P values (significances) for the presence of the Band in sperm heads of the 
sorted fractions of donors and patients, based on the Chi2 test 
Band 
Contrast 
Donor Patient 
Control vs CMA3 + <0.001 0.551 
Control vs CMA - 0.346 0.061 
CMA3 + vs CMA3 - <0.001 0.20 
Control vs mBBr + <0.001 0.001 
Control vs mBBr -  0.042 0.687 
mBBr + vs mBBr - 0.01 0.003 
Ctrl vs DTT-mBBr + 0.225 <0.001 
Ctrl vs DTT-mBBr - 0.105 <0.001 
DTT-mBBr+ vs.DTT-mBBr- 0.686 0.640 
 
pooled (+) and (+/-) intensity categories, 82% of the sperm in the donor and 55% in 
the patient did show a band. In the intensity (-) category, this difference did not 
occur (donor 32% vs. patient 36%). Fig. 4 and Table 3 also show a different tendency 
in the appearance of this band in the donor compared to the patient. In the donor, 
Band 
  - 
 
  + 
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both CMA3(+) and mBBr(+) fractions are enriched for nuclei with a band, an effect 
not observed in the patient. Selection for mBBr gives opposite results for donor and 
patient: in the patient the band is more prominent in the mBBr(-) fraction. When 
selecting for the total thiol content, no differences were found in the donor. Patient 
sperm showed a decrease in the frequency of band+ cells, for both fractions in a 
comparable proportion. 
  
Nuclear morphology, vacuoles and axial structures 
Table 4 gives the frequencies of the nuclear morphologies observed, as outlined 
in the M & M section. Contrary to the standard morphology scores based on the strict 
criteria (see M & M), the samples of donor and patient did not differ that much using 
the morphology scoring system adapted for fibrin encapsulated DAPI stained nuclei. 
Especially more tapered and pyriform shaped nuclei were found in the patient 
sample. The frequency of nuclei with detectable vacuoles was 30% in the donor and 
41% in the patient. The axial coiled fluorescing structure (see Fig. 1.8) was mostly 
found in round-pyriform shaped nuclei, at about equal percentages in patient (10%) 
and donor (7%). 
 
Table 4: Nuclear morphology frequencies in fibrin encapsulated spermatozoa 
 % Morphology* 
 Normal Round Tapered Round-pyriform 
Donor (n=900) 53 17 14 16 
Patient (n=1050) 39 22 25 14 
* Morphology described in Materials and Methods 
 
 
TUNEL 
The agreement between observers on the TUNEL score was r = 0.93 (Spearman 
rank correlation). Chi square analysis yielded a significant observer effect in 3 out of 
13 comparisons (data not shown). For further statistics, the observers have been 
pooled.   
The TUNEL scores before FACS presented in Table 5 show that in the donor, 
the staining protocols had little effect on the outcome. However, an effect of the 
mBBr staining, with or without DTT treatment, was observed in the patient. After 
FACS sorting (Table 6), the control fraction of the donor did not seem to be affected 
contrary to the patient, where a significant increase was found. 
By sorting of the specific fractions, significant differences emerged (see Table 6): 
CMA3(+), mBBr(-) and DTT-mBBr(-) fractions contain more nuclei susceptible to 
exhibit free 3’OH DNA ends. Trends in the patient always followed that of the donor, 
but at higher rates. 
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Table 5: Percentage TUNEL positive sperm in the different staining categories before 
FACS sorting 
Donor Patient Category 
n (%) n (%) 
Unstained (control) 469 11 a 438 23 b 
CMA3 491 16 a 151 25 b 
MBBr 462 10 a 477 47 b 
DTT-mBBr 456 6 a 467 58 b 
a vs b P <0.001 
 
Table 6: Percentage TUNEL positive sperm in the different sorted fractions 
Donor Patient 
Fractions 
n % P n % P 
Before FACS 469 10.7 438 22.8 
Gate A* (control) 432 7.4 
   
  0.09 413 33.4 
 
0.001 
CMA3+ 554 39.7 422 62.8 
CMA3- 539 2.6 
 
<0.001 515 23.9 
 
<0.001 
mBBr+ 697 17.8 600 40.8 
mBBr- 651 32.7 
 
<0.001 518 59.2 
 
0.002 
DTT-mBBr+ 649 11.7 615 31.7 
DTT-mBBr- 621 20.9 
 
<0.001 148 65.5 
 
<0.001 
*see Figure 2 (FACS plots) 
 
Transmission electron microscopy 
From the donor sample, two FACS-sorted fractions (mBBr(+) and (-)) have been 
processed for transmission electron microscopy. Fig. 5 gives four examples 
representing closed (dense) and more open chromatin structures. In the mBBr(+) 
fraction, 90 % of nuclei (n = 58) showed closed chromatin, contrary to only 56% of 
nuclei (n = 63) in the mBBr(-) fraction. 
Figure 5: Transmission electronmicroscopy images of human spermatozoa of the 
mBBr(+) and (-) FACS fractions 
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DISCUSSION 
 
Methodological considerations 
The FACS measurements obtained in this study especially for the DTT-mBBr 
stained samples did not yield the sharp Gaussian curves as reported before (Rufas et 
al., 1991; Seligman et al., 1994), although the rise in intensity of the right side main 
populations of Fig. 2c and 2d (for before and after DTT reduction respectively) was 
comparable to the data of (Seligman et al., 1994). When the orientation of the head 
relative to the excitation/ emission light path is stable (Pinkel et al., 1979), such that 
the nucleus is always exited at its flat surface, the measurements and hence selection 
of fractions are more accurate and possibly would lead to more pronounced effects 
after selection. However, the routine FACS setting is adequate, provided pronounced 
biological variation is present in the samples. 
Because the entire spermatozoon was used, free thiol groups present in the tail 
(Seligman et al., 1994; Sutovsky et al., 1997) would increase the mBBr fluorescent 
measurements obtained. Evaluation of the influence of the thiols present in the tail of 
human spermatozoa was tested on air-dried sperm that were subsequently treated as 
for a FACS experiment. The free thiol contribution of the tail was assessed using a 
spot-measurement of mBBr fluorescence with a fluorescence microscope connected 
to a digital camera. The digital images acquired were analysed for the fluorescence 
intensity (data not shown). The ratio between nucleus and midpiece was 0.21 while 
for the tail the ratio was 0.10. The contribution of the tail was uniform for all sperm 
morphology. A proportional increase of fluorescence over the head but not over the 
tail was measured, indicating that in the DTT treated samples the head is the main 
contributor of fluorescence. Although we cannot exactly state the influence of the tail 
variance in the mBBr(+) or (-) selection, the data discussed below indicate the 
selection performed to be due to nuclear free thiol status.   
 
Antibody specificity and localization 
According to Table 1, mAb#36 recognises both free ds-DNA and nucleosomes. 
It contrasts with some other mAb’s from lupus prone mice that recognise 
nucleosomes but not free DNA. This result is interpreted as mAb#36 detecting DNA 
on the nucleosomes as well. Using this mAb#36 in mouse, a labelling pattern is 
detected in the post acrosomal posterior nucleus of the great majority of sperm (Fig 
1b), where more open chromatin in a most likely nucleosomal configuration is found 
(Pittoggi et al., 1999; Pittoggi et al., 2001). 
The patterns obtained by mAb #36 in mouse and human sperm could reflect the 
distribution of nucleosomes, considering that the accessibility of the antibody is 
assured. Without chromatin weakening, the antibody cannot access the chromatin 
(Zalensky et al., 1993; Zalensky et al., 2002); therefore, decondensation of the 
chromatin by for instance DTT usually is part of sperm IF protocols. The fixation, 
DTT and immunofluorescence protocol used here did not cause obvious 
morphological modification of the human and mouse sperm nuclei. We avoided any 
drying of the specimen by fibrin clot incubation, achieving reliable antigen detection. 
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The agreement between observers per fraction underlines the distinctive staining 
patterns of mAb#36 in human sperm. 
In agreement with the early notion that human sperm is much more variable 
when ejaculated than for instance rodent sperm (Bedford et al., 1973), the labelling 
pattern found with mAb #36 shows a large variation. However, the total spectrum of 
patterns was not different between donor and patient. In the patient, the overall label 
intensity was higher in sorted and unsorted fractions compared to the donor. The 
fact that the outer contour of the ellipsoid semi-flattened nucleus is the most 
vulnerable region for antibody penetration suggests that the chromatin at the 
periphery of the nucleus with the highest curvature is most susceptible for 
penetration by the antibody.  
The score for overall intensity is highly correlated with the fraction of nuclear 
outer contour labelled (defined as more or less than 50% rim, see Fig 3). Overall, we 
could not distinguish labelling gradients over the sperm nuclei that yielded an 
additional insight into the gradient of compaction, which is from the anterior to the 
posterior side of the nucleus.  
One distinct immunolabelling feature observed was a fluorescence negative 
band in the post acrosomal area (Fig.1a(1.2), immediately adjacent to the tail. This 
phenomenon could be observed in nuclei that were from very lightly (intensity -) to 
more heavily labelled. 
When comparing the localisation of this band with published literature on 
sperm chromatin topology, no definitive nuclear structure can be deduced. The 
nuclear annulus that was first described by (Ward et al., 1989b) could serve as a 
template of heavily packed DNA that is inaccessible for the antibody. In  subsequent 
work (Barone et al., 1994), the nuclear annulus, which is a posterior localised 
structure from which the nuclear matrix originates, was also demonstrated in human 
sperm. The region is neither visible by DNA dyes nor with thiol fluorescence before 
or after DTT reduction. 
In the chromatin structure studies of Zalensky et al., (1993), aimed to describe 
centric heterochromatin aggregation, the most compacted nuclei showed a centre, 
which could not be localised with respect to the implantation fossa. The same 
authors report that for subsequent fluorescence in-situ hybridisation (FISH) analysis, 
the DNA of the randomly orientated human telomeres was more sensitive to DNase I 
or micrococcal nuclease activity than the centric satellite sequences that are localised 
in the more heparin resistant chromocenter region. The appearance of the non-
fluorescent posterior band in 68% of donor cells indicates this configuration to be a 
normal differentiation characteristic. Nuclei can for two reasons not show it: because 
of mal-development of the underlying structure or because of nuclear compaction 
and inaccessible DNA over the whole nucleus. These nuclei could be regarded as 
fully differentiated. 
Another distinctive immuno-labelling pattern has been coined axial coiled 
element, demonstrated in Fig. 1a (1.8). It is tempting to speculate that at the basis of 
the looped domains, where these attach to the nuclear matrix, the abnormally 
differentiated chromatin becomes accessible for the antibody. This structure was 
Chapter 4 
 70 
mostly found in round-pyriform shaped nuclei of both donor and patient. 
  
Correlations between sorting parameters, mAb#36 fluorescence and DNA breakage 
Clearly CMA3 staining intensity and mAb #36 fluorescence are correlated in 
both donor and patient. No correlations with free thiol (mBBr) groups could be 
found, neither in the donor nor in the patient. An opposite effect in mAb#36 intensity 
for donor and patient was found for DTT-mBBr(-) sperm. The usually greater 
susceptibility of patient nuclei to the DTT treatment could account for this finding.  
The scatter plots (Fig. 2) show that the patient has a much larger variation in 
total thiol level, which is associated with incomplete protamination for the larger 
part of the nuclei. Sperm of the patient contains a subpopulation of nuclei with 
higher free thiol levels compared with the donor, likely representing nuclei that are 
delayed in crosslinking of protamines. This effect has also been observed by Zini et 
al., (2001). Thus, the higher level of IF in the patient correlates with a non-
homogeneous histone to protamine change, most likely between and within nuclei. 
Strangely enough, selection for DTT-mBBr(+) nuclei in the patient, does not lead to a 
reduction of mAb#36 fluorescence, as observed in the donor. An opposite tendency 
in the mAb#36 was observed in the DTT-mBBr(-) fraction for both patient and donor. 
Obviously, mAb#36 does not describe all aspects of the chromatin differences 
between patient and donor. 
The incidence of nuclei showing the posterior non-fluorescent band is increased 
in the CMA3(+) and mBBr(+) donor fractions (but not in the patient, Fig 4). The 
intensity distribution in the CMA3(+) and mBBr(+) fractions also differs, as more 
heavily labelled nuclei are found in case of CMA3(+) selection, while lightly labelled 
nuclei were found in the mBBr(+) fraction. Thus, visibility of the band in the mBBr(+) 
fraction occurs in a more lightly labelled background. Support for the fact that the 
mBBr(+) and (-) fractions differ in nuclear architecture comes from the observations 
by transmission electron microscopy, showing the mBBr(+) fraction to be more 
homogeneous and better condensed on average.        
When the data on nuclear characteristics and DNA breakage are interpreted 
(Table 6), some trends are visible. The TUNEL sensitivity is markedly elevated in the 
CMA(+) fractions. Thus, the correlation between CMA3 fluorescence and sensitivity 
for in situ nick translation as found by (Manicardi et al., 1995) is confirmed by our 
data. Also, total thiol status does have an effect: more highly protaminated nuclei are 
less TUNEL sensitive. Lower free thiol levels correlate with a higher TUNEL score. 
The fact that within the individual, selection for thiol status (mBBr) is related to 
TUNEL sensitivity but ineffective for mAb#36 staining, indicates nuclear 
degeneration to start at the level of the DNA, rather than at the level of chromatin. 
This would favour the interpretation of TUNEL positive cells to be apoptotic (Sakkas 
et al., 2002; Shen et al., 2002).    
In an attempt to integrate all nuclear parameters in the donor, one could ask 
which nuclear configuration is most beneficial for fertility. With CMA3 minor 
fluorescence as a prerequisite, higher free mBBr helps in defining a population that 
differentiates correctly. These cells have a higher frequency of showing the band and 
chromatin is better compacted (TEM). The fact that IF free nuclei are much more 
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numerous in the donor than in the patient, suggests this to be a positive mark as 
well.  Overcondensed nuclei as described by Francavilla et al., (1996) and Seligman et 
al., (1994), could fall in this category, though, more advanced protamination reduces 
the chances on nuclear degeneration as measured by TUNEL (Table 6). 
In the patient, these relations in principle should hold, but selection does not 
lead to a diminishing mAb#36 signal. Thus, one unknown component of chromatin 
compaction is less well developed in patient sperm, even in the gated sample 
(representing 60% of the total FACS particles). The much more error prone nuclear 
differentiation in the patient is also illustrated by comparing the Figs 2e and 2j: in the 
patient, a dominant population in the CMA3/mBBr blot can hardly be found. 
 
Prospects 
Up to now, the SCSA assay, measuring the resistance of the DNA double helix 
towards high acid histone/protamine extraction is one of the sperm tests that 
correlates best with in vivo fertility and conventional IVF. In explaining their results, 
the authors (Evenson et al., 2002) state that fractions of more than 30 – 40% AO red 
fluorescing nuclei per ejaculate, predict a nuclear parameter for the whole sperm 
population that is negative for fertilization/embryonic development. As the mAb#36 
fluorescence patterns apply to at least 80% of nuclei in the donor and the great 
majority of nuclei in the patient, this parameter could be taken into account in further 
evaluations of the SCSA technique.   
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ABSTRACT 
 
In this study we present the physiological changes observed in ejaculated 
spermatozoa of normospermic men after exposure to hydrogen peroxide (H2O2) or γ-
radiation.  
Methods: Motility changes as well as membrane and DNA-damage were 
determined in spermatozoa after incubation with 25 µM/l of H2O2 during increasing 
intervals of time (0-60 minutes and after 24 h) or irradiation of cells using γ rays. 
Annexin V-binding in combination with propidium iodide was used for the 
assessment of membrane changes after each incubation time. TdT-mediated-dUTP 
nick-end labelling (TUNEL) was used to evaluate DNA-damage.  
Results: After 1 h incubation of the spermatozoa with H2O2, almost all cells were 
positive for Annexin-V, while no significantly increase in TUNEL positivity was 
observed. TUNEL results were significantly higher 24 h after incubation with H2O2  
(10-16.3%, P=0.03). In the control group (cumulus cells), an increase in the percentage 
of TUNEL positive cells was observed after 15 min of incubation with H2O2 and 
showed a five-fold increase after 24 h (from 8.1-72.1%, P<0.001).  TUNEL positive 
cells after γ-radiation increased with the doses and post-irradiation time (from 10.8-
47.2%).  Interestingly, when only motile spermatozoa from irradiated samples were 
analysed, only 0.5% were TUNEL positive.  
Conclusion: Motility may be a relevant physiological marker for DNA-intact 
sperm after exposure of spermatozoa to H2O2 and γ irradiation. 
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INTRODUCTION 
 
With the introduction of intracytoplasmic sperm injection (ICSI), the risk of 
introducing DNA-damaged spermatozoa into the oocytes increases, especially in 
cases of poor sperm quality (Twigg et al., 1998; Lopes et al., 1998b; Ahmadi et al., 
1999a; Irvine et al., 2000). DNA-damage due to apoptosis has been found to occur in 
the testis during spermatogenesis predominately at spermatogonia and dividing cells 
level (Yin Y. et al.,1998; Lee et al., 1997; Tesarik et al., 1998; Host et al., 1999; 
Pentikainen et al., 1999; Sakkas et al., 1999b; Print et al., 2000). It is also increased in 
spermatozoa of poor quality as measured with the terminal deoxynucleotidyl 
transferase (TdT)-mediated UTP-nick end label (TUNEL) or Comet assay (Hughes et 
al., 1996; Sun et al., 1997; Irvine et al., 2000). The increased sensitivity to DNA damage 
in abnormal spermatozoa is probably due to failed chromatin condensation, which 
makes the DNA more accessible to damage (Bianchi et al., 1993; Twigg et al., 1998; 
Sakkas et al., 1998). Therefore, the presence of DNA fragmentation in ejaculated 
spermatozoa might correlate to defects in the spermatogenesis, as has been suggested 
by Gandini and colleagues (Gandini et al., 2000). DNA fragmentation is more evident 
in atypical forms (Lopes et al., 1998b), confirming that morphology and sperm count 
correlate with testicular function. Elevated percentages of apoptotic spermatozoa 
also have been found after infections of the reproductive tract, cancer and other 
pathologies (Baccetti et al., 1996; Sharma et al., 1999; Gandini et al., 2000). However, 
scarce data have been published concerning the sensitivity of sperm to DNA damage 
or the mechanisms involved in cell death of ejaculated sperm cells from 
normospermic donors (Maione et al., 1997; Blanc et al., 2000). This is important to 
elucidate especially in those pathologies where normal spermatozoa are exposed to 
non-physiological damaging agents. In vivo, this damage to the sperm cells probably 
occurs after completing maturation at the post-testicular level. This occurs for 
example in cases of anejaculation, where spermatozoa are exposed to elevated levels 
of reactive oxygen species (ROS) for long periods of time before (electro)ejaculation 
(de Lamirande et al., 1995).  
ROS are a known inductor of apoptosis in somatic cells (Ratan et al., 1994) and 
in maturating spermatozoa at testicular level (Gorczyca et al., 1993). It is not clear 
whether ROS are also responsible for triggering DNA breaks in mature spermatozoa. 
Radiation is also responsible for chromosome aberrations (Tateno et al., 1996) and 
DNA fragmentation in spermatozoa (Haines et al., 1998).  
The aim of this study was to determine and evaluate the physiological changes 
of ejaculated spermatozoa after exposure to free oxygen radicals or gamma radiation. 
The understanding of the possible mechanism of cell death of ejaculated 
spermatozoa as results of the exposure to these agents may lead us to find markers 
for undamaged spermatozoa to use for ICSI. This might be important for the 
treatment of men whose semen has been stored for a long time in the epididymis, e.g. 
in cases of anejaculation or obstruction.  
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MATERIAL AND METHODS 
 
Sperm samples and controls 
Semen samples of seven normospermic donors attending our fertility 
department were used to study the effect of H2O2 (n= 7) or gamma-radiation (n= 4) 
on ejaculated spermatozoa (H2O2 has been used as a source of free radicals). Samples 
were collected by masturbation into sterile containers and were delivered to the 
laboratory within 1 hour after ejaculation.  
Sperm morphology was evaluated using the WHO criteria (WHO, 1999). Sperm 
concentration and motile assessment were performed in a Makler chamber after 
centrifuging the semen samples during 10 min at 500g over an 80% PureSperm 
gradient (Nidacon International AB, Gőttenborg, Sweden). Subsequent washings 
were done Human Tubal Fluid (HTF) culture medium (Quinn et al., 1985) 
supplemented with 10% plasma solution (CLB, Amsterdam, The Netherlands)). The 
reason for using this fraction of the ejaculates is to have a homogeneous population 
to diminish variations between different aliquots of one sample.  
 Cumulus cells of six IVF-patients were used as controls because, unlike 
spermatozoa, these (somatic) cells are transcriptionally active. Cumulus cells were 
collected and analysed at the day that oocytes were harvested for IVF. 
 
Induction of DNA-strand breaks 
Sperm samples were incubated in culture medium with a final concentration of 
25 µM/l H2O2 for different intervals of time (0, 5, 15, 30 and 60 min) at 30°C and 
cumulus cells were incubated for 0, 15 and 30 min at 37°C at the same H2O2 
concentration. Higher concentration of H2O2 caused immediately immobilisation of 
spermatozoa (data not shown). Incubations were stopped by the addition of 10 
µg/ml catalase (Sigma Chemicals, St Louis, MO, USA) and by washing the samples 
immediately after with IVF-medium. Samples that were incubated for 0 and 60 
minutes were split in 2 aliquots to assess membrane and DNA-damage immediately, 
and after another 24 h incubation (long term effect after damage induction). Control 
cells were incubated only for 0, 30 and 60 minutes and 24h under similar 
experimental conditions (incubation at 37°C, reaction was stopped by addition of 10 
µg/ml catalase). Aliquots of sperm samples were also exposed to increasing doses of 
0, 1, 5 and 50 Grays γ-radiation (dose rate: 4.7 Grays/min) at room temperature 
(Gamma cell 1000, Atomic Energy of Canada, Canada). Motility changes, membrane 
and DNA-damage were assessed in all cell samples immediately after irradiation and 
after 24 h incubation at 37°C.    
 
Determination and selection of motile spermatozoa 
Immediately after each incubation period with H2O2 or radiation, the 
percentage and quality of sperm motility was assessed in a Makler chamber to record 
any changes caused by H2O2 or γ-radiation. For these proposes, any kind of motility 
observed whether progressive motility or not, was considered “motile”. 
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The motile fraction from four out of seven sperm samples, which were 
previously irradiated with 5 Gray and incubated for 24 h, was selected for the 
determination of DNA damage. The sperm suspension was diluted in 5% 
polyvinylpyrrolidone solution (PVP; Medicult a/s, Jylling, Denmark) and 
spermatozoa were individually selected using an ICSI-injection pipette (Humagen, 
Charlottesville, VA, USA) and micromanipulators. Motile sperm in PVP were 
transferred to a glass slide and labelled with TUNEL. At least 150 motile 
spermatozoa per sample were selected for analysis.   
 
Determination for membrane damage 
Membrane damage was assessed using Annexin-V stain (Nexins b.v., 
Kattendijke, The Netherlands) in combination with propidium iodide (PI, Sigma 
Chemicals) for evaluation of vitality (Glander et al., 1999). In vital cells with an intact 
plasma membrane, phospholipid phosphatidylserine (PS) is located on the inner 
leaflet of the plasma membrane. The disturbance of membrane function starts with 
the translocation of PS from the inner to the outer leaflet and results in exposure of 
PS, where Annexin V binds. Samples were incubated for 15 min at room temperature 
in 0.5 µl of ready-to-use Annexin V-fluorescein isothiocyanate (FITC) solution in 300 
µl binding buffer and mixed with 5 µl of PI. The FITC-labelled spermatozoa were 
analysed in a flow cytometer (Coulter Epics XL-MCL, Miami, FL, USA); a minimum 
of 10 000 cells was examined for each sample. 
 
Determination of DNA-damage 
DNA fragmentation induced in spermatozoa or cumulus cells was measured 
using the TUNEL assay (Cell Death Detection kit, Roche Biochemicals) following the 
manufacturer’s specifications with minor modifications. TUNEL identifies single and 
double stranded DNA breaks by labelling the free 3’-OH termini with modified 
nucleotides in an enzymatic reaction with terminal deoxynucleotidyl transferase 
(TdT). TdT polymerises free 3’-OH DNA ends in a template-independent manner, 
incorporating labelled nucleotides.  Briefly, air-dried slides were fixed with 4% 
paraformaldehyde at room temperature and rinsed with phosphate-buffered saline 
(PBS), pH 7.4, and then permeabilised with 2% Triton X-100. The TdT-labelled 
nucleotide mix was added to each slide and incubated at 37 °C for 60 min. Slides 
were rinsed twice in PBS and then counterstained with 10 mg/ml 4,6-diamidino-2-
phenylindole (DAPI). From each sperm sample, one droplet of the sperm suspension 
was air dried on a glass slide for the determination of DNA-breaks with the TUNEL 
assay. Controls were included in every experiment: for the negative control TdT was 
omitted in the nucleotide mix. Positive controls were generated by incubating the 
sperm cells during 10 minutes at room temperature with 50 units/ml DNase I 
(Boehringer Mannheim, Mannheim, Germany). TUNEL labelling of the positive 
controls varied between 87-98% of the cells. 
At least 500 spermatozoa or 200 cumulus cells per sample were evaluated using 
a fluorescent microscope. The number of cells per field stained with DAPI (blue) 
were first counted; the number of cells with green fluorescence (TUNEL positive) 
were expressed as a percentage of the total sample. 
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Statistical analysis 
Statistics were carried out with the statistical SPSS for Windows software 
package version 9.0 (SPSS Inc., Chicago, IL, USA). Calculations were performed 
using the paired two-tailed non-parametric test (Wilcoxon) or χ2-test where 
appropriate. Pearson’s Correlation was used to calculate the correlation between 
TUNEL positive cells and radiation doses. Statistical differences were considered 
significant at P<0.05. 
 
 
RESULTS 
 
Effect of oxidative stress 
Sperm motility of the spermatozoa decreased significantly after 5 minutes 
incubation with H2O2 (from 79 to 4 %; P< 0.001), and it was zero after 15 minutes. 
Annexin-V binding was found to increase shortly after the addition of H2O2 followed 
by an increase of PI positive cells. Annexin-V became almost 100% positive already 
after just 60 min incubation (Figure 1). No significant increase of TUNEL positive 
cells was found within the first 60 min of incubation with H2O2, while a significant 
increase was found in those samples that were incubated for 24 h after damage 
induction with H2O2 (10.0 vs. 16.3% respectively; P = 0.03). 
When control (cumulus) cells were exposed to similar incubation conditions (25 
µmol/l H2O2, at 37 °C), a significantly higher percentage of Annexin-V positive/PI 
negative and TUNEL positive cells was found after 30 min incubation (48.1 and 
43.2% respectively). A five-fold increase of TUNEL positive cells was found after 
additional 24 h incubation (from 8.1 to 72.1%, P<0.001), (see Figure 2). 
 
Effect of γ-radiation 
DNA-damage can be induced directly in spermatozoa by subjecting them to 
increasing doses of γ-radiation. DNA-breaks (TUNEL positive cells measured 
immediately after radiation) were found to increase proportionally (r=0.91) to the 
radiation doses applied (9.4, 13.3, 14.3 and 25.2% for 0, 1, 5 and 50 Gray respectively, 
see Figure 3). Sperm motility decreased with the doses applied, although still more 
than 50% of the cells were still motile even after 50 Gray. After incubation of the 
sperm samples for an additional 24 h, motility was further decreased and increasing 
number of TUNEL positive cells were observed (12.3, 19.2, 26.5 and 43.8% TUNEL 
positive cells after 0, 1, 5 and 50 Gray respectively, P<0.05). All samples were also 
analysed for Annexin-V and PI binding and no increase in membrane damage was 
observed in these samples in these samples before or after radiation (data not 
shown). 
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Figure 1: Damaged induced by H2O2 in spermatozoa after different intervals of time. Motility, 
membrane damage (annexine V and PI) and DNA fragmentation (TUNEL) were recorded after 0, 5, 
15, 30 and 60 minutes incubation with H2O2 and after additional 24 hours incubation after damage 
induction (mean ± SD).  
 
Figure 2: Damaged induced by H2O2 in cumulus cells after 0, 15 and 30 minutes incubation with H2O2 
and 24 hours after damage induction. Results of the measurements of membrane damage (annexine V 
and PI) and DNA fragmentation (TUNEL) were significantly different after each interval of time 
(mean ± SD). 
 
Figure 3: A) Percentage motile spermatozoa and B) Percentage DNA fragmentation (TUNEL) 
observed in spermatozoa after applying increasing doses of gamma radiation. Light bars represent the 
percentage on motile cells (A) or TUNEL positive cells (B) immediately after radiation was applied; 
dark bars represent the same samples 24 hours later (mean ± SD) (¤,*,** P < 0.01). 
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Selection of motile spermatozoa after γ-radiation 
The selected motile cells of four irradiated samples (5 Gray, 24 hs post 
irradiation) showed a negligible number of DNA breaks in the TUNEL assay. From 
the total of 350 individually selected motile cells, only two spermatozoa (0.5%) were 
positive for TUNEL. This is significantly different from the original sample of which 
the cells were selected (26.5%, P< 0.001). 
 
 
DISCUSSION 
 
In this study, we analysed the changes that H2O2 or γ-radiation caused in 
mature, ejaculated sperm cells from normospermic men at membrane and nuclear 
levels. The data presented here provide evidence for the importance of sperm 
motility as a marker for the identification of intact DNA in spermatozoa. These 
results are based on DNA fragmentation analysis by the TUNEL assay after exposure 
of normal ejaculated spermatozoa to cytotoxic agents. Also, motility changes were 
observed after exposure of cells to γ-radiation, in correlation with the DNA damage 
induced, but independently of the membrane integrity as measured by Annexin V 
and PI. The damage observed showed a different pattern than expected.  
Programmed cell death or apoptosis is the process in which the cells activate an 
intrinsic death programme and kill themselves in a controlled way. Most, if not all, 
nucleated mammalian cells are capable of undergoing apoptosis and constitutively 
express all the proteins required to execute the death. The final stage of this 
programmed cell death is DNA fragmentation caused by activation of endogenous 
endonucleases. Fragmented DNA in spermatozoa can be detected with the Comet 
(Hughes et al., 1996; Donnelly et al., 2000) or the TUNEL assay (Sun et al., 1997). Both 
techniques are becoming widely used for the determination of DNA damage in 
spermatozoa of infertile patients (Hughes et al., 1996; Lopes et al., 1998b), in 
irradiated sperm cells (Haines et al., 1998) and in spermatozoa patients exposed to 
cytotoxic agents during cancer treatment (Chatterjee et al., 2000). 
To evaluate whether changes found in the spermatozoa (which lack an effective 
DNA-repair capacity and have no caspase activity (Weil et al., 1998) follow the 
normal pattern of cell death, cumulus cells were exposed to similar experimental 
conditions and analysed for membrane changes with the Annexin V-binding assay 
and for DNA-fragmentation with TUNEL assay. Cumulus cells, which are 
transcriptionally active, became apoptotic as soon as 15 minutes after incubation with 
H2O2, as it can be observed from the measurements of Annexin V-binding and 
TUNEL. A significant increase in TUNEL positive cells was observed after 30 
minutes incubation with H2O2 (P<0.01). The difference observed between cumulus 
cells and spermatozoa after exposure to oxidative agents suggests that normal 
condensed chromatin in spermatozoa is more resistant to DNA fragmentation, 
probably due to its highly condensed nucleus and reduced nuclear activity.  
Spermatozoa have high levels of polyunsaturated fatty acids in the membrane, 
which are responsible for fluidity and, therefore to the same extent, the motility of 
the sperm. The presence of free radicals causes changes in the distribution of the 
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phosphatidyl serine  (PS) of the membrane, which can be measured with the Annexin 
V-binding assay (Glander et al., 1999). Motility strongly decreases as soon as 1 min 
after the addition of H2O2 (data not shown), and all spermatozoa became immotile 
after 15 min. Although changes at the membrane level are evident, no changes in the 
percentage of TUNEL positive cells were found during the first hour of incubation in 
the presence of H2O2 confirming the results of (Hughes et al., 1996) but in contrast to 
the results presented by Lopes et al., (1998a). This difference can be explained by the 
fact that the last author used samples of infertile men, which are probably more 
sensitive to DNA damage than spermatozoa from normal men.  Furthermore, higher 
levels of H2O2 were used by these authors. In our setting, it was only when the sperm 
samples were incubated for additional 24 h after damage induction that a significant 
increase in DNA-damage was detected compared with the samples without previous 
damage induction (16.3 versus 10.0 % respectively, P<0.05). This result suggests that 
normal spermatozoa in the presence of oxidative agents become immotile long 
before any DNA-damage can be detected.  
DNA breaks in spermatozoa can be directly induced by irradiation with γ-rays 
(Haines et al., 1998). However, fertilisation capacity and pronuclear formation is not 
impaired in damaged cells (Twigg et al., 1998; Ahmadi et al., 1999a; Ahmadi et al., 
1999b). We also found a significant increase in DNA fragmentation, which is 
proportional to the doses of radiation applied. However there was neither a 
significant difference in motility, nor a change in the Annexin V-binding capacity, 
immediately after irradiation of the cells. This suggests that the damage at first 
instance seems to be restricted to the nucleus. Interestingly, DNA damage was more 
evident after incubation of the cells for 24 h after the radiation was applied, with a 
significant decrease in motility (P=0.01) and an increase in TUNEL positivity 
(P=0.03).  
The activation of endogenous nucleases in mature sperm cells upon interaction 
with exogenous DNA has been already reported (Gorczyca et al., 1993; Weil et al., 
1998). We hypothesise that the initial damage is enhanced by the activation of an 
intrinsic mechanism (activation of endonucleases) that causes the cells to go into 
apoptosis. Although mature spermatozoa are not transcriptionally active, 
endonuclease activity is still found in both epididymal and ejaculated spermatozoa 
and it can be triggered in response to exogenous DNA, causing partial degradation 
of the sperm endogenous chromosomal DNA (Maione et al., 1997; Spadafora 1998). 
Therefore, in cases of obstructive azoospermia or anejaculation, cell breakdown 
caused either by cell ageing or ROS can contribute large amounts of DNA fragments, 
which may be responsible for the activation of endogenous endonucleases. It is also 
possible that mitochondria, which not only metabolise energy for sperm flagellar 
propulsion but also play an important role in cell death, are affected by the presence 
of a high concentration of ROS, disturbing the membranes of the organelle and its 
metabolising function. Dysfunctional mitochondria (Donnelly et al., 2000) together 
with other mechanisms such as oxidation of glycolitic (cytosolic) enzymes may 
contribute to the changes of motility observed in spermatozoa.   
Using motile spermatozoa selected from sperm samples with high levels of 
DNA-breaks (from the 5 Gray γ-radiated aliquots, mean TUNEL 26.5%), were only in 
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2 out of 350 cells (0.5%) positive in the TUNEL assay (P< 0.001). This finding 
indicates that motility can be used as one of the physiologic markers for the selection 
of undamaged cells in ICSI procedures. This is a very important fact, because 
damaged spermatozoa still have the ability to fertilise the oocytes after ICSI (Twigg et 
al., 1998), but lead to poor embryo development and high pregnancy loss rates 
(Sakkas et al., 1998; Ahmadi et al., 1999b). 
In conclusion, the results presented in this article may be relevant for the 
understanding of the processes at both membrane and DNA level which are 
involved in sperm damage following their exposure to agents such as H2O2 or γ 
irradiation. Motility was found to be a relevant physiological marker for intact DNA. 
Further research on DNA damage of the motile (morphological normal) spermatozoa 
which are the candidates to be selected for ICSI, should be carried out in order to 
evaluate the reliability of motility as marker for DNA integrity. 
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ABSTRACT 
 
Objective: to evaluate sperm head normality in epididymal sperm samples from 
obstructive azoospermic (OA) patients. As epididymal samples in obstructive 
azoospermia contain a mixture of immature, mature and aged spermatozoa, we 
evaluated whether the selection criteria used in routine ICSI (morphology and 
motility) is adequate for selecting “normal” sperm from epididymal samples. 
Materials and Methods: surgically retrieved spermatozoa from the caput 
epididymis of 15 azoospermic patients and ejaculated samples of nine normospermic 
donors were used. Sperm samples were stained with a DNA-specific stain (Feulgen) 
and evaluated with the computerized karyometric image analysis (CKIA) system. 
Original (unselected) samples and a selected “normal” sperm fraction (using the ICSI 
criteria of normal morphology and motility at a 400x magnification) were evaluated. 
Results: a larger variation in almost all measured parameters was found in 
epididymal samples as compared with ejaculated samples. The qualitative analysis 
(normality of the individual sperm cell) and quantitative analysis (percentage normal 
sperm per category) of the selected sperm fractions showed differences between 
epididymal and ejaculated sperm, especially for optical density (stainability) and 
chromatin texture. Selection of epididymal sperm using the ICSI criteria yielded a 
sperm fraction with similar size as selected ejaculated sperm, but with a lower optical 
density (OD) and a larger variation in the OD within the nucleus. The frequency of 
normal sperm per sample significantly increased after selection, this improvement 
was stronger in donors compared with patients.  
Conclusions: a two-fold increase in the number of morphological normal 
spermatozoa was found after ICSI-selection in epididymal sperm samples, as 
evaluated with the CKIA method. The variation of the parameters related to the 
chromatin condensation of epididymal sperm indicates that some of the selected 
spermatozoa show hypo- or hyper-condensed chromatin.  
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INTRODUCTION 
 
Sperm cell integrity is of fundamental importance for fertilization and embryo 
development (Aytoz et al., 1998; Van Dyk et al., 2000; Bartoov et al., 2001; Tesarik et 
al., 2002; Morris et al., 2002). During in-vivo conception and IVF, a natural selection 
process is involved. With the introduction of intracytoplasmic sperm injection (ICSI) 
however, the selection depends on the technician’s eye and experience. This selection 
is mainly based on motility and morphological characteristics at a maximum 
magnification of 400x. Using these markers, high fertilization and pregnancy rates 
can be achieved with ICSI (Palermo et al., 1992), indicating its competence for an 
effective treatment. Whether these selection criteria are adequate and safe for all 
patients is of concern especially in extremely poor sperm samples and in non-
ejaculated sperm.  
One approach to obtain information about the relationship between selection 
criteria and possible genetic risks in the offspring is to assess sperm normality and 
DNA integrity of a selected sperm fraction to use for fertilization. In this study, we 
focus on the nuclear normality of epididymal sperm from patients suffering from 
obstructive azoospermia (OA). In samples obtained from OA males, different 
maturational stages are expected to be found. In addition to immature and mature 
sperm, with respectively incomplete and complete DNA condensation (Saowaros et 
al., 1979; Evenson et al., 1986), post-mature and damaged cells may be present in 
epididymal samples.  
In a previous report, we found that even the slightest sperm tail motility of 
ejaculated sperm is a good marker for the selection of undamaged sperm evaluated 
with the TdT-UTP nick end labelling (TUNEL) assay (Ramos et al., 2001). This finding 
was also valid for motile epididymal sperm from patients with OA (Ramos et al., 
2002b). With the purpose to obtain a further insight into the quality of manually 
selected spermatozoa, we adapted a computerized karyometric image analysis 
(CKIA) system to evaluate sperm nucleus (Ramos et al., 2002a). This method is based 
on the stainability of the cells with a DNA specific stain (Feulgen) in combination 
with CKIA. The advantage of this sperm quality assessment is the integral and 
objective evaluation of the head features of human spermatozoa. CKIA analyses a 
series of parameters which are related to different aspects of the nucleus: 
morphometry (e.g. form, size, etc.), DNA-stainability and characteristics of the 
chromatin texture. The qualitative analysis of each nucleus as well as the quantitative 
analysis of the sample (frequency of normal sperm per sample) can be obtained by 
CKIA.  
The aim of this study is to examine whether the nuclear characteristics of 
epididymal spermatozoa from OA patients are comparable to that of ejaculated 
sperm samples from fertile donors.  Moreover, we evaluated whether ICSI selection 
criteria (“normal” morphology and motility at the routine magnification under an 
ICSI microscope) are suitable markers for the identification of “normal” spermatozoa 
according to the CKIA criteria.  
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MATERIALS AND METHODS 
 
Patients and controls 
Surgically retrieved spermatozoa of the caput epididymis of 15 azoospermic 
patients undergoing a microsurgical sperm aspiration (MESA) or a percutaneous 
epididymal sperm aspiration (PESA) were examined. Cryopreserved semen samples 
of nine normospermic donors from the sperm bank of the University Medical Centre 
Utrecht (UMC Utrecht) were used as controls.  
All patients signed an informed consent for participation in the study. The 
project was approved by the Ethical Committee of the University Medical Centre 
Nijmegen (UMCN, CMO) and the Dutch Central Committee for Research Involving 
Human Subjects (CCMO, The Hague).  
 
Sperm samples 
Epididymal and donor sperm samples were processed as described previously 
(Ramos et al., 2002a). Briefly, spermatozoa were concentrated by washing the 
samples in human tubal fluid culture medium (HTF, Cambrex, Bio Whittaker 
Europe, Vervier, Belgium) supplemented with 10% human plasma proteins (GPO; 
CLB, Amsterdam, the Netherlands), twice (5 minutes) at 500x g.  
From patients and donors, a droplet of the total sperm sample was let to air-dry 
on a glass slide for the analysis for the unselected sperm population. The rest of the 
sperm sample was used for selecting spermatozoa as follows: 1 µl of sperm 
suspension was placed in 5 µl of a 5% polyvinylpyrrolidone solution (PVP; Medicult, 
Denmark) and left to swim out for a couple of minutes. Using a magnification of 
400x, spermatozoa were selected with the use of micromanipulators and an ICSI 
injection pipette (Humagen, USA). Motile and morphologically normal spermatozoa 
as observed at 400x magnification were individually selected. This procedure was 
repeated until enough sperm (50-100) were collected for analysis.   
 
Feulgen stain 
All chemicals were provided by Merck, Darmstadt, Germany, unless indicated 
differently. Air-dried sperm samples were pre-fixed in a freshly prepared Carbowax 
/ NaCl 0.9% solution (1/1 v/v) (100% Carbowax: 2% Polyethyleneglycol MW 1500 in 
50% ethanol) during at least 24 hours (at 4ºC). Subsequently, the samples were fixed 
for one additional day with 100% Carbowax (at 4ºC) and then immersed in Böhm 
solution (formalin 10%, 5% acetic acid glacial, 85% methanol) for two hours. After 
fixation, nuclei were stained according to the Feulgen-Schiff reaction (hydrolysis in 5 
N HCl for 60 minutes and 30 minutes in Schiff-reagent at room temperature). The 
slides were mounted in Permount (Fischer Scientific, Fairlawn, New Jersey, USA).  
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Table 1: Summarized description of the parameters, the codes and normal ranges 
determined for sperm analysis with the CKIA method. Normal ranges are adapted 
from Ramos et al., 2002. 
Category Code Description of the parameter Normal range 
area nuclear area in µm2 5.5-8.0 
fell elliptic factor (minimum/maximum diameter) 0.52-0.70 
ben bending energy (difference between highest and 
lowest value in the smooth Freeman difference chain 
code (SFDC)) 
1100-1800 
Morphometry 
(describes 
size and 
shape of 
cells) 
nmac nominal mean curvature; factor derived from the 
SFDC 
22-38 
OD optical density (mean optical density of the pixels or 
stainability of the cell) 
0.75-0.86 
IOD integrated optical density (area x OD) 4.29-5.27 
Densitometry 
(related to the 
stain intensity) 
varOD mean variation of the OD of the nucleus 0.18-0.30 
meanhis mean grey value of the line of the maximal diameter 85-135 
sdhis mean standard deviation of the grey values of the 
line of maximal diameter 
38-54 
Chromatin 
texture  
(quantification 
of the pattern 
distribution) cvhis mean coefficient of variation of sdhis 0.37-0.57 
 
CKIA 
The measurement specifications of the CKIA method have been extensively 
described in a previous report (Ramos et al., 2002a). Cryopreservation of the sperm 
samples did not influence the outcome of CKIA (data not shown), but special 
attention is required to the stabilization of the light source during the CKIA 
assessment. Only intact spermatozoa were assessed (debris of fragmented cells 
mainly found in the patients samples were eliminate from the measurements).  
The karyometric parameters recorded for each cell can be grouped in three 
categories: 1) morphometric parameters, which describe size, form and shape of the 
nuclei; 2) densitometric parameters, related to staining intensity (DNA content) and 
3) chromatin texture parameters, related to the stain distribution patterns. The 
description of each individual karyometric parameter, its code and the normal ranges 
as established in our previous report (Ramos et al., 2002a) are presented in Table 1. 
The normal ranges are based on mean and one SD values obtained from the 
measurements of ejaculated sperm samples from normospermic donors. 
In this study we defined the qualitative analysis of a sperm as the value 
assessed for each parameter  per cell (normality of the individual sperm cell). A cell 
is considered “normal” when the values assessed for all parameters analysed were 
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within the normal ranges. The quantitative analysis is defined as the frequency of 
“normal” sperm in each category (morphometry, DNA-stain, chromatin texture) and 
in the summed categories (percentage normal sperm/sample).  
 
Statistical analysis 
Differences between the samples were analysed with the one-way analysis of 
variance (ANOVA) and the Mann Whitney-U test when corresponding. P-values 
<0.05 were considered statistical significant. Data were analysed using the SPSS 11.1 
software package (SPSS Inc., Chicago IL, USA). 
 
 
RESULTS 
 
Qualitative analysis of the CKIA  
In Figure 1, microphotographs of unselected and selected ejaculated sperm 
from a fertile donor sample and epididymal caput sperm from a patient are shown 
(Feulgen staining, 1000x magnification). In Table 2, the mean and SD value of each 
parameter in the unselected and selected sperm populations are presented. In the 
unselected samples, statistically significant differences between patients and donors 
were found only in those parameters related to the cell morphometry (area, fell, ben) 
and the integrated optical density (IOD).  
 
Table 2: Qualitative analysis of the CKIA parameters (mean ± SD) for patients and 
fertile donors in the original sample (unselected sample) and after selection of cells 
using the ICSI criteria. 
Parameter* Unselected spermatozoa Selected spermatozoa 
 Patients Donor Patients Donor 
area 7.09 ± 0.59 6.35 ± 0.53 0.004 6.76 ± 0.54 6.71 ± 0.39 n.s. 
fell 0.60 ± 0.05 0.65 ± 0.03 0.01 0.61 ± 0.04 0.65 ± 0.03 0.018 
ben 1589 ± 148 1454 ± 102 0.02 1547 ± 155 1400 ± 69 0.01 
nmac 32.6 ± 4.0 30.3 ± 2.0 n.s. 32.1 ± 2.9 29.1 ± 2.5 0.012 
OD 0.80 ± 0.04 0.82 ± 0.04 n.s. 0.77 ± 0.04 0.81 ± 0.02 0.003 
IOD 5.69 ± 0.47 5.19 ± 0.45 0.015 5.21 ± 0.53 5.45 ± 0.25 n.s. 
varOD 0.25 ± 0.03 0.23 ± 0.03 n.s. 0.27 ± 0.03 0.23 ± 0.02 0.002 
meanhis 108 ± 10 107 ± 13 n.s. 117 ± 14 105 ± 6 0.015 
cvhis 0.44 ± 0.05 0.43 ± 0.08 n.s. 0.41 ± 0.06 0.48 ± 0.04 0.005 
sdhis 46.3 ± 3.3 44.7 ± 3.2 n.s 46.0 ± 3.4 48.7 ± 3.4 0.05 
* The codes of each parameter are described in Table I. 
n.s.: not significant 
 
In contrast, in the selected sperm fractions of both epididymal and ejaculated 
origin, the mean values of all parameters, except for “area” and “IOD”, were 
statistically significant different between patients and donors. In other words, sperm 
P P
  Evaluation of epididymal sperm by CKIA 
 89 
selection results in sperm heads of similar size, but chromatin texture and stainability 
of the nucleus differ between samples. Another important finding is the larger 
variation (expressed in the SD) in the measurements found in the selected 
epididymal sperm cells.  
 
 
Unselected ejaculated sperm 
 
Unselected epididymal sperm 
 
Selected ejaculated sperm 
 
Selected epididymal sperm 
Fertile donor Patient 
Figure 1: Unselected en selected Feulgen stained spermatozoa of a patient and a fertile donor (1000x 
magnification). 
 
Quantitative analysis of the CKIA 
In table 3 the results of the quantitative analysis (grouped into the categories 
morphometry, DNA-stainability and chromatin texture, and the combination of these 
categories) are expressed in percentages. For both patients and donors, the selection 
of sperm resulted in an increase in the frequency of normal spermatozoa in each 
category. However, the improvement in the frequency of “normal” sperm after 
selection was significantly higher in donor samples compared with patient samples, 
except for the category morphometry. Figure 2 helps to visualize these results and 
also shows the median and extreme values. No statistical differences were found in 
the unselected (original) samples of both patients and donors in any category.  
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Table 3: Quantitative analysis of the unselected and selected sperm fractions of 
patients and fertile donors presented as the percentages of normal sperm nuclei in 
each category and in all categories (% total normal). 
Patients Donors % normal sperm  
per category   Unselected Selected P Unselected Selected P 
% Morphometry 40.5 ± 12.5 54.6 ± 12.8 0.005 46.2 ± 11.9 53.9 ± 12.1 n.s. 
% DNA stainability 48.0 ± 17.8 61.5 ± 14.1 0.037 52.8 ± 15.0 81.3 ± 8.5 <0.001 
% Chromatin texture 46.1± 15.1 49.7 ± 16.2 n.s. 42.3 ± 12.1 69.3 ± 16.2 0.001 
% Total  12.3 ± 8.2 23.7 ± 9.4 0.001 17.2 ± 8.4 40.5 ± 11.8 <0.001 
P values calculated with Mann Whitney U test. n.s.: not significant 
 
Figure 2: Box plot representation of the improvement of nuclear normality after selection by CKIA 
analysis: percentage normal for each category separately (a, b, c) and for all categories integrated (d). 
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DISCUSSION 
 
In this study, epididymal and ejaculated sperm samples were analysed with the 
CKIA system.  The original sperm samples were compared with a sperm fraction that 
was selected for motility and normal morphology, mimicking the ICSI procedure. 
Using these markers for selection (morphology and motility), a two-fold increase in 
the frequency of “normal” sperm was observed in epididymal and ejaculated 
samples. Nevertheless, even in the best samples only 55% of the selected 
spermatozoa scored normal with CKIA.  
A possible explanation for the relative low numbers of sperm scoring “normal” 
with CKIA relies on the accuracy of the normal ranges used. The normal ranges 
described in our previous study (Ramos et al., 2002a) were derived from the mean ± 
1SD of CKIA measurements obtained from sperm samples that were previously 
classified as normospermic by the WHO criteria. Validation and eventually 
adjustment of these normal ranges needs to be performed in a much larger fertile 
population. On the other hand, in the perspective of the present study, CKIA is still 
of value, because specific types of samples are compared with each other without 
making statements about normality or fertilising potential. 
A remarkable finding in the evaluation of the qualitative measurements is that 
in the unselected sperm samples, only those parameters related to the morphometry 
were significantly different between donors and patients. After selection, however, 
the reverse was found: epididymal and ejaculated samples differed in all parameters, 
except for the area (morphometric parameter). The justification for this finding was 
that the selection is mainly based on morphometric criteria (like size, form and area) 
but do not include other nuclear characteristics of the spermatozoa. We conclude that 
spermatozoa with similar external characteristics do not necessary hold the same 
internal structures. This points to a shortage in the routine sperm selection and needs 
further investigation. 
A lower mean value in the optical density (OD) and integrated OD parameters 
was found in epididymal sperm, contrary to our expectation. The OD and IOD are 
related to the accessibility of the stain in the nuclear chromatin (Bito et al., 1999) and 
this is higher in immature sperm (Saowaros et al., 1979). However, a larger variation 
in the OD within the nucleus (varOD) was also found in epididymal sperm that 
indicates differences in chromatin packaging. We speculate that a fraction of the 
epididymal samples might be “hypercondensed” sperm. In samples obtained from 
OA patients, besides immature and mature cells, aged cells are present. These post-
mature or aged spermatozoa may have continued thiol crosslinking and present 
some degree of chromatin hypercondensation. Hypercondensed nuclei are less 
accessible for Feulgen stain, leading to our present results. Currently we stated 
investigations based on this hypothesis by studying packaging of spermatozoa from 
different origins and correlate this packaging with DNA damage and repair.  
Taking into account the results of the quantitative analysis, in each CKIA 
category (see Tables 1 and 3) patient and donor samples did not differ before 
selection. After selection, a larger frequency of “normal” spermatozoa was found in 
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both patients and donors. However, higher improvements were achieved in the 
densitometric and chromatin texture categories of donor sperm samples. Therefore, 
selection for motility and normal morphology in an ICSI setting increases the 
frequency of “normal” sperm as assessed by CKIA, but the improvement in the 
frequency of normal sperm differed per sperm sample and per origin.  
In conclusion, an increase in the frequency of morphological normal 
spermatozoa was observed after selection by morphology and motility under ICSI 
conditions. This finding joins the results of our previous work, where motile selected 
spermatozoa showed an increase in the nuclear integrity assessed by TUNEL (Ramos 
et al, 2002b). The present results give rise to further research on sperm chromatin 
packaging and DNA damage in spermatozoa from different origins. 
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ABSTRACT 
 
Obstructive azoospermia (OA) includes a heterogeneous group of patients with 
a clinical history of obstruction such as congenital bilateral absence of vas deferens 
(CBAVD), post vasectomy/failed vaso-vasostomy, trauma, infection or is 
unexplained (others/unknown). The rate of DNA damage and abnormal chromatin 
condensation in epididymal sperm of OA patients was investigated for the different 
aetiology subgroups.  
Methods: DNA damage in caput epididymis spermatozoa was assessed with the 
TdT-UTP nick end labelling (TUNEL) assay and chromatin condensation status was 
measured with chromomycin A3 (CMA3) stain in 53 OA patients. FSH, inhibin B and 
a testicular biopsy were obtained from all patients.  
Results: no difference between FSH and inhibin-B levels or the testicular histology 
was found between the different aetiologies of OA. All epididymal sperm samples 
showed high levels of TUNEL positivity. CMA3 rates showed large variation within 
the samples, however, a significant difference in chromatin condensation degree was 
found between the different aetiologies of obstruction. The highest levels of CMA3 
positive cells were found in the CBAVD and “others/unknown” groups compared 
with the post-vasectomy samples. Epididymal sperm of post vasectomy men show 
similar rates of abnormal chromatin condensation as ejaculated sperm of fertile 
donors.  
Conclusions: Despite histological and hormonal normality in all obstructive 
azoospermic males included in this study, indicators for DNA damage and abnormal 
chromatin condensation were highly elevated in caput epididymal sperm. The 
chromatin abnormality rate differed between obstructive azoospermic patients. The 
physiological cellular heterogeneity found in the chromatin condensation between 
patient subgroups is probably influenced by the aetiology of the obstruction.  
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INTRODUCTION 
 
The introduction of intracytoplasmic sperm injection (ICSI) has made possible 
the use of spermatozoa, which otherwise would not be able to fertilize oocytes 
(Palermo et al., 1992). Although good fertilization rates has been obtained using 
epididymal sperm (Tarlatzis et al., 2000), the safety of the use of non-ejaculated 
spermatozoa in ICSI  should be further investigated. Epididymal or testicular 
spermatozoa have not yet completed chromatin condensation (Saowaros et al., 1979) 
and may contain high rates of DNA breaks (Ramos et al., 2001; O'Connell et al., 2002). 
Hence, there is an increasing need for assessing the DNA integrity of spermatozoa to 
evaluate whether the use of sperm from infertile or azoospermic men for fertilization 
is a safe procedure. It is known that ejaculated spermatozoa of infertile males do not 
only differ in sperm count and morphology but also in DNA damage (Sun et al., 
1997), chromatin structure (Evenson et al., 1999), fertilization capacity (Esterhuizen et 
al., 2000) and/or genetic anomalies (Van Dyk et al., 2000). Some reports on the quality 
of epididymal sperm published show that, while no increase in genetic anomalies are 
found in cases of obstructive azoospermia, differences at nuclear level are found in 
epididymal sperm (Foresta et al., 1995b; Francavilla et al., 1996; Steele et al., 1999; 
Palermo et al., 2002; O'Connell et al., 2002). 
Chromatin condensation is also related to male fertility potential (Manicardi et 
al., 1995; Sakkas et al., 1995; Sun et al., 1997; Manicardi et al., 1998). Since 
abnormalities in nuclear condensation is related to DNA damage in ejaculated 
sperm, epididymal sperm should be also susceptible to damage because of the 
incomplete chromatin condensation. In a previous study on epididymal spermatozoa 
from obstructive azoospermic patients (Ramos et al., 2002b), we have demonstrated a 
high frequency of DNA damage in sperm heads using the TdT UTP-nick end 
labelling (TUNEL) assay. However, if only motile spermatozoa were analysed, the 
frequency of occurrence of DNA damage was no different as in the motile fraction 
from ejaculates of normospermic men, indicating the importance of this 
physiological marker as selection criteria for ICSI. In the same study, DNA damage 
was assessed in patients with obstructive azoospermia unrelated the aetiology of the 
obstruction. To take into account, in epididymal samples in OA, a mixture of 
immature, mature and aged cells are present. Because the cause of the azoospermia 
and especially the origin of the obstruction are very diverse, it is relevant to 
investigate whether the integrity of epididymal spermatozoa is comparable in all 
cases of OA. 
In the present study, we continued our investigation on DNA damage in 
epididymal sperm in relation to the chromatin condensation status using the 
chromomycin A3 (CMA3) fluorochrome. Both parameters were evaluated in 
different aetiologies of obstruction: 1) congenital bilateral absence of the vas deferens 
(CBAVD), 2) post-vasectomy or failed vasovasostomy and 3) idiopathic obstructive 
azoospermia or due to other causes among which trauma, inflammation, etc. 
(“others/idiopathic”). In order to render a more complete insight into the physiology 
of spermatogenesis in these patient groups, the follicular stimulating hormone (FSH), 
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inhibin B, and the testicular histology was evaluated in all patients. The results are 
discussed from the perspectives of a faulty spermatogenesis, epididymal transport 
and the aetiology of the obstruction.  
 
 
MATERIALS AND METHODS 
 
Patients and controls 
Obstructive azoospermic patients (n= 53) attending our fertility centre were 
included in this study. Obstructive azoospermia was defined as absence of 
spermatozoa in two or more consecutive semen analyses, concomitantly with the 
presence of epididymal sperm during a percutaneous epididymal sperm aspiration 
(PESA) procedure and a mean Johnsen score in the testicular biopsy ≥ 8 (Johnsen 
1970). After an evaluation of medical history, biochemical markers, physical 
examination and genetic screening (for CBAVD alleles), the aetiology of the 
obstruction was classified as follows: a) CBAVD  (n= 15), b) post vasectomy patients 
(acquired obstruction due to vasectomy or failed vaso-vasostomy, n= 19) and c) a 
heterogeneous group with history of trauma, infection, etc. or unknown/idiopathic 
(“others/unknown” n=19).  
All patients signed an informed consent for participation in the study. The 
project was approved by the Ethic Committee of the University Medical Centre 
Nijmegen (UMCN, CMO) and the Dutch Central Committee for Research Involving 
Human Subjects (CCMO, The Hague).  
Semen samples of 13 anonymous normospermic donors, according the World 
Health Organization criteria (WHO 1999), were used as controls for the TUNEL and 
CMA3 assays. 
 
Sperm samples and testicular biopsy 
From all 53 azoospermic patients, fresh epididymal spermatozoa from the head 
of the epididymis (caput) were obtained under local anaesthesia by PESA as 
described by Craft and colleagues (Craft et al., 1995a), together with an open 
testicular biopsy. The testicular biopsy was fixed in Bouin’s fluid until mounting in 
paraffin and sections were stained with haematoxylin-eosin for the histological 
examination at the Pathology Department of the UMCN. Biopsies were classified 
using the score described by Johnsen based on at least 25 tubular cross sections 
(Johnsen 1970).  
Fresh epididymal sperm were concentrated by washing the samples in human 
tubal fluid culture medium (HTF, Cambrex, Bio Whittaker Europe, Belgium) 
supplemented with 10% human plasma proteins (GPO; CLB, Amsterdam, the 
Netherlands), two times (5 minutes) at 500 x g. The sperm count was assessed 
following the WHO criteria (WHO 1999). Cryopreserved (ejaculated) sperm samples 
(controls) were also processed as for the epididymal samples.  
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Blood samples 
A blood sample was obtained from all patients (not from the controls) for the 
determination of FSH and inhibin B in serum. FSH was measured with the 
Fluorescence Immuno Enzymatic assay kit (Abbott Diagnostics, USA) using the 
Random Access Analyser (Type AxSYM, Abbott, USA), reference range in our 
laboratory is 1.5-11.0 IU/l. Dimeric inhibin-B was quantified using a solid phase 
sandwich enzyme-linked immunosorbent assay (ELISA) specific for the 
measurement of inhibin-B in human serum (Oxford Bio-Innovation Ltd, Oxford, 
UK). The assay was performed as described in the kit. Sensitivity of the assay is 
estimated <15 pg/ml with high specificity (about 1% cross reaction with inhibin-A). 
 
Chromatin condensation  
Defects in chromatin condensation that increase the accessibility of the DNA for 
dyes were analysed using chromomycin A3 (CMA3) (Evenson et al., 1986). For the 
CMA3 (Sigma-Aldrich, Steinheim, Germany) staining we used the procedure 
described by Bianchi et al. (Bianchi et al., 1993). A droplet of 5 µl of cell suspension 
was air-dried on a glass slide. Cells were fixed during 5 minutes in cold (4°C) 
methanol/acetic acid, 3:1, and washed twice with phosphate-buffered saline (PBS, 
Sigma, MO, USA), pH 7.4. Each slide was treated with 100 µl CMA3 solution (0.25 
mg/ml in McIlvaine buffer, pH 7.0 containing 10 mM MgCl2) in the dark for 20 
minutes at room temperature. Slides were washed 3 times 5 min. in PBS and 
mounted in mounting medium for fluorescence (Vectashield, Vector laboratories, 
Inc. CA, USA). 
Chromatin condensation was assessed by scoring the CMA3 stained 
spermatozoa as positive or negative (positive cells are poorly condensed).  
Evaluation of the stain intensity was carried out using a Leitz DM RBE fluorescent 
microscope provided with a band pass filter (I3, excitation BP 450-490 nm, emission 
LP 515) connected to a Macintosh computer. Digital images were captured and 
analysed with the image analysis package software (IPLab spectrum software, Signal 
analysis corporation, USA). Cells were considered positive when the fluorescence 
intensity was > 1000 (arbitrary units; lowest and highest detected fluorescence in 
human sperm cell were 400± 50, and 2600 ± 200 respectively). A mean of 184 ± 88 and 
199 ± 100 cells were scored for patients and controls respectively. The results are 
presented as the percentage of positive cells per sample. 
 
DNA-damage  
The determination of DNA-breaks in sperm samples of patients and controls 
was carried out using the TUNEL assay (Cell Death Detection kit, Roche 
Biochemicals, Mannheim, Germany) following the manufacturer’s specifications with 
minor modifications. Briefly, air-dried spermatozoa on glass slides were fixed with 
4% paraformaldehyde in PBS, during 10 minutes at room temperature and rinsed 
twice with PBS (5 minutes) followed by membrane permeabilization with 0.2% 
Triton X-100 in PBS, for 10 minutes. The TdT-labelled nucleotide mix was added to 
each slide and incubated at 37 °C for 60 minutes. Slides were rinsed twice in PBS. 
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Subsequently, the sperm nuclei were counterstained with 4,6-diamidino-2-
phenylindole (DAPI, Sigma, MO, USA; 0.01mg/l in PBS). The slides were mounted 
in Vectaschild. The total number of blue staining sperm nuclei per field (DAPI) was 
first counted. The number of cells with green fluorescence (TUNEL positive) was 
expressed as a percentage of the total cell number. A mean of 308 ± 131 and 498 ± 182 
cells were measured per patient and controls respectively.   
 
Statistical analysis 
Prior the statistical analysis, non-normally distributed data were logarithmic 
transformed in order to stabilize variances. For a better clinical interpretation of the 
data, the untransformed median and ranges are presented in the Tables. In case of 
more than two groups, one-way analysis of variance (ANOVA) was used with the 
corresponding Tukey contrast test.  
Pearson correlation-test of the logarithmic transformed data was used to 
evaluate the relationship between the different parameters in relation to the aetiology 
of the obstruction. Statistical differences were considered significant at P<0.05. 
Statistics were carried out with the SPSS 11.1 for Windows software package (SPSS 
Inc., Chicago, IL, USA) 
 
 
RESULTS 
 
Clinical results in relation to the aetiology of the azoospermia 
All obstructive azoospermic patients in this study had a positive epididymal 
sperm retrieval and a mean Johnsen score ≥ 8.4. From the different aetiologies of 
azoospermia, the median and ranges for age, FSH, inhibin B and Johnsen score are 
given in Table 1. The only significant difference between the groups was the age of 
the post-vasectomy patients. The FSH and inhibin B levels showed a large variation 
in all aetiology groups but no statistical difference was found for between groups. 
FSH and inhibin B negatively correlated in the CBAVD (r= - 0.88, P< 0.001) and 
“others/unknown” groups (r= - 0.72, P< 0.001) but not for the post-vasectomy 
patients (r= -0.37, not significant). Inhibin B and FSH of controls were not available.   
 
Chromatin condensation and DNA damage 
The median and ranges of the percentage TUNEL and CMA3 positive cells are 
given in Table 2. For a better visual interpretation of the data, the results are 
illustrated in a box plot representation (Figure 1, median, the 25 and 75% quarters 
and minimum/maximum values for each group and controls). High percentages of 
DNA damaged cells (TUNEL positive) were found in all epididymal samples 
compared with the control (ejaculated) samples (P< 0.001). TUNEL rates in the 
different aetiologies of obstruction mutually did not differ. High rates with large 
variation in chromatin condensation degree (CMA3) were measured in most 
epididymal samples compared with the controls (P<0.001). However, analysis of the 
chromatin condensation related to the different aetiologies of obstruction showed 
important differences between the different aetiologies of obstruction. Epididymal 
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spermatozoa of CBAVD and “other/idiopathic” patients have significant higher 
rates of CMA3 positive sperm compared with the post vasectomy group (P= 0.001). 
 
Table 1: Median (ranges) of the clinical characteristics of patients with obstructive 
azoospermia. 
Obstructive azoospermia  
CBAVD Others/unknown Post-vasectomy 
n 15 19 19 
Age (years) 
31.8 b 
(26-41) 
35.2 b 
(29-49) 
45.3 a 
(35-60) 
FSH (IU/ml) 
3.6 
(1.3-15.0) 
3.9 
(1.7-17.4) 
4.9 
(1.5-8.4) 
Inhibin B (pg/ml) 
148 
(63-222) 
132 
(15-247) 
172 
(42-276) 
Johnsen Score 
9.3 
(8.4-9.9) 
9.0 
(8.5-10) 
9.4 
(8.6-9.7) 
a vs. b P<0.05 (ANOVA – Tukey test) 
 
In contrast, the frequency of CMA3 positive cells in the post vasectomy group does 
not statistically differ to that of ejaculated normospermic men, although a twice as 
large variation was measured in the patient group (SD= 24.6 and 11.5 for post 
vasectomy and controls respectively). Moreover, only for the post-vasectomy and 
control samples, a correlation between CMA3 and TUNEL was found (r= 0.51, 
P=0.07), but not for the other aetiologies (Figure 2). Evaluation of FSH and inhibin B 
versus CMA3 and TUNEL showed a significant negative correlation between inhibin 
B and CMA3 in the CBAVD group (r= -0.57, P=0.04). Such correlation was not found 
for the post vasectomy men (r= -0.07).  
 
Table 2: Median (ranges) of the TUNEL and CMA3 measurements in epididymal 
sperm grouped by the aetiologies of azoospermia and in the ejaculated sperm of 
controls. 
Obstructive azoospermia  
CBAVD 
(N=15) 
Others/unknown 
(N=19) 
Post-vasectomy 
(N=19) 
Controls 
(N=13) 
% TUNEL 37.5 b 
(22-69) 
36.7 b 
(24-47) 
37.9 b 
(10-66) 
9.7 a 
(4-14) 
% CMA3 58.7 d 
(12-88) 
65.3 d 
(28-97) 
29.4 c 
(6-81) 
30.2 c 
(9-45) 
a vs. b P < 0.001,  c vs. d P <0.05 (ANOVA- Tukey test of log transformed values) 
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Figure 1: Box plot representation of the CMA3 and TUNEL rates for patients and donors. The boxes 
represent the 25% and 75% of the measurements; the thick line is the median (FVV= post-vasectomy 
or failed vaso-vasostomy). 
 
Figure 2: Correlation between CMA3 and TUNEL for patients (*) and controls (•). A weak correlation 
was found for the post-vasectomy group (r=0.42, P=0.07) and control (r=0.51, P=0.07), but not for the 
other aetiologies. The regression line corresponds to the post-vasectomy group (                ),  
controls (               ) and CBAVD/others (             ) respectively. 
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DISCUSSION 
   
In this study, we focussed on the nuclear characteristics of epididymal sperm of 
patients with obstructive azoospermia. Clinical parameters in relation to the 
aetiologies of obstructive azoospermia were analysed in relation to the abnormal 
chromatin condensation and DNA damage. High frequencies of DNA damage and 
abnormal condensation were found in spermatozoa recovered from the caput 
epididymis of azoospermic patients. These results are in concordance to our prior 
report on DNA damage (Ramos et al., 2001) and chromatin condensation status of 
epididymal sperm by others (Saowaros et al., 1979; Evenson et al., 1986). However, 
the abnormal chromatin condensation rate in the epididymal samples in cases of OA 
differs from a normal physiological situation. We hypothesize that the different 
aetiologies of the obstruction may contribute to some of the differences found in OA 
patients. Especially in the CBAVD and “others/unknown” groups, sperm 
condensation abnormalities were significant higher than in epididymal samples of 
post vasectomy men. Interestingly, only for the post-vasectomy samples, abnormal 
chromatin condensation (CMA3) was related to the DNA damage (TUNEL) in a 
similar pattern as for ejaculated samples (Manicardi et al., 1995; Bianchi et al., 1996). 
In contrast to our expectation, the higher rates of CMA3 positive cells in the CBAVD 
and “others/unknown” samples did not lead to higher TUNEL positive cells. This 
observation suggests that some nuclear characteristics of epididymal sperm may 
differ per aetiology.  
FSH and especially inhibin B are considered good markers for spermatogenesis 
(Pierik et al., 1998). While FSH and inhibin B concentration of the post-vasectomy 
males were found within the levels described for normospermic men (Jensen et al., 
1997; Pierik et al., 1998), inhibin B concentration in CBAVD and others/unknown 
patients was similar to the levels described for moderate and severe oligospermia 
(Pierik et al., 1998). While the testicular histology scored ≥8.4 according to the 
Johnsen score (Johnsen 1970), still in four out of 53 cases (7.5%) inhibin B levels were 
below the cut-off value for severely impaired spermatogenesis (80 pg/ml) (Pierik et 
al., 1998; Meachem et al., 2001; Brugo-Olmedo et al., 2001). These inconsistencies (low 
inhibin B and normal spermatogenesis) remark the differences in spermatogenesis 
regulation present in OA, and the limited value of hormones in the diagnosis of 
completed spermatogenesis, and consequently, of obstructive azoospermia. 
The high level of DNA damage observed in epididymal spermatozoa in 
obstructive azoospermia is probably a consequence of the a-physiological situation in 
the obstructed epididymis. Two mechanisms may explain this finding: a) cell ageing 
due to the long stay in the epididymis, cell breakdown and generation of reactive 
oxygen species (ROS), and b) incomplete chromatin condensation (SH cross linking 
between protamines) at the level of the caput epididymis (Saowaros et al., 1979), 
rendering the nuclei more sensitive for damage.    
With reference to the first option (a) the high level of DNA damage of sperm 
may be a consequence of the long stay of sperm cells, affecting DNA integrity by a 
prolonged exposure to ROS generated from aged cell breakdown. ROS affect sperm 
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motility before DNA damage could be detected. This option was evaluated in vitro in 
a previous study using ejaculated samples and by others (Aitken et al., 1998; Ramos et 
al., 2001).  
The second mechanism (b), defects or incomplete chromatin condensation were 
analysed using the binding properties of the CMA3 fluorochrome. This fluorescent 
dye binds to C-G nucleotides of DNA when the cell nucleus is not completely 
condensed (Evenson et al., 1986; Bianchi et al., 1993). In physiological situations, 
chromatin condensation (SH-linking) progresses from caput to cauda epididymis, 
(Saowaros et al., 1979; Haidl et al., 1994) diminishing the accessibility to DNA dyes. 
As expected, using CMA3 fluorochrome as a marker for chromatin condensation 
defects, we found high levels of binding in almost all caput epididymal sperm 
samples and a large variation in CMA3 binding within samples. However, the 
degree of condensation showed different patterns between the different obstructive 
azoospermic aetiologies. The highest frequencies of CMA3 positive cells were found 
in the CBAVD and “other/unknown” patients, while the CMA3 binding of post-
vasectomy sperm samples overlapped with that of ejaculated samples. We are aware 
of the restriction for not being able to compare epididymal sperm of OA men with 
epididymal sperm of fertile men, however, the observation of differences in 
chromatin condensation present between the aetiologies of obstruction is remarkable. 
The difference in chromatin condensation found may indicate that some maturation 
defects may be generated already at the testicular level, even when spermatogenesis 
is normal as determined by a histological standard method. This suggests that other 
(unknown) factors can influence chromatin condensation. One possible explanation 
for the differences found in condensation status is based on the phase of life in which 
the obstruction occurred: before or after gonadal maturation. Some hints support our 
observations: 1) spermatogenetic defects and failure of testicular development have 
been described in adult CBAVD patients (Meng et al., 2001); 2)  genital anomalies, e.g. 
small testes have been reported in children with cystic fibrosis (Blau et al., 2002); 3) 
epididymal spermatozoa of CBAVD patients have a lower fertility capacity with IVF 
(Patrizio et al., 1995) compared with the post-vasectomy patients. Therefore, we 
hypothesize that, if the obstruction occurs before sexual maturation, testicular 
development in humans may also be affected as it has been described in animal 
studies (Inaba et al., 1998), inducing abnormal sperm maturation. Therefore, different 
nuclear characteristics in epididymal spermatozoa may be found in obstructive 
azoospermia.  Whether abnormal nuclear condensation has any effect on the ICSI 
procedure outcome should be further investigated. 
In summary, no significant differences were found in the hormone levels (FSH 
and inhibin B) or testicular histology (Johnsen score) in the different aetiologies of 
obstructive azoospermia. Lower inhibin B levels with a large between-patients 
variation were found in obstructive azoospermia, especially in CBAVD and 
unknown causes of obstructive azoospermia. In all epididymal samples analysed, a 
two to ten fold increase in TUNEL positive cells was found compared with ejaculated 
samples from normospermic men. While high levels of abnormal chromatin 
condensation measured by CMA3 staining were found in epididymal samples, we 
observed large differences between the different obstructive aetiologies.   
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In conclusion, our results suggest that differences in chromatin condensation 
present in epididymal spermatozoa are partially related to the origin of the 
obstruction, being more accentuated in patients suffering from CBAVD or unknown 
causes of obstructions compared to epididymal sperm of post-vasectomy men. DNA 
damage in caput epididymal sperm measured with TUNEL is not related to 
chromatin condensation except for the post-vasectomy samples. The clinical 
relevance of the different nuclear condensation degree for the fertility treatment of 
OA patients should be further investigated. 
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ABSTRACT 
  
The aim of this study is to determine the degree of DNA fragmentation in 
spermatozoa obtained of men with obstructive azoospermia or anejaculation 
compared to ejaculated spermatozoa from fertile donors.  
Materials and Methods: Forty-one patients with obstructive azoospermia or 
anejaculation and 10 donors were included in this study.  Sperm samples were 
obtained surgically from the epididymis or testis of men with azoospermia or 
anejaculation and by ejaculation in fertile patients. DNA-fragmentation was analyzed 
in the total sample and in a motile fraction that was isolated as in routine ICSI 
procedures. DNA breaks were measured using the TdT-mediated dUTP nick end-
labelling (TUNEL) assay.  
Results: A higher percentage of cells with DNA-breaks was found in men with 
obstructive azoospermia or anejaculation compared with donors (mean 18.9% and 
6.2% respectively). A significant lower degree of DNA-fragmentation was observed 
in the motile fraction from patients compared with donors (0.4% vs. 0.6%).  
Conclusion: High percentages of cells with DNA damage were found in sperm 
samples from men with obstructive azoospermia or anejaculation, but a very low 
frequency of damage to the DNA was observed in the motile fraction. In an ICSI-
setting, the use of motile sperm retrieved from epididymis or testis of men with 
obstructive azoospermia does not seem to pose a higher genetic risk for the progeny 
than does use of motile ejaculated sperm. 
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INTRODUCTION 
 
High fertilization rates and pregnancies have been achieved in cases of 
obstructive azoospermia by using epididymal sperm for IVF in combination with 
ICSI (Hovatta et al., 1995; Nagy et al., 1995; Silber et al., 1995b). This practice is 
routinely used worldwide (Friedler et al., 1998; Aytoz et al., 1998; Tournaye et al., 
1999; Palermo et al., 1999); in the Netherlands this technique was successfully (Dohle 
et al., 1998) until a moratorium in 1995 was applied. The main reason for this 
moratorium was concern about possible long-term negative effects on the health of 
the children born after ICSI using non-ejaculated sperm (Meuleman et al., 1998b). 
Non-ejaculated spermatozoa may be immature or senescent because of the long stay 
in the obstructed epididymis, conditions that may introduce genetic risks if these 
spermatozoa are used for fertilization.  
Use of non-ejaculated spermatozoa poses various risks. First, injection of 
testicular sperm into oocytes may produce unknown effects in offspring owing to 
uncompleted genomic imprinting, incomplete chromatin condensation, and 
incomplete protamination (Golan et al., 1996; Tesarik et al., 1998b). However, in the 
mouse, no evidence has been seen of active genomic imprinting during the transit of 
the sperm through the epididymis (Yanagimachi 1998), and no imprinting defects 
have been found until now in children born after ICSI (Manning et al., 2000a). In 
addition, epididymal spermatozoa from obstructive azoospermic patients may be 
damaged by aggressive molecules because of their long stay in the epididymis. This 
idea has not been studied. Damaged spermatozoa can fertilize oocytes (Twigg et al., 
1998; Ahmadi et al., 1999b) and the risk to the offspring when such spermatozoa are 
used may be higher than that in normal IVF or ICSI (Ahmadi et al., 1999a).   
We used the TdT-mediated dUTP nick-end labelling (TUNEL) assay. This assay 
identifies single and double-stranded DNA breaks, labelling free 3’OH termini with 
modified nucleotides in a template-independent manner (Sun et al., 1997). In a 
previous study (Ramos et al., 2001), we found that after a gamma radiation dose of 5 
Gray and an incubation time of 24 hours, motile sperm almost exclusively were 
negative on the TUNEL assay whereas the rest of the irradiated sample had 
significantly more damage. This finding indicates that motility may be used as a 
marker to identify undamaged sperm cells. 
We used the TUNEL assay to evaluate the risks of using epididymal and 
testicular spermatozoa from men with obstructive azoospermia or anejaculation in 
ICSI and to compare the frequency of DNA damage in non-ejaculated spermatozoa 
with that obtained by electroejaculation. DNA-breaks were determined in the total 
sample and in selected motile cells to investigate whether motility can act as a 
marker to identify undamaged cells in ICSI procedures.  
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MATERIALS AND METHODS  
 
Patients 
Sperm samples were obtained from 41 patients attending our hospital for 
fertilization surgery (e.g., vasovasostomy or vasoepididymostomy), electro-
ejaculation, or fertility diagnosis. Thirty-six patients had obstructive azoospermia, 
and 5 had spinal cord injury. Ejaculated samples from 10 fertile donors from the 
University Medical Centre Utrecht sperm bank were used as controls. The duration 
of obstruction ranged from 6 months to 20 years. Informed consent for patient 
participation was obtained from patients, and the project was approved by the local 
ethics committee for Medical Research.  
Sperm samples were obtained during surgery by using microsurgical sperm 
aspiration (MESA, 9 patients) or percutaneous epididymal sperm aspiration (PESA, 
18 patients). Nine samples were obtained by testis biopsy to confirmation of 
obstructive azoospermia.  In 5 patients with spinal cord injury, an ejaculated sample 
was obtained by electrostimulation. We decided to include these patients because 
their spermatozoa also remain in the epididymis for long periods, as for obstructive 
azoospermia. 
 
Sperm collection and preparation of samples 
Surgical aspirates from the epididymis or from electroejaculation were collected 
in human tubal fluid (HTF, Bio Whittaker Europe, Verviers, Belgium) culture 
medium (Quinn et al., 1985) and washed twice (5 minutes each time) at 500 x g to 
concentrate the samples. Motility rates, sperm count, and morphology were assessed 
following the World Health Organisation criteria (WHO,1999). Testicular tissues 
were placed in Petri dishes with 2 mL of human tubal fluid medium and macerated 
between two glass slides to recover single spermatozoa. Cryopreserved sperm 
samples from 10 fertile donors were used as controls for the determination of DNA 
breaks in spermatozoa.  
A droplet of cell suspension from each sample was allowed to air dry on glass 
slides for the TUNEL assay. 
 In 24 epididymal samples and 10 donor samples, the motile fraction was 
isolated and analyzed for the presence of DNA breaks. Motile spermatozoa was 
selected as follows: one µL of sperm suspension was placed in 5 µL of 5% 
polyvynilpyrrolidone solution (PVP; Medicult, Jyllinge, Denmark), and sperm were 
allowed to swim out for a couple of minutes. Using a magnification of X400, 
spermatozoa were selected by using micromanipulators and an ICSI injection pipette 
(Humagen, Chalottesville, VA). Morphologically normal spermatozoa (those that 
showed any progressive motility in the PVP solution) were individually selected, 
placed on a glass slide, and allowed to dry before fixation. Because this procedure is 
time consuming, a mean of 40 sperm cells (range: 10-109) per patient and 88 sperm 
cells (range 65-123) per donor could be selected in this way for the TUNEL assay.   
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TUNEL 
Air-dried sperm samples were used to determine DNA-breaks with the TUNEL 
assay (Cell Death Detection kit, Roche Biochemicals, Mannheim, Germany). We 
followed the manufacturer’s specifications, with minor modifications. In brief, air-
dried samples were fixed with 4% para-formaldehyde at room temperature, rinsed 
with phosphate-buffered saline (PBS, Sigma, St. Louis, MO, USA) (pH 7.4) and made 
permeable with 2% Triton X-100. The TdT-labelled nucleotide mix was added to each 
slide and incubated at 37 °C for 60 minutes. Slides were rinsed twice in PBS and 
counterstained with 4,6-diamidino-2-phenylindole (DAPI, Sigma, MO, USA). The 
total number of cells per field stained with DAPI (blue) was counted, and the number 
of cells with green fluorescence (positive on TUNEL) was expressed as a percentage 
of the total cell count. 
  
Statistical analysis 
The SAS software package (SAS Institute, Inc., Cary, NC) was used for all 
statistical analyses. Means and medians with 95% CIs were estimated by using a 
mixed linear model. Statistical differences were considered significant at P<0.05. 
 
 
RESULTS 
 
The quality of sperm from patients and donors is summarized in Table 1. The 
amount of spermatozoa recovered varied depending on the location and method of 
collection (from 10 000 spermatozoa in testis to 350 x 106 spermatozoa in 
electroejaculates). Although the motility rate was low in most of the patient samples, 
motile (and even progressive) spermatozoa were always found. In epididymal 
samples, the best motility was found in samples obtained by PESA of the cauda or 
caput epididymis. These aspirations were mostly performed far from the location of 
obstruction in order to harvest younger cells. Morphology could be determined in 30 
patients; the percentage of normal forms was similar to that in fertile donors (Table 
1). 
Table 2 shows the results of the TUNEL assay. Higher percentages of DNA-
breaks were found in patients compared with donors (18.9% vs. 6.2%, P< 0.001); the 
highest levels of fragmentation were observed in samples obtained from the vas 
deferens (mean fragmentation rate 29.2% [range 4.4- 65.4]). No clear correlation was 
found between the percentage of TUNEL-positive cells and the duration of the 
obstruction (data not shown), even for those samples obtained by electroejaculation. 
We were able to select and analyze the motile fraction by TUNEL in all donors’ 
samples and 24 patients samples. A total of 955 patient spermatozoa (mean, 40 cells 
per patient) and 885 donor spermatozoa (mean, 88 spermatozoa per donor). A 
significant lower rate of DNA-damage was found in both patients and donors after 
selection of the motile fraction (20.1% vs. 0.4% before and after selection, 
respectively, in patients, [P <0.001] and 6.2% and 0.6% for donors respectively [P= 
0.03]) (Table 3). The difference in degree of DNA fragmentation in the motile fraction 
between patients and donors (0.4% vs. 0.6%) was not significant. 
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Table 1: Quality of non-ejaculated spermatozoa, spermatozoa acquired by electro-
ejaculation, and ejaculated spermatozoa of fertile donorsa 
Sperm origin N Mean sperm count x 
106cells/ ml (range) 
Mean motility (%) 
(range) 
Mean sperm with 
abnormal morphology 
(%) (range) 
Testicular 9 0.1 
(0.001-0.5) 
11 
(<1- 30) 
NA 
Epididymal 
(caput/ cauda)
18 12 
(0.05-70) 
12 
(1-70) 
84 
(60-92) 
Vas deferens 9 4.5 
(0.01-20) 
26 
(<1- 80) 
83 
(63-94) 
 
 
Patients 
 
Electro-
ejaculates 
5 140 
(35-350) 
6 
(<1-15) 
78 
(65- 90) 
Donors 
 
Ejaculated 10 109 
(60-150) 
63 
(60-75) 
79 
(58- 88) 
Note: NA= not analyzed (because the cells counted were not sufficient for a reliable result). 
a Assessed by using World Health Organization criteria. 
 
 
 
Table 2: TUNEL positive cells, by sperm origin 
 
Sperm origin 
Mean no. of 
counted cells 
TUNEL positive 
cells (%) 
Testicular 193 9.3 ± 2.3 
Epididymal (caput/ cauda) 420 17.4 ± 4.0 
Vas deferens 280 29.2 ± 6.7 
Electroejaculates 411 15.9 ± 2.9 
 
Patients 
(n= 41) 
Mean patient group 338 18.9 ± 2.4 a 
Donors  
(n= 10) 
ejaculated 533 6.2 ± 0.7 a 
Note: values with the plus/minus sign are means ± SD. TUNEL= TdT-mediated dUTP nick end 
labelling.  
a P<0.001 
 
 
 
Table 3: DNA damage in spermatozoa form the full sample and after selection of 
motile fraction  
Percentage TUNEL positive spermatozoa  
Original sample Motile fraction 
 
P value 
Patients (n=24) 20.1± 2.0 0.4 ± 0.2 <0.001 
Donors  (n= 10) 6.2 ± 0.7 0.6 ± 0.3 0.03 
P value 0.001 0.9  
Note: values are means ± SD. 
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DISCUSSION 
 
We found that with the TUNEL assay, the integrity of DNA in the motile 
fraction of epididymal or testicular semen of patients with obstructive azoospermia 
was similar to that in fertile donors. Only a small proportion of cells (0.4% in patients 
and 0.6% in donors) was positive with TUNEL. This finding suggests that motility 
can be used to identify undamaged cells that are candidates for ICSI in cases of 
obstructive azoospermia.  
A consequence of the long stay of spermatozoa in the obstructed epididymis is 
cell aging and cell death. It is therefore important to see whether senescent, 
damaged, or dying spermatozoa in obstructive azoospermia or anejaculation may be 
erroneously selected for ICSI. Because spermatozoa from patients with spinal cord 
injuries and men with obstructive azoospermia undergo similar aging effects (de 
Lamirande et al., 1995), we included the former patients in our study. 
A probable risk posed by use of epididymal or testicular spermatozoa in ICSI is 
that DNA condensation of the chromatin may not be completed in non-ejaculated 
spermatozoa, implying that these cells are more sensitive damaging or toxic agents, 
such as radical oxygen species (ROS). ROS primarily cause membrane damage in 
spermatozoa before any DNA fragmentation can be measured (Ramos et al., 2001). 
We found high proportions of TUNEL-positive sperm cells in samples from patients 
compared with donors (18.9% vs. 6.16%; P <0.001). The highest rates of DNA damage 
were observed in samples obtained close to the obstruction such as those obtained 
from the vas deferens during vaso-vasostomy (mean 29.2%). This finding indicates 
that fresh sperm cells may continuously flow toward the epididymis in obstructive 
azoospermia. On the one hand, motile spermatozoa are relatively young cells and 
may therefore be safe to use in ICSI. On the other hand, because men with 
azoospermia experience no outflow of spermatozoa, sperm cells of different ages 
with different degrees of damage (e.g. caused by ROS) may be also present in the 
epididymis.  
Of note, pronucleus formation has been achieved after injecting oocytes with 
spermatozoa exposed to damaging agents (Twigg et al., 1998). However, the in-vitro 
development of the embryos and live fetuses from these zygotes was problematic 
(Ahmadi et al., 1999b). In contrast, high fertilization and subsequent good pregnancy 
and delivery rates has been obtained by using motile epididymal sperm, suggesting 
that undamaged sperm must have been selected and used for ICSI. This idea is in 
agreement with findings from clinical practice (Tarlatzis et al., 1998; Bonduelle et al., 
1999).  
Although maturational processes related to epididymal transport may be 
beneficial for conventional fertilization (e.g.: chromatin condensation, protamination, 
and gain of motility), they seem not to be essential for fertilization of oocytes in ICSI 
(Hammadeh et al., 1999). In the studied patients, the physiologic variable most 
affected was motility; morphology as assessed by routine procedures was similar to 
that in fertile donors.  
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When only motile spermatozoa with normal morphology (as determined at a 
magnification of X400) were selected for TUNEL, a very low percentage of damaged 
cells was found compared with the total sample (in patients, 0.4% and 20.1% 
respectively; P<0.001). The percentage of damaged cells after selection of the motile 
fraction was similar in patients and donors (0.4% and 0.6% respectively). Therefore, 
we believe that in patients with normal spermatogenesis (e.g., those with obstructive 
azoospermia), motility is a reliable marker for intact spermatozoa when selecting 
cells for use in ICSI.  
In conclusion, we found greater rates of DNA damage in surgically retrieved 
sperm samples from patients with obstructive azoospermia or anejaculation. 
However, on analysis of the motile fraction by using the TUNEL assay, the 
proportion of damage was not significant. This finding underscores the importance 
of sperm selection during the ICSI procedure to minimize the hypothetical risk for 
genetic defects in the offspring. Although our results indicate that ICSI using motile 
non-ejaculated spermatozoa seems to be safe, we still support conscientious follow-
up of the children born from this technique. 
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ABSTRACT 
 
Male genital tract obstructions may result from infections, previous inguinal 
and scrotal surgery (vasectomy) and congenital bilateral absence of the vas deferens 
(CBAVD). Microsurgery can sometimes be successful in treating the obstruction. In 
other cases and in cases of failed surgical intervention, the patient can be treated by 
microsurgical or percutaneous epididymal sperm aspiration (MESA, PESA) or 
testicular sperm extraction (TESE) and intracytoplasmic sperm injection (ICSI). We 
present the results of 39 ICSI procedures for obstructive azoospermia in 24 couples. 
The aetiology of the obstruction was failed microsurgery in 11 patients, CBAVD in 
nine and genital infections in four. Sperm retrieval was accomplished via MESA in 
four cases, PESA in 18 cases and via TESE in 11 cases. TESE was only applied when 
PESA failed to produce enough spermatozoa for simultaneous ICSI. In six patients, 
the ICSI procedure was performed with cryopreserved spermatozoa after an initial 
PESA procedure. Fertilization occurred in 47% of the metaphase II oocytes; embryo 
transfer was performed in 92% of procedures and resulted in a clinical pregnancy in 
13/39 procedures. Ongoing pregnancy was achieved in 10/39 procedures. One 
pregnancy was terminated early after prenatal investigation showed a cytogenetic 
abnormality (47,XX+18, Edwards syndrome). The other nine pregnancies resulted in 
the live birth of 10 children, without any congenital abnormalities. Epididymal and 
testicular retrieved spermatozoa were successfully used for ICSI to treat obstructive 
azoospermia, and resulted in an ongoing pregnancy in 10 of 24 couples (41.6%) after 
39 ICSI procedures, a success rate of 25.6% per treatment cycle and of 27.7% per 
embryo transfer.  
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INTRODUCTION 
 
Azoospermia is found in 10% of male infertility cases and is caused by a 
testicular insufficiency in the majority of patients. In 20% of cases, a bilateral 
obstruction of the male genital tract is responsible for the azoospermia (Hendry et al., 
1994). In the presence of a history of previous scrotal or inguinal surgery or recurrent 
genital infection, an obstruction can be suspected. These patients are characterized by 
normal testis volume and normal concentrations of gonadotrophins [luteinizing 
hormone (LH)/follicular stimulating hormone (FSH)]. In 1-2% of the infertile male 
population, congenital bilateral absence of the vas deferens (CBAVD) is found 
(Anguiano et al., 1992). The definitive diagnosis of obstructive azoospermia is made 
by performing a testicular biopsy, showing normal spermatogenesis. 
Microsurgical repair of vas deferens obstructions or epididymal blockage can 
result in spontaneous pregnancies in 27-56% of cases (Belker et al., 1991; Jarow et al., 
1997). The results are determined by several factors, including site and duration of 
the obstruction, epididymal function, recurrent genital tract infections and sperm 
antibodies. In cases of poor sperm quality after the operation, assisted reproductive 
techniques (ART) have been applied successfully. Recently, intracytoplasmic sperm 
injection (ICSI) has become available for treatment of severe oligospermia (Palermo 
et al., 1992). This technique has also been applied to treat azoospermia if viable 
spermatozoa could be retrieved from the epididymis or the testis, giving results 
similar to those of ICSI for oligospermia (Devroey et al., 1994; Silber et al., 1994). 
We present the results of 39 ICSI procedures for obstructive azoospermia in 
combination with microsurgical epididymal sperm aspiration (MESA), percutaneous 
epididymal sperm aspiration (PESA) or testicular sperm extraction (TESE). 
 
 
MATERIAL AND METHODS 
 
Patients  
The combination of ICSI and sperm retrieval was offered to couples with male 
factor infertility due to bilateral genital obstruction. The mean age of the treated 
males was 38.1 years (SD 6.3), the mean age of the treated females was 34.1 years (SD 
4.2). All males had normal testicular volume, normal serum FSH concentration and, 
on testicular biopsy, a normal sperm count according to the Johnson scoring system 
(Johnsen 1970). Azoospermia was found on at least two occasions. In men with 
CBAVD genetic analysis of common cystic fibrosis transmembrane conductance 
regulator (CFTR) gene mutations were performed on the patient and his spouse. 
These couples were counselled for genetic risks concerning cystic fibrosis inheritance 
before the procedure. In cases of pregnancy, all patients were offered prenatal 
screening, amniocentesis and ultrasound examination. Informed consent was 
obtained from all couples after explanation of the experimental nature of the 
treatment and its known and unknown medical and genetic risks.  
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Ovulation induction and oocyte retrieval  
Pituitary down-regulation was achieved by administering a gonadotrophin-
releasing hormone analogue (GnRHa), triptoreline (Decapeptyl®, Ferring, 
Hoofddorp, The Netherlands) subcutaneously once a day. Multiple follicle 
development was induced with human menopausal gonadotrophin (HMG) 
(Humegon, Organon, Oss, The Netherlands). Depending on the size of the follicles 
and the serum oestradiol concentration, a single injection of 10000 IU of human 
chorionic gonadotropin (HCG) (Pregnyl, Organon) was administrated and a 
transvaginal ultrasound-guided follicular aspiration was performed 34-36 h later. 
 
Oocyte processing 
Oocyte preparation was performed according to the protocol as described by 
(Palermo et al., 1992), with the modification of a maximum of 3 min hyaluronidase 
treatment. Only intact oocytes showing a polar body were microinjected. 
 
Sperm retrieval 
The MESA procedure was performed under general anaesthesia as an 
outpatient procedure. After exposure a dilated tubule of epididymis was 
microsurgically opened and its fluid examined for the presence of motile 
spermatozoa. After four MESA procedures had been performed, the procedure was 
abandoned in favour of PESA in all subsequent cases. Percutaneous aspiration of the 
epididymal head (Tsirigotis et al., 1995) was performed under local anaesthesia of the 
spermatic cord (Figure 1). In the case of an unsuccessful PESA procedure, a testicular 
excisional biopsy (TESE) was performed for extraction of viable spermatozoa (Silber 
et al., 1995c). 
Figure 1. Percutaneous epididymal sperm aspiration (PESA). A 19-gauge butterfly needle is inserted 
into the epididymal head. A mild vacuum is applied and the butterfly needle is moved gently within 
the epididymal head. Clear epididymal fluid is aspirated into the collecting tube for microscopical 
examination. 
 
Sperm Processing 
Following MESA/PESA, the epididymal aspirates were diluted in 10 ml in-vitro 
fertilization (IVF) medium and centrifuged for 10 min at 1500 g. The supernatant was 
removed and the pellet was resuspended in 10 ml IVF medium and the same 
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centrifugation procedure was performed. After removal of the supernatant, the cell 
pellet was incubated until the start of the ICSI procedure. Approximately 1µ of this 
suspension was added to 50 µl of polyvinylpyrrolidone (PVP) solution or diluted in 
50 µl IVF medium in case of very poor motility. 
During the TESE procedure, the testicular biopsies were performed under local 
or general anaesthesia. After obtaining a testicular sample, its adequacy was 
immediately assessed: depending on the outcome of the first sample (i.e. the 
presence or absence of spermatozoa), more testicular tissue might be necessary. In 
the laboratory, the tissue sample was shredded by means of two sterile glass slides 
and a suspension of the cells was made in IVF medium. During an incubation period 
of at least 2 h, spermatozoa were allowed to gain motility. After the incubation 
period, the suspension was centrifuged for 5 min at 300 g and the supernatant was 
removed and recentrifuged for 10 min at 1500 g. Shortly before the injection 
procedure, ~1 µl of the cell pellet suspension was added to 50 µl of IVF medium.  
During the MESA/PESA and TESE laboratory procedures, none of the 
suspensions or washing media was discarded. If spermatozoa were absent in the 
pellet, they might still be found in one of the other suspensions. 
 
ICSI procedure 
Commercially available injection pipettes (Gynotec®, Maiden, The Netherlands) 
were used with an outer and inner diameter of 7 and 5 µm respectively. The oocyte 
holding pipette had an outer and inner diameter of 90 and 10 µm respectively. One 
drop of sperm-PVP solution was placed in the centre of a Petri dish, surrounded by 5 
drops of IVF medium containing metaphase II oocytes. All drops were covered by 
paraffin oil. The ICSI procedure was performed under a 400x magnification, using 
hydraulic micromanipulators and microinjectors. A single spermatozoon was 
isolated, immobilized and aspirated tail-first into the injection pipette. The oocyte 
was fixed the holding pipette and the injection pipette was pushed through the zona 
at the opposite side. Breakage of the ooplasmic membrane was initiated by gentle 
suction with the injection pipette, and one spermatozoon was injected immediately 
after membrane breakage was observed. 
 
Fertilization 
At 16-18 h after microinjection, the oocytes were microscopically examined. 
Normal fertilization was defined by the presence of two pronuclei and a second 
polar body. Depending on the day of embryo transfer, embryo cleavage was judged 
3, 4 and 5 days after the ICSI procedure. A maximum of two embryos was 
transferred into the uterine cavity and supernumerary embryos of good 
morphological quality were cryopreserved. Pregnancy was confirmed 18 days after 
oocyte retrieval by a positive pregnancy test. A clinical pregnancy was defined as the 
presence of at least one gestational sac with a foetal heart beat. An ongoing 
pregnancy was defined as a clinical pregnancy beyond 12 weeks of gestation. 
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RESULTS 
  
The combined sperm retrieval-ICSI procedure included 39 treatment cycles in 
24 couples. Azoospermia was present in all men in at least two semen samples. 
CBAVD was present in nine patients, a history of recurrent infections in four and a 
previous surgical intervention in the scotrum or the inguinal region, including failed 
microsurgery, in 11. 
MESA was preformed in the first four patients only, and was successful in all. 
Subsequently, PESA was introduced as the first approach for epididymal sperm 
retrieval for future cases. PESA was successful in 18/29 (62%) procedures. In 11 cases 
of failed epididymal sperm retrieval, an excisional testicular biopsy was performed 
under local or general anaesthesia in the same procedure, and viable spermatozoa 
were found in 9/11 (82%)biopsies. In one patient, a repeated biopsy had to be 
performed on the same day, which yielded viable spermatozoa, which were 
successfully used for ICSI. Only in one case of TESE could no viable spermatozoa be 
found after incubation. Sperm cryopreservation was performed only after 
epididymal retrieval and was successfully used in six patients as a sperm source 
where the first combined cycle had failed. 
 
Table 1: Results of 39 ICSI cycles with epididymal (MESA/PESA), testicular (TESE) 
retrieved spermatozoa and spermatozoa, which were cryopreserved (CRYO) after 
initial PESA procedure 
 
Cycles Oocytes 
MII 
oocytes 
Fertilization 
(%) 
Embryo 
transfer (%) 
Pregn. 
(%) 
Ongoing 
Preg. (%)
MESA/PESA 22 275 186 101 (54) 21 (95) 9 (41) 6 (27) 
TESE 11 127 90 32 (36) 11 (82) 4 (36) 4 (36) 
CRYO  
(after PESA) 
6 52 27 27 (33) 6 (100) 0 (0) - 
Total 39 454 303 303 (47) 39 (92) 13 (33) 10 (26) 
 
Table 1 summarizes the results of the 39 treatment cycles. Oocyte retrieval 
resulted in a total of 454 oocytes, of which 66.7% had extruded the first polar body 
(metaphase II oocytes). Fertilization occurred in 47 of the metaphase II oocytes after 
the ICSI procedure. The fertilization rate and embryo transfer after MESA/PESA and 
TESE was similar. Transfer of two embryos into the uterine cavity was performed in 
36/39 (92%) cycles, resulting in a clinical pregnancy in 13/39 (33.3%). In eight cycles, 
26 supernumerary embryos of good morphological quality were cryopreserved. 
Thawing of the embryos was performed for five patients and embryos were 
transferred in two couples. This, however, did not result in clinical pregnancies. 
MESA/PESA procedures produced 27% ongoing pregnancies and TESE procedures 
produced 36% ongoing pregnancies. Ten ongoing pregnancies occurred in 24 couples 
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(41.7%), a pregnancy rate of 25.6% per treatment cycle and 27.7% per embryo 
transfer. Frozen-thawed epididymal spermatozoa were successfully used for a 
second ICSI procedure in six couples. Unfortunately, no pregnancy occurred in these 
patients. Amniocentesis was performed in eight out of 10 pregnancies, and gave 
normal karyograms in seven pregnancies. One pregnancy was terminated early for 
trisomy 18 (47 XX+18, Edwards syndrome). Nine deliveries occurred at term, 
resulting in 10 babies with no obvious congenital malformations. Birth weight was 
low in two children (<P50; (Kloosterman 1969)), one singleton and one twin baby 
(Table 2).  
 
Table 2: Pregnancy and delivery results of 39 ICSI procedures combined with 
surgical or percutaneous sperm retrieval 
Patient 
Prenatal 
diagnosis 
Delivery term M/F 
Birth weight 
(g) 
Percentile 
(P)* 
1 46, XX 38 weeks F 3555 P90 
2 46, XY 41 weeks M 4110 P95 
3 46, XY 37 weeks M 2435 P15 
4 46, XY 36 weeks M 2660 P50 
5 (twin) 46, XX 
46, XX 
35 weeks F 
F 
2270 
2370 
P40 
P50 
6 47, XX +18 Early termination F   
7 46, XX 42 weeks F 4160 P95 
8 - 41 weeks F 3990 P90 
9 - 41 weeks F 4190 P90 
10 46, XY 41 weeks M 3760 P75 
* Percentile (Kloosterman et al., 1970) 
 
 
DISCUSSION 
 
Ductal obstruction occurs in 20% of azoospermic patients. Acquired ductal 
obstructions account for most of the cases of obstructive azoospermia and can 
sometimes successfully be treated by microsurgery. Infections of the ductal system 
and surgery of the scrotum and the groin are the main causes of this type of 
obstruction. Surgical sperm retrieval has been introduced as an alternative for 
microsurgery and is used in cases of failed vasectomy reversal. Initial attempts to 
perform IVF with epididymal sperm showed limited results, due to poor sperm 
quality after retrieval (Pryor et al., 1984; Temple-Smith et al., 1985). In 1988, Silber 
introduced a microsurgical technique for sperm aspiration, the MESA procedure, 
which was successful in 10 of 32 cases of CBAVD (Silber et al., 1988). The combined 
MESA/IVF procedure gave a pregnancy rate of 10-14% (The Sperm Microaspiration 
Retrieval Techniques Study Group, (1994)). Recently, the ICSI procedure has been 
introduced for the treatment of severe male factor infertility (Palermo et al., 1992). 
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Combining the ICSI procedure with the MESA procedure has resulted in high 
fertilization rates and pregnancies in 31-34 of treatment cycles (Devroey et al., 1994; 
Tournaye et al., 1994).  
We have performed the ICSI procedure with surgically or percutaneously 
retrieved spermatozoa from the epididymis (MESA/PESA) or the testis (TESE) in 39 
treatment cycles. PESA was introduced as a minimal invasive technique of sperm 
retrieval in an outpatient clinic setting under local anaesthesia, and was successful 
in 62 of cases (Figure 1). Several reports have shown PESA to be successful in the 
majority of cases of obstructive azoospermia (Tsirigotis et al., 1995; Craft et al., 1995b; 
Collins et al., 1996). The advantages of PESA are: minimal discomfort for the patient, 
low complication rate compared to open surgery, repeatability and the production 
of clear aspirated fluid with usually minimal blood contamination and less debris. 
PESA does not require microsurgical skills, is easy to learn and can be performed as 
an outpatient clinic procedure. In a recent report, PESA was shown to be as effective 
as MESA with comparable pregnancy rates (Meniru et al., 1997). 
In a series of 47 men, PESA was unsuccessful in 11 cases and a subsequent 
MESA procedure was performed, which gave viable spermatozoa in only two cases 
(Tsirigotis et al., 1995). In cases of non-obstructive azoospermia, MESA and PESA 
were usually unsuccessful and a testicular biopsy was performed. 
Testicular biopsy may be an alternative to PESA as a source of spermatozoa. 
Successful harvesting of spermatozoa has been reported with TESE using both the 
open biopsy technique and more recently the testicular fine needle (TEFNA), 
although needle biopsies were less effective as compared to open biopsies (Friedler 
et al., 1997). Late complications have been described after testicular sperm retrieval 
techniques, including inflammation, haematoma and even devascularization of the 
testis (Schlegel et al., 1997). Therefore we believe that PESA should be the first 
technique to be performed in cases of obstructive azoospermia. 
We have chosen to treat only cases of obstructive azoospermia because of the 
unknown medical and genetic risks of treating azoospermia due to testicular 
insufficiency. It has been shown that non-obstructive azoospermia may be 
associated with cytogenetic abnormalities, including a high degree of sex 
chromosome aneuploidy (Persson et al., 1996; Yoshida et al., 1997) and 
(micro)deletions of the Y chromosome (Reijo et al., 1995). 
In this study, nine cases of CBAVD were selected for this treatment. CBAVD is 
found in 2% of infertile men and has recently been described as a primary genital 
form of cystic fibrosis. CBAVD is highly associated with mutations of the cystic 
fibrosis transmembrane conductance regulator gene  (CFTR;(Oates et al., 1994)). 
Since CBAVD is accompanied by the absence of the seminal vesicles, these men 
consistently produce a low semen volume with a low pH. Spermatogenesis, in 
CBAVD appears normal, but spermatozoa derived from the caput epididymis 
appear to have a low fertilizing capacity, because of their short passage through the 
epididymis (Silber et al., 1988). In couples with CBAVD-related infertility, genetic 
screening of the patient and his partner is mandatory before MESA/ICSI procedures 
are performed. The risk of inheritance of cystic fibrosis (CF) or CBAVD is mainly 
determined by the presence of a CFTR-gene mutation m the partner (1:25): if she 
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also carries a mutation, there is a 25-50 chance of a form of CF (severe, mild, 
CBAVD) in the offspring (Anguiano et al., 1992). In all cases treated in the present 
report, no common mutations of the CFTR gene were found in female partners. 
In conclusion, ICSI has been shown to give a high fertilization rate with 
ejaculated, epididymal and testicular spermatozoa. We have combined ICSI with 
surgical and percutaneous sperm retrieval in men with bilateral obstruction of the 
genital tract, which resulted in an ongoing pregnancy rate of 25.6% per treatment 
cycle. Non-obstructed cases of azoospermia excluded from this treatment due to 
their potential genetic risks.  
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DISCUSSION 
 
The studies presented in this thesis were performed within the outlines of a 
more extensive research project on the potential risks for children born after ICSI, 
especially when epididymal sperm is used. Epididymal sperm from patients with 
obstructive azoospermia (OA) were studied regarding nuclear condensation and 
systematic DNA breakage. The effectiveness of markers generally used for the 
selection of sperm in ICSI procedures, such as morphology and motility, was 
estimated as well. Subsequently, theoretical risks concerning the use of epididymal 
sperm are discussed. Finally, the clinical characteristics of OA patients and the 
outcome of the ICSI procedure with epididymal sperm are described. Preliminary 
conclusions about the safety of using epididymal sperm for ICSI are made. 
  
 
1. EPIDIDYMAL SPERM IN OBSTRUCTIVE AZOOSPERMIA 
 
 1.1 Heterogeneity and integrity of human sperm 
In this discussion we will use two concepts that together can describe human 
sperm samples. Heterogeneity refers to the differences found in morphology, 
chromatin condensation and nuclear damage while sperm integrity is commonly 
used for normal chromatin condensation and absence of measurable DNA breaks 
(Bianchi et al., 1993; Sakkas et al., 1999a). Variation in chromatin condensation arises 
during spermiogenesis and maturation in the epididymis. The high chromatin 
heterogeneity found in ejaculated human sperm of normospermic donors (relative to 
many mammalian species) is even more increased in infertile samples (chapter 4), 
being highly related to sperm integrity. Therefore, in studying the role of the male 
gamete in the fertilization process by artificial reproduction, one should focus on 
sperm integrity.  
Since ICSI facilitates conception by sperm that otherwise would not be able to 
fertilize, it is important to establish the most adequate selection criteria to choose the 
appropriate gametes (i.e. sperm with high integrity) for fertilization. In normal 
conception and conventional IVF, the best predictive factor for fertilization using the 
World Health Organization (WHO, 1999) semen parameters, is the sperm 
morphology (Zollner et al., 1996; Menkveld et al., 2001). In ICSI, sperm morphology 
has a limited prognostic value (Oehninger et al., 1996; Kupker et al., 1998). The high 
fertilization rates achieved with ICSI (Tarlatzis et al., 2000), indicates that the 
heterogeneity in morphology of human sperm does not necessary hinder fertilization 
nor conception. A valuable predictive factor for embryo development and pregnancy 
is sperm integrity (Sakkas et al., 1998; Evenson et al., 1999; Ahmadi et al., 1999a; 
Morris et al., 2002). Sperm integrity is also related to sperm motility (Morris et al., 
2002). The trigger to investigate this parameter in relation to sperm integrity came 
from publications reporting low fertilization and pregnancy rates in ICSI with 
immotile sperm (Shibahara et al., 1999a; Shibahara et al., 1999b; Pasqualotto et al., 
2002). 
  Discussion and General Conclusions  
 125 
 
1.2 Selection markers for sperm normality and integrity 
The current sperm selection criteria for ICSI are based on the rough morphology 
(at 400x magnification) and motility. In this thesis, both markers have been evaluated 
for their capacity to select distinctly morphologically normal and intact (non-
apoptotic) epididymal spermatozoa. The novelty of the studies in this thesis is that 
following epididymal sperm retrieval, sperm was selected using these common 
criteria (rough morphology and motility) and subsequently evaluated for normality of 
the head, using the computerized karyometric image analysis assay (CKIA, chapter 
6) and for DNA integrity using the TdT UTP-nick end-labelling assay (TUNEL, 
chapter 8). 
 
¾ The evaluation of morphology of the sperm head in chapter 6 uses a DNA 
specific (Feulgen) stain in combination with the CKIA assay. The stainability of the 
nucleus depends on the accessibility of the stain to the DNA (a function of nuclear 
compaction). The typical chromatin structure of sperm hampers the DNA 
quantification of chromatin compaction and the interpretation of chromatin texture 
parameters (chapter 3). Visual selection in unstained (vital) epididymal samples was 
less effective than in normal semen, still enhancing the fraction of CKIA-normal 
sperm heads by a factor two (chapter 6).  
The heterogeneity of chromatin condensation was also investigated using the 
binding properties of the fluorochrome chromomycin A3 (CMA3), which is highly 
susceptible to variation in condensation (chapter 4) and by a monoclonal antibody 
(mAb) specific for double strand DNA. For a better insight of chromatin texture 
patterns, different FACS derived sperm fractions from a normal donor and from 
teratospermic patients (after selection for high/low CMA3 binding capacity, 
high/low free thiol- and high/low total thiol fluorescence) were stained using the 
mAb and scored by the TUNEL assay (chapter 4). In this study, we have attempted 
to find out which nuclear features are characteristic for normally differentiated 
sperm heads.   
 
¾ The second sperm selection marker routinely used in ICSI is motility. Our 
work (chapter 5) is in line with other studies (Aitken et al., 1998; Kemal-Duru et al., 
2000; Morris et al., 2002) and shows this physiological parameter (motility) to be of 
great importance for the selection of sperm with good nuclear integrity. The selection 
of motile (epididymal) sperm drastically reduced the frequency of sperm with 
measurable DNA breaks, as evaluated with the TUNEL assay (chapter 8). Other 
assays used for the evaluation of sperm integrity (DNA damage) such as the Comet 
assay, the acridine orange based sperm chromatin structure assay (SCSA) and in situ 
nick-translation (Sun et al., 1997; Evenson et al., 1999; Zini et al., 2000; Morris et al., 
2002) also yield close correlations between sperm motility, integrity and/or fertility. 
One aspect of the TUNEL assay that deserves further attention is the sensitivity of 
this technique (for detecting low rates of DNA fragmentation) and the possibility of 
quantifying the amount of DNA breaks. Using increasing amounts of irradiation to 
induce DNA damage in human sperm, we could detect an increase in the TUNEL 
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positivity after doses between 5- 50 Gy (chapter 5). Others, applying the Comet assay 
(Hughes et al., 1996; Haines et al., 1998) could detect an increase in DNA damage after 
irradiation doses between 5-25 Gy, while structural chromosome abnormalities have 
been induced in sperm irradiated at doses lower than 1 Gy (Kamiguchi et al., 2002). 
 
Abnormal chromatin condensation confers to the DNA a higher susceptibility to 
damage, which may influence fertilization and especially embryo development 
(Sakkas et al., 1998). A significant relationship between chromatin condensation and 
DNA damage has been observed in the different sperm fractions in both fertile and 
infertile men described in chapter 4. Epididymal sperm samples from OA patients, in 
contrast to the normal physiological situation, contain a mixture of immature, 
mature, aged (overcondensed or hypercondensed) and damaged/dead spermatozoa 
(chapter 6 and 7). In epididymal samples, chromatin heterogeneity increases even 
more because of the incomplete and likely variable cross linking between and within 
protamines in the caput epididymis (Saowaros et al., 1979; Kosower et al., 1992). 
The results from the study of epididymal sperm in OA patients show that the 
current selection parameters (morphology and motility) contribute to an increase in 
the frequency of spermatozoa without measurable DNA damage to levels 
comparable to those of normospermic males in the ejaculate. Therefore, the risk 
resulting from the use of morphologically normal and motile epididymal sperm from 
OA patients is assumed to be comparable to ICSI with ejaculated sperm. However, in 
poor sperm samples these markers are probably not the only ones to select sperm 
with a low chance of damage. Because of the impossibility to use DNA stains to 
differentiate between the various sperm populations prior to fertilization, future 
studies on sperm selection should focus on sperm membrane markers. The 
advantage of membrane markers is that the first signs of cell damage (comparable to 
early markers in apoptosis) can be found at the outer cell membranes before the 
nucleus is affected (as a late marker for apoptosis), as observed in chapter 5 (using 
Annexin V, propidium iodide (PI) and TUNEL). Studies of other membrane 
characteristics for the identification of “normal” spermatozoa have been performed 
by the group of Huzsar (Huszar et al., 1990; Huszar et al., 1992) and by the group of 
Sutovsky (Sutovsky et al., 2001a; Sutovsky et al., 2001b; Sutovsky et al., 2002; Sutovsky 
et al., 2003). The group of Huszar uses the binding capacity of mature sperm to 
hyaluronic acid and the group of Sutovsky studies the ubiquitination of the sperm 
outer membrane. 
Membrane markers may be of great usefulness in the preselection of “normal” 
sperm. With the combination of markers, we hope to improve the selection criteria 
for ICSI. 
 
 
2. THE RISK FOR ICSI OFFSPRING  
 
2.1  Genetic risks related to obstructive azoospermia  
Most of the reports on genetic screening and follow-up of ICSI children are 
related to ejaculated sperm. In only a few publications the follow-up of children 
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conceived by non-ejaculated sperm is presented separately. The authors of these 
publications conclude that most of the concerns at the time of the introduction of 
ICSI are not justified, at least for the short term follow up (Bonduelle et al., 1998; 
Bonduelle et al., 1999; Bonduelle et al., 2003). Although preliminary reports are 
reassuring, ICSI candidates should be considered at an increased risk for carrying 
and transmitting genetic anomalies to the offspring. Non-obstructive oligo- and 
azoospermic men (NOA) hold higher risks to carry chromosome aberrations and 
gene mutations (Yoshida et al., 1997; Dohle et al., 2002). In the particular case of OA, a 
large group of patients may be carrier of a genetic mutation in the CFTR gene, which 
is related to CBAVD and cystic fibrosis (Oates et al., 1994; Silber et al., 1995b). If both 
partners are carrier, preimplantation genetic diagnosis (PGD) should be considered.  
The frequency of de novo chromosome mutations after ICSI with ejaculated sperm 
(1.6% [n= 1492] for sex chromosome aneuploidy and structural rearrangements of the 
autosomes together) was not statistically different from that of ICSI offspring from 
OA fathers (2.4% [n= 83], (Bonduelle et al., 2002b). As in the general population these 
frequencies are 0.5%, the de novo chromosomal anomalies observed in the ICSI 
offspring are increased (Bonduelle et al., 2002b). 
The high rates of DNA damage (chapter 8 and (Steele et al., 1999) present in 
epididymal spermatozoa in OA may be a risk factor for the induction of chromosome 
anomalies.  
 
2.2  Genomic imprinting risks and non-ejaculated sperm 
Following the publication of Ariel and colleagues (Ariel et al., 1994), there was 
concern in The Netherlands about possible negative effects on gene imprinting by the 
use of (immature) testicular and epididymal sperm for ICSI. These authors found 
that in mice, the methylation patterns of some (non-imprinted) genes were modified 
during epididymal transport. The more recent study on the paternal methylation of 
the imprinted H19 and MEST/PEG1 genes during spermatogenesis by (Kerjean et al., 
2000) shows that the imprinting has been completed at the spermatid stage. Animal 
experiments using (immature) testicular sperm could not find an effect on genomic 
imprinting in the offspring at the blastocyts stage (Shamanski et al., 1999). Therefore, 
we may conclude that the use of mature testicular and epididymal sperm would 
probably not modify paternal imprinting in the offspring. Data on genomic 
imprinting status in human offspring conceived by ICSI with non-ejaculated (n= 9) 
and ejaculated (n= 83) human sperm did not show methylation abnormalities 
(Manning et al., 2000b). On the other hand, a relation between epigenetic diseases 
and artificial reproduction techniques (ART) in general has been found by (Gosden et 
al., 2003). Because of the very low incidence of genomic imprinting defects in the 
general population and the long-term manifestation of epigenetic diseases, it is 
premature to make any definitive statement on this issue.  
 
 2.3 Malformation rates and non-ejaculated sperm  
Follow up studies in ICSI children conceived with non-ejaculated sperm show 
that congenital anomalies are not related to the origin of sperm (Bonduelle et al., 
2002a). In a total of 105 and 206 follow-up children born from epididymal sperm and 
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testicular sperm, the malformation rates were 3.8% and 2.9% respectively (IVF 
children, 4.6% [n = 2955], NS). Although these authors conclude that there is no 
ground for concern using sperm from different sources, the number of children 
tested in obstructive azoospermia is still too small. Because OA males treated in The 
Netherlands constitute a well-defined group with follow up of all children, we hope 
in the near future to reach a better insight into the risks of the use of epididymal 
sperm in obstructive azoospermia.    
 
 2.4 Classification and diagnosis of obstructive azoospermia 
Notwithstanding the clinical importance of the type and source of sperm in 
cases of azoospermia, an important shortcoming of most publications is the lack of 
information about its origin (epididymal or testicular sperm) and/or the aetiology of 
the azoospermia. In the particular case of OA, there is no consensus in the 
classification or the source of sperm (from testis or epididymis). Due to the strict 
inclusion criteria for the treatment of azoospermia with ICSI in The Netherlands, we 
had the opportunity to acquire detailed information on the characteristics of OA 
males. Based on the results presented in chapter 2, we conclude that in men with the 
clinical symptoms of obstruction, the presence of sperm at a PESA procedure is 
enough evidence for completion of spermatogenesis, equivalent to a Johnsen-Score 
≥8. This conclusion is not modified by additional information such as: the level of 
inhibin B, FSH and the cause of obstruction. The presence of epididymal sperm 
(completed spermatogenesis) does not exclude a diminished sperm production (with 
lower sperm counts per testicular tubule). On this basis, spermatogenesis should be 
classified as “complete” or “uncomplete (arrested)” rather than “normal” or 
“abnormal”. Patients with a clinical diagnosis of OA, such as post-vasectomy or 
CBAVD, may present some degree of diminished spermatogenesis, with sufficient 
motile epididymal sperm to use for ICSI. 
The diagnosis of OA is not only indicative for a higher take-home-baby rate 
with ICSI compared to NOA (Friedler et al., 2002; Vernaeve et al., 2003; Schwarzer et 
al., 2003), but also for counselling about potential genetic risks for the offspring. In 
men with NOA heritable and de novo genetic anomalies are found in higher 
frequencies than in men with OA (except for the CFTR gene) (Silber et al., 1995b; 
Dohle et al., 2002).  
The management of azoospermia requires a diagnostic strategy with the least 
invasiveness for the patient. Because testing of individual clinical parameters in the 
identification of patients with completed spermatogenesis shows some limitations 
(Tournaye et al., 1997b; Ballesca et al., 2000; Meachem et al., 2001), PESA as a 
diagnostic tool was evaluated in chapter 2. Nowadays in our centre, the diagnosis of 
OA in men with a clinical diagnosis of obstruction is based on the presence of sperm 
at PESA, while a testicular biopsy for histological evaluation is performed only in 
those men in whom no sperm could be retrieved by PESA. Another clinical 
advantage of PESA compared to a testicular biopsy is the possibility to 
cryopreserved sperm, which is successful in 60% of the retrievals (data not shown), 
reducing the need for repetitive PESA and tissue damage.   
  Discussion and General Conclusions  
 129 
We are working on the development of a prognostic model combining different 
(non-invasive) clinical parameters in order to determine the chances for each 
individual patient to have completed spermatogenesis (Johnsen Score≥8). The first 
version of this prognostic model is presented in the Appendix of this thesis. Whether 
the model will replace the need for a diagnostic PESA or a testicular biopsy should 
be evaluated in a prospective study. 
 
 2.5 Epididymal vs. testicular sperm  
Due to controversial opinions concerning the use of testicular or epididymal 
sperm in cases of OA, there is no general consensus on the preferential use of one or 
the other. No differences have been found in the implantation, pregnancy and/or 
miscarriage rates between epididymal and testicular sperm in cases of OA (Silber et 
al., 1995a; Rosenlund et al., 1997; Palermo et al., 1999; Wennerholm et al., 2000; 
Tarlatzis et al., 2000; Schwarzer et al., 2003). We conclude from the literature that, in 
cases of OA, the source of sperm does not affect the ICSI outcome. A series of studies 
support the use of testicular sperm, because epididymal sperm may contain higher 
fragmentation and mutation rates in both nuclear and mitochondrial DNA compared 
with testicular samples (Steele et al., 1999; O'Connell et al., 2002). We are aware of the 
fact that epididymal samples have large numbers of dead or damaged cells 
compared with testicular samples. However, evaluation of the total sperm 
population may lead to misinterpretation of the quality of those single sperm with 
good morphology and motility that could be used for ICSI. Therefore, studies on 
sperm quality in the era of ICSI should be restricted to the motile sperm fraction with 
good morphology characteristics, as applied in our clinical studies (chapter 6 and 8). 
After isolation of the morphologically “normal” and motile epididymal sperm, a 
significant improvement in sperm quality was achieved, relative to the original 
samples, with low levels of DNA-damaged as in ejaculated sperm from fertile donors 
after the same selection procedure.  
Incomplete sperm chromatin condensation, as supposed to be found in 
epididymal and testicular sperm, does not seem to influence the fertilization and 
pregnancy rates obtained after ICSI (chapter 9 and (Silber et al., 1995a; Friedler et al., 
2002). The ICSI-PESA pregnancy rates are comparable to those of routine ICSI in our 
clinic (Woldringh et al., in press).  
In conclusion, based on the international literature, the use of epididymal or 
testicular sperm in OA has yet not revealed risks to the offspring, exceeding those of 
ICSI with ejaculated sperm, although only small series have been studied yet. It 
would be of interest to study testicular sperm in OA and compare the outcomes with 
epididymal sperm of the same probands.  
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3. GENERAL CONCLUSIONS 
 
From the results presented in this thesis, the following general conclusions can 
be drawn: 
 
¾ Selection of sperm by motility and normal morphology (at 400x magnification) 
increases the frequency of spermatozoa without detectable DNA damage (as 
assessed by the TUNEL assay, chapter 5 and 8) and increases by a factor two the 
frequency of morphological “normal” sperm according to CKIA criteria (chapter 6). 
Therefore, both selection criteria should be applied in all ICSI procedures, 
independent from the origin of the sperm.  
 
¾ A large heterogeneity at the nuclear level (chromatin) is found in human 
ejaculated sperm (chapter 3 and 4), which is more pronounced in ejaculated sperm in 
teratoasthenospermia (chapter 4) and in epididymal sperm of OA patients (chapter 
7).   
 
¾ In properly diagnosed OA, PESA results into the recovery of sperm, indicative 
for completed spermatogenesis (chapter 2). When no sperm is retrieved by PESA, a 
testicular biopsy should be taken if a final diagnosis is desirable.  
 
¾ Data from PESA-ICSI programmes (chapter 9 and our clinic since 2001) 
illustrate that fertilization and pregnancy rates do not differ significantly from ICSI 
with ejaculated semen when morphologically normal and motile sperm of OA 
patients are used. 
 
¾ The study of epididymal sperm integrity in men with OA is the first step in 
the process of estimating possible risks for the ICSI offspring. Until the results of the 
follow-up of the PESA-ICSI children are available, this fertility treatment should be 
carefully evaluated and therefore be restricted to those centres responsible for 
research.    
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APPENDIX 
 
STATISICAL MODEL FOR THE PROGNOSIS OF A JOHNSEN SCORE ≥ 8   
 
The objective of this section is to develop a prognostic model to predict a 
completed spermatogenesis (Johnsen Score ≥8; J-Score) without the need of an 
invasive procedure such as the testicular biopsy. Furthermore, the performance of 
the model presented is discussed as well as its clinical application.  The data of all 
147 azoospermic patients presented in Chapter 2 are used and the probability of a 
completed spermatogenesis (J-Score ≥8) is studied using univariate and multivariate 
logistic regression with additional selection procedures. The following clinical 
parameters: patient age, FSH, inhibin-B, testosterone, LH, volume of the largest 
testicle and aetiology of the azoospermia are evaluated on their ability to 
discriminate completed spermatogenesis from uncompleted spermatogenesis.  
Table 1 shows first, that the dichotomised FSH (1 = FSH < 6.5 IU/l; 0 =FSH is 
≥6.5 IU/l) and the logarithmic transformed inhibin-B perform better than the 
untransformed values when comparing the R2 and the area under the ROC-curve 
(AUC).  
 
Table 1:  The crude odds ratio of the non-invasive parameters of the probability of a 
J-Score ≥8, using univariate logistic regression  
 n Odds ratio 95% CI R
2 (%) AUC (%) 
age (years) 147 1.18 1.06-1.30 17 75 
FSH (IU/l) 141 0.88 0.80-0.97 10 68 
d-FSH (1-0) 141 0.14 0.05-0.45 16 72 
Inhibin B (pg/ml) 132 1.03 1.01-1.04 29 81 
Ln-inhibin B 132 5.89 2.59-13.37 34 81 
LH (IU/l) 138 0.95 0.79-1.14 1 57 
Testosterone 140 0.99 0.92-1.06 1 56 
Testis volume 138 1.43 1.18 – 1.74 20 79 
Aetiology 147   25 79 
Post-vasectomy  10.82 1.13-103.81   
CBAVD  8.71 0.90-83.87   
Unknown  0.57 0.16-2.05   
Others  1.0 Reference   
n: the number of patients included, as result of  possible missing data; OR: Odds ratio, values > 1, 
indicate positively correlated to increased probability of J-score ≥8 and values < 1, indicate negatively 
correlated to increased probability of Johnsen score ≥8; CI: confidence interval; R2: rescaled R-square, 
indicating the percentage explained variance; AUC: area under the ROC-curve as a measure of 
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predictive discrimination, 50% is equivalent to random guessing and 100% is perfect prediction; d-
FSH: dichotomized FSH (1= FSH <6.5 IU/ml; 0=FSH ≥ 6.5 IU/ml); ln-inhibin B: logarithm 
transformed inhibin B; CBAVD: congenital bilateral absence of the vas deferens 
 
 
Second, although, most parameters are statistically significant related to the 
ability to discriminate completed from uncompleted spermatogenesis (compare the 
95%CI) and even some are acceptable considering their discriminating power (AUC 
> 70%), the prognostic level reached was still very low (R2 ≤ 34%). In conclusion a 
multivariable model is required to obtain a satisfactorily prognostic model to 
discriminate completed from uncompleted spermatogenesis. 
 
The probability of a J-Score ≥8 (p) of a patient (i) in a logistic model can be 
calculated as follows: 
iXe1
iXe
ip β
+
β
=  
 
Using the three multivariate logistic models, βXi is: 
A:  βXi= -10.83 + 2.57 * PVi + 16.19 * CBAVDi + 0.64 * testvoli – 0.73 * CBAVDi * testvoli 
B:  βXi= -9.93 + 0.30 * testvoli + 1.47 * ln-inhibinBi 
C:  βXi= -2.52 + 0.29 * testvoli – 1.78 * d-FSHi 
 
With,  
PVi , the post-vasectomy status of patient i:  1 = yes, 0 = no, 
CBAVDi , the CBAVD status of patient i:  1 = yes, 0 = no, 
Testvoli , testicular volume of patient i in ml, 
Ln-inhibinBi , the natural logarithm of value of the inhibinB of patient i, 
d-FSHi , the FSH status of patient i: 0 = FSH < 6.5 IU/ml, 1 = FSH ≥ 6.5 IU/ml  
 
 
Table 2 presents the adjusted odds ratios of the prognostic variables of (A) the 
best model, (B) the best model that includes inhibin-B and (C) the best model that 
includes FSH, using multivariate logistic regression with selection procedures.  Note 
that, due to individual missing data the number of patients from whom these models 
are not calculated are different. Therefore it is not clear whether the prognostic 
ability of model B is lower compared with the prognostic ability of model A, 
however the R2 is lower (40% compared to 49% for model B and A, respectively). The 
inclusion of patients with missing data on some variables may lead to different 
results, as model selection procedures can only be performed on the subset of 
patients with complete data sets. Furthermore, the final model needs to be validated 
before use in a clinical setting. With this in mind, the probability of a completed 
spermatogenesis of an individual patient can be calculated using the developed 
models.  
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Table 2:  The adjusted odds ratio of the non-invasive parameters of the probability of 
a J-Score ≥ 8, using multivariate logistic regression with selection procedures. 
Model 
(n) 
Parameter OR 95% CI R2 (%) AUC (%) 
Testis volume 1.88 1.35 ; 2.66 20 79 
CBAVD 999.99# 33.63 ; 1000 34 84 
CBAVD*testvol 0.48 0.25 ; 0.91 40 85 
A 
(138) 
Post vasectomy 13.11 1.42; 120.63 49 85 
Ln-inhibin B 4.35 1.62; 11.68 31 81 B 
(125) Testis volume 1.35 1.05; 1.73 40 88 
d-FSH 0.17 0.05; 0.56 19 74 C 
(134) Testis volume 1.33 1.09; 1.63 31 84 
Adjusted: adjusted for all other variables in the model used; n: the number of patients included, as 
result of possible missing data; OR: Odds ratio, values > 1, indicate positively correlated to increased 
probability of J-Score ≥8 and values < 1, indicate negatively correlated to increased probability of 
Johnsen score ≥8; CI: confidence interval; R2: rescaled R-square, coefficient of determination, indicated 
the percentage explained variance; AUC: area under the ROC-curve as a measure of predictive 
discrimination, 50% is equivalent to random guessing and 100% is perfect prediction; #: indicating 
nearly perfect discrimination; CBAVD: congenital bilateral absence of the vas deferens. 
 
 
Clinical application of the model 
 The best model found is based on those variables that are sufficient and 
complete to contribute independently to the prediction of a completed 
spermatogenesis. Using only the values of the prognostic variables of a patient, 
the predicted probability of a J-Score ≥8 can be calculated from the formulas of 
the corresponding multivariable logistic model as presented above. Also a 
nomogram may help to find the predicted probability using a graphical 
presentation or a table presentation. However, for clinical interpretation it may 
be desirable to have a cut-off value for the predicted probability, above which it 
is considered to be high. The optimal cut-off value for the predicted probability 
is then chosen so that the sum of the sensitivity and the specificity to 
discriminate completed from uncompleted spermatogenesis was maximal. This 
condition is reached at that point on the ROC curve where vertical the distance 
to the X=Y line is maximal. Note that the distance of the ROC curve to this line 
represents the discriminatory power of the model.   
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Figure 1: The ROC curves of the three prognostic models (A: solid line; B: short dashes; C: dot and 
long dashes) for the probability of a J-Score ≥8 using multivariate logistic regression. The stars (*) 
indicate the proposed cut-off values for the probability of J-Score ≥8 under the condition of equal 
point of misclassification. 
  
Table 3: Maximal cut-off values by the prognostic model for the probability of a J-
Score ≥8 
Model Y* Cut-off value Sensitivity Specificity 
A 0.76 0.79 0.95 0.81 
B 0.71 0.92 0.79 0.92 
C 0.59 0.88 0.78 0.81 
(*) Sensitivity + specificity-1: maximum distance of the ROC-curve to the X=Y line 
 
For a better understanding of this prognostic model in the clinical practice, 
data and results of two patients from our data file are presented. Random selected 
patients with similar clinical characteristics but with different aetiologies of 
azoospermia were chosen. The calculation of the probability of a J-Score ≥8 is as 
follows: 
 
Patient 1: Aetiology of obstruction: CBAVD  
FSH= 5.4 IU/ml (d-FSH= 0) 
Inhibin-B= 149 pg/ml  (ln-inhibin B= 5.00) 
Testicular volume= 15 ml 
Patient 2:  Aetiology of obstruction: unknown 
FSH= 9.4 IU/ml (d-FSH=1) 
Inhibin-B= 103 pg/ml (ln-inhibin B= 4.63) 
Testicular volume= 15 ml 
 
*
*
*
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Patient 1 
Model A: βXi= -10.83 + (2.57*0) + (16.19*1) + (0.64*15) – (0.73*1*15)= 4.72 
Model B:  βXi= -9.93 + 0.30*15 + 1.47 * 5.0= 1.92 
Model C:  βXi= -2.52 + 0.29* 15 + 0 = 1.83 
 
Patient 2 
Model A: βXi= -10.83 + (2.57*0) + (16.19*0) + (0.64*15) – (0.73*0*15)= -1.23 
Model B:  βXi= -9.93 + 0.30*15 + 1.47 * 4.63= 1.37 
Model C:  βXi= -2.52 + 0.29* 15 - 1.78*1 = 0.05 
 
 
Once the βXi value is calculated, the probability is calculated using the formula for 
pi. 
 
The results of the predicted probability for both patients are presented in the table 
below: 
Model  Cut-off 
values 
Patient 1 
(observed J-Score: 9.36) 
Patient 2 
(observed J-Score: 6.80) 
Model A 0.79 0.99 0.23 
Model B  0.92 0.87 0.80 
Model C  0.88 0.86 0.51 
predicted  J-Score  ≥ 8 < 8 
Model A: for both patients the predictive chance to obtain is very high. This is not coincidental, as 
model A scores the highest for the combination of sensitivity and specificity; 
Model B: only for patient 1 the calculated probability was almost at the cut-off level, while for patient 
2 it was lower; 
Model C: again for patient 1, the probability to obtain a J-Score≥8 was at the level of the cut-off values, 
but for patient 2, this was low. 
 
 
Finally, we expect that after the inclusion of a larger group of men and the further adjustment 
of parameters, a universal model(s) can be derived by the combination of these three separate 
models. 
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A male factor is involved in approximately 50% of all cases of infertility. 
Azoospermia is present in about 5% of childless couples. An obstruction in the 
efferent tract as the cause of azoospermia occurs in nearly 30-40% of azoospermic 
males. Infertility by obstructive azoospermia (OA) can be treated with 
intracytoplasmic sperm injection (ICSI) using epididymal or testicular sperm. 
Whether the quality of epididymal sperm obtained from men with OA is comparable 
to that from a normal ejaculate is important for the effectivity of ICSI and the genetic 
integrity of the offspring, as epididymal sperm may be immature, mature or aged. 
There was concern about the risks for the offspring of the ICSI procedure with non-
ejaculated sperm. This led in 1996 to a moratorium on the use of non-ejaculated germ 
cells for ICSI in the Netherlands. The aim of this thesis is to provide a better insight 
into the quality of epididymal sperm retrieved by the percutaneous epididymal 
sperm aspiration (PESA) procedure. The markers currently used for the selection of 
sperm in ICSI procedures, such as morphology and motility, were evaluated in 
epididymal sperm. The studies in this thesis are grouped in three sections: 1) 
characterization of the study population (OA patients); 2) pre-clinical studies: 
methods and techniques used to study human spermatozoa and 3) clinical studies: 
assessment of epididymal sperm quality in OA patients. Finally, the clinical results of 
ICSI with non-ejaculated sperm obtained in the period before the moratorium are 
described.  
In Chapter 1, an overview of the incidence and classification of azoospermia is 
presented together with background information about sperm production 
(spermatogenesis), sperm chromatin characteristics, maturation and transport in 
physiological situations. A short description of the Dutch situation concerning the 
use of non-ejaculated sperm for ICSI and a review of international clinical results of 
ICSI with non-ejaculated sperm is given.  
In Chapter 2, patients with OA were characterized for the clinical presentation 
of this disorder. The routine clinical parameters (such as FSH, inhibin-B, testis 
volume, etc.) were related to sperm production (spermatogenesis), successful PESA 
retrieval and the different origins of OA.  Although the clinical presentation of OA 
showed a large variation in the clinical parameters between patients, the presence of 
sperm at PESA was found to be the most accurate parameter for the prediction of a 
completed spermatogenesis (Johnsen score ≥8; sensitivity 93% and specificity 94%). 
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As a result of this finding, we now use the presence of sperm at a PESA procedure as 
the major indication for an obstruction leading to azoospermia.  
The assessment of sperm quality and DNA integrity includes the evaluation of 
external and internal features such as nuclear shape, chromatin condensation and 
DNA damage. The second part of this thesis comprises preclinical studies (Chapter 3, 
4 and 5) in which the techniques and methodologies for the study of the sperm 
nucleus were validated in ejaculated spermatozoa.  
The external features of the sperm head were evaluated by staining with a 
DNA-specific stain (Feulgen) in combination with the computerized karyometric 
image analysis (CKIA, Chapter 3). A total of eight CKIA parameters were found to 
be appropriate for the characterization of the sperm nucleus. The evaluation of the 
CKIA method for its capacity to identify morphological intra-sample differences 
(difference between spermatozoa within a sample) showed a variability of 5%. For 
the inter-sample analysis, reliability coefficients were all >70% (indicative for the 
suitability of the system to differentiate sperm samples from different patients). 
Therefore, an objective description of the human sperm nucleus can be achieved with 
CKIA, yielding high inter- and intra-patient reliability coefficients (reproducibility). 
CKIA can thus be considered as a new tool for the evaluation of the quality of human 
spermatozoa.  
The DNA of the spermatozoon is highly packed with specific nuclear proteins 
(forming together the chromatin). Human sperm is characterized by a large 
heterogeneity in chromatin condensation within and between samples. Abnormal 
chromatin condensation results in a higher susceptibility of the sperm to DNA 
damage. In Chapter 4, nuclear condensation and chromatin structure patterns were 
evaluated by combining fluorochromes with different binding properties. Whether 
abnormal chromatin condensation resulted from a faulty replacement of the nuclear 
proteins during maturation (histones by protamines) or from a lower crosslinking 
between protamines, was evaluated by sorting spermatozoa for low and high 
fluorescence levels. Sorted fractions were further scored for DNA damage with TdT-
UTP nick-end labelling (TUNEL). These same sperm fractions were also stained with 
a monoclonal antibody against double stranded DNA (mAb#36) to identify 
chromatin structure features. A positive correlation was found between abnormal 
chromatin and DNA damage (TUNEL positive). Three distinctive staining features 
were observed with mAb#36 in human sperm heads: overall nuclear intensity of the 
signal, extension of the signal in the contour (rim) of the nucleus and the presence of 
a non-fluorescence region (band) in the posterior nucleus. Our results show that 
sperm differentiation is much more susceptible to error in infertile men, leading to an 
even larger sperm heterogeneity. The characterization of sperm by the mAb#36 
method gives a new insight in the concept of sperm quality, as it reveals the internal 
structure of the nucleus together with the external morphology. Yet, it is still difficult 
to define the range of sperm head normality. 
DNA damage in ejaculated sperm was studied in an in vitro model (Chapter 
5). Two systems that induce DNA damage in somatic cells (H2O2 to produce a 
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reactive oxygen species (ROS), and gamma irradiation) were used on ejaculated 
sperm samples to study the hypothesis that DNA damage can be induced in matured 
sperm. Systematic DNA damage was assessed with the TUNEL assay. Sperm 
motility was recorded in spermatozoa after exposure to ROS or gamma radiation and 
correlated with membrane changes (characterized by Annexin-V and propidium 
iodide, PI) and DNA damage (TUNEL). In the ROS system, cell membranes were 
most reactive (Annexin-V and PI positivity) leading to loss of motility, while no 
significant increases in the percentage of TUNEL positive sperm was measured 
during the first hour post incubation with ROS. Sperm motility was affected before 
any nuclear changes could be detected. Conversely, immediately after irradiation, no 
changes in Annexin-V/PI membrane markers or motility were recorded. At an 
incubation time of 24 hours post-irradiation (50 Gray), the percentage of TUNEL 
positive sperm increased to 47.2% (control value 10.8%, P =0.03) and sperm motility 
decreased. After 24 hours of in vitro incubation (26.5% TUNEL positive, 5 Gray), 
motile sperm were selected for the TUNEL assay and only 0.5% positive nuclei were 
observed. This observation supports the hypothesis that motility is a relevant marker 
for sperm selection in ICSI. 
In the third section, the techniques and methodologies described in Chapter 3, 
4 and 5 were applied to epididymal sperm from OA patients. The novelty of the 
work presented in this thesis is that the assessment of sperm quality was performed 
in the total sperm sample and in a fraction, which comprised the ICSI selection 
criteria: normal morphology (at a 400x magnification) and motility.  
Morphology as a selection parameter for the identification of normal 
spermatozoa in epididymal samples was evaluated using CKIA (Chapter 6). The 
nuclear characteristics of epididymal sperm, such as shape, DNA-stainability and 
chromatin texture were evaluated in the original sample and in the fraction selected 
by ICSI criteria. Sperm selection increased the frequency of morphologically normal 
spermatozoa in both epididymal (12.3% to 23.7%) and ejaculated samples (17.2% to 
40.5%). In normal ejaculates, selection resulted into a maximum of 55% normal sperm 
according to the CKIA criteria. The selected epididymal sperm fractions do show a 
larger variation in chromatin condensation and texture, suggesting that epididymal 
samples contain sperm with signs of hypo- and hypercondensation. 
Hypercondensed chromatin is less accessible for Feulgen stain.  
Based on the knowledge that in ejaculated samples less condensed chromatin 
is related to a higher susceptibility to damage in the DNA (see chapter 4), we 
evaluated whether in epididymal spermatozoa chromatin condensation and DNA 
damage follow this same pattern (Chapter 7). The degree of chromatin condensation 
(a marker for maturity) was related to the origin of the obstruction, but no differences 
in testicular histology or hormone levels were found between OA patients. A high 
rate of DNA damage was found in all epididymal samples, whereas the frequency of 
abnormal chromatin condensation was significantly higher in patients with 
congenital bilateral absence of vas deferens (CBAVD) or unknown causes of 
obstruction compared with epididymal samples from post-vasectomy men. 
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Moreover, in CBAVD patients no relation between these parameters were found, 
while DNA damage and chromatin condensation was related in post-vasectomy 
males. This finding suggests that chromatin condensation in OA is probably 
influenced by the origin of the obstruction.  
Motility as a selection parameter for sperm with low levels of systematic DNA 
damage was evaluated with the TUNEL assay in Chapter 8. DNA damage of 
epididymal and ejaculated samples was assessed in the total sperm population and 
in the selected motile sperm fraction using the criteria of motility and morphology. 
All epididymal samples (total sperm population) showed a high frequency of DNA 
damage (average 18.9% TUNEL positive). Selection of sperm significantly decreased 
the frequency of DNA damaged cells: less than 1% of the motile sperm were TUNEL 
positive. We concluded that the use of motile epididymal sperm markedly decreases 
the probability that sperm with systematic DNA damage is injected with ICSI to 
almost zero. This was expected based on the results of Chapter 5. 
In Chapter 9, the clinical ICSI outcome (fertilization-, pregnancy- and birth 
rates) using non-ejaculated sperm from OA in the period before the moratorium is 
described. In 10 out of 39 treatments, an ongoing pregnancy was achieved using 
epididymal or testicular sperm from OA patients, resulting in an ongoing pregnancy 
in 10 of 24 couples (41.6%). Together with the results of the ICSI-PESA procedures 
performed in our centre in the period after 2001 (data not presented), we conclude 
that by the use of epididymal sperm from OA patients, pregnancy rates are 
comparable to that of the routine ICSI procedure with ejaculated sperm.  
The main conclusions from this work are: 1) sperm selection by motility and 
morphology increases the frequency of normal undamaged sperm in both 
epididymal and ejaculated samples; 2) human sperm shows a large heterogeneity in 
chromatin condensation status, which is more pronounced in infertile samples and in 
epididymal samples from men with OA; 3) the presence of sperm at a PESA 
procedure is indicative for a completed spermatogenesis and 4) high fertilization and 
pregnancy rates can be achieved after selecting motile and morphologically normal 
sperm for the ICSI procedure.  
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Infertiliteit veroorzaakt door een mannelijke factor (al dan niet i.c.m. een 
vrouwelijke factor) komt in ongeveer 50% van alle kinderloze paren voor. 
Azoospermia (de afwezigheid van zaadcellen in het ejaculaat) komt voor bij ca. 5% 
van alle onvruchtbare mannen. Obstructie in de zaadleiders (vasa deferentia) is in 30 
à 40% de oorzaak van de azoospermie. De infertiliteit bij obstructieve azoospermia 
(OA) kan tegenwoordig behandeld worden door chirurgisch verkregen zaadcellen 
uit de bijbal (epididymis) of uit de bal (testikel) direct te injecteren in de eicel (Intra 
Cytoplasmatische Sperma Injectie, ICSI). Niet-geëjaculeerde zaadcellen uit de bijbal 
kunnen onrijp, rijp of verouderd zijn. Tot voor kort was het onbekend hoe de 
kwaliteit van chirurgisch verkregen zaadcellen (uit de bijbal van mannen met OA) 
was in vergelijking met geëjaculeerd zaad. Het potentiële risico dat aan het gebruik 
van epididymaal zaad is verbonden, veroorzaakte in Nederland bezorgdheid over de 
veiligheid van deze procedure. Dit heeft uiteindelijk geleid tot het stoppen (het 
“moratorium”) van het gebruik van niet-geëjaculeerde zaadcellen voor reproductieve 
doeleinden. De in dit proefschrift beschreven resultaten geven meer inzicht in de 
kwaliteit van zaadcellen die uit de bijbal zijn verkregen door middel van een punctie 
(Percutane Epididymale Sperma Aspiratie (PESA). In epididymal sperma werden de 
huidige parameters om zaadcellen te selecteren voor de ICSI procedure, zoals de 
morfologie en de beweeglijkheid (motiliteit), geëvalueerd. Het onderzoek 
gepresenteerd in dit proefschrift is verdeeld in 3 secties: 1) klinische kenmerken van 
de mannen met OA; 2) preklinische studies: evaluatie van methodologie en 
technieken die gebruikt worden bij humaan sperma en 3) klinische studies: het 
bepalen van de kwaliteit van epididymaal sperma van OA patiënten. Ten slotte zijn 
de klinische resultaten van ICSI met niet-geëjaculeerde zaadcellen in de periode van 
vóór het moratorium beschreven.  
In Hoofdstuk 1 wordt de incidentie en classificatie van azoospermie 
besproken, gevolgd door een beschrijving van de normale zaadproductie 
(spermatogenese) en  de veranderingen van het chromatine in de zaadcelkern in 
relatie tot de rijping en transport van zaadcellen in fertiele mannen. Een 
samenvatting van de Nederlandse situatie met betrekking tot het gebruik van niet-
geëjaculeerde zaadcellen en de internationale resultaten van ICSI met chirurgisch 
verkregen zaad wordt hier gepresenteerd.  
Samenvatting        
  
Samenvatting 
 158 
In Hoofdstuk 2 worden klinische parameters zoals FSH, LH, inhibine B en het 
volume van de testis gerelateerd aan de zaadproductie, de spermawinning met PESA 
en de oorzaak van de obstructie. Hoewel de klinische parameters verschillen tussen 
OA patiënten, blijkt het vinden van zaadcellen bij een PESA procedure de beste 
parameter om een volledige spermatogenese te voorspellen (Johnsen score ≥8; 
sensitiviteit 93% en specificiteit 94%). Dit heeft geleid tot een verandering in beleid. 
Tegenwoordig wordt de PESA procedure gebruikt om bij mannen met een klinische 
verdenking op een obstructie zaadcellen te kunnen winnen, waarbij dan de 
belastende- en niet geheel risicoloze testisbiopsie kan worden overgeslagen.  
Het is belangrijk om te weten of het in de zaadcelkern aanwezige DNA van 
goede kwaliteit is. In het tweede deel van dit proefschrift (Hoofdstuk 3, 4 en 5) 
worden de preklinische studies gepresenteerd waarin de technieken en 
methodologie voor het onderzoek naar de kwaliteit van de zaadcelkernen worden 
toegepast op geëjaculeerd zaad.  
In Hoofdstuk 3 zijn de externe kenmerken (b.v. vorm, grootte, etc.) van de 
zaadcelkernen onderzocht met een DNA-specifieke kleuring (Feulgen) in combinatie 
met de “computerized karyometric image analysis” (CKIA) techniek. In totaal zijn er 
acht parameters gevonden die geschikt zijn voor de karakterisering van de kern van 
de humane zaadcel. De intra-sample variabiliteit (verschil tussen steekproeven van 
zaadcellen binnen een monster) van de CKIA methode is 5%. De inter-patiënt 
variabiliteit (verschil tussen patiënten) is geëvalueerd m.b.v. de betrouwbaarheids-
coëfficiënten van deze parameters. Deze coëfficiënten waren allemaal groter dan 
70%. Dit betekent dat het mogelijk is om met CKIA een beschrijving van de kwaliteit 
van de kern van zaadcellen te geven. CKIA is daarom een nieuwe en geschikte 
methode voor een objectieve beoordeling van de kern van de zaadcel. 
De kern van een zaadcel bevat zeer dicht op elkaar gepakt DNA in combinatie 
met eiwitten (chromatine). Een typerende eigenschap van humaan sperma is de 
enorme heterogeniteit in de chromatine condensatie binnen een monster. Een gevolg 
van een verlaagde chromatine condensatie is een verhoogde gevoeligheid van het 
DNA voor schade. Om de condensatie en de structuur van het chromatine te 
bestuderen werden fluorochromen met verschillende bindingseigenschappen 
gebruikt (Hoofdstuk 4). De vraag is of de abnormale condensatie een consequentie 
van een fout in de vervanging van de kerneiwitten (histonen door protamines) is of 
komt door een onvoldoende condensatie in de epididymale fase van de rijping. Om 
hier meer inzicht in te krijgen, werden de hoge en lage fluorescentie fracties van een 
goed en een slecht sperma monster apart gesorteerd en geanalyseerd met de TdT- 
UTP nick end labelling test (TUNEL, meet de DNA-schade) en met een monoklonaal 
antilichaam tegen dubbel strengs DNA (mAb#36) dat de aanwezigheid van kaal 
DNA in combinatie met de toegankelijkheid voor het antilichaam meet. De 
zaadcelfracties met de hoogste concentratie van protamines hadden het meest 
gecondenseerde chromatine en lieten een lage frequentie zien van (meetbare) DNA 
schade. De karakterisering van de chromatine structuur met mAb#36 is gebaseerd op 
de intensiteit van het fluorescerende signaal, de fluorescentie langs de rand van de 
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kern en de aanwezigheid van een donkere niet-fluorescerend band in de basis van de 
kern. De verhouding van deze kenmerken varieerde per zaadfractie. De resultaten 
laten zien dat de normale rijping van zaadcellen minder goed verloopt bij infertiele 
mannen waardoor de heterogeniteit van het zaad per monster nog groter wordt. De 
karakterisering van humaan sperma  met de mAb#36 biedt dus een nieuwe 
mogelijkheid om de kernstructuren van de zaadcellen te bestuderen.  
De schade in het DNA van geëjaculeerd sperma is in een in vitro model 
onderzocht (Hoofdstuk 5). Twee bekende systemen die schade in somatische cellen 
kunnen induceren (toevoegen van reactieve zuurstof radicalen (ROS, via 
waterstofperoxide) en gamma straling) werden toegepast op geëjaculeerde 
zaadmonsters om de hypothese te onderzoeken dat beweeglijke zaadcellen 
onbeschadigd DNA hebben. De schade in het DNA werd bepaald met de TUNEL 
test en de schade aan de celmembraan met Annexine-V en propidium iodide (PI). Na 
het toedienen van verschillende doses ROS of straling werd de beweeglijkheid van 
de zaadcellen gemeten en vervolgens gecorreleerd aan membraan- en DNA-schade. 
Membraanschade kon direct na de toevoeging van ROS worden aangetoond en dit 
correleerde met een sterke afname van de beweeglijkheid. Bestraling gaf geen 
toename van membraan schade en ook geen afname van de beweeglijkheid. TUNEL 
positieve cellen (DNA schade) konden pas 24 uur na het toevoegen van ROS worden 
waargenomen. De belangrijkste conclusie is dat de beweeglijkheid van de zaadcellen 
is verminderd voordat de DNA-schade gemeten kan worden. Direct na bestraling 
was de beweeglijkheid van de zaadcellen niet veranderd. De DNA-schade was dosis- 
en tijdsafhankelijk. Vierentwintig uur na een dosis van 50 Gray was 47.2% van de 
zaadcellenkernen TUNEL positief (in vergelijking met 10.8% in de onbestraalde 
controle). Wanneer de bestraalde monsters 24 uur werden geïncubeerd, was slechts 
0,5% van de bewegelijke cellen positief voor TUNEL (5 Gray: 26.5% van de kernen is 
TUNEL positief in het totale monster). Deze bevinding versterkt de hypothese dat de 
beweeglijkheid van zaadcellen een belangrijke parameter is voor de selectie van zaad 
tijdens de ICSI procedure. 
In het derde deel van dit proefschrift worden de technieken, beschreven in 
Hoofstuk 3, 4 en 5, toegepast op chirurgisch verkregen sperma van OA patiënten. 
Het bijzondere van deze studies is dat de kwaliteit van de zaadcel werd bepaald 
zowel in het totale monster als in een fractie die werd geselecteerd volgens de 
huidige criteria voor ICSI (normale morfologie (op 400x vergroting) en aanwezigheid 
van motiliteit). 
Morfologie als criterium voor de selectie van normale zaadcellen in 
epididymale monsters werd getoetst in Hoofdstuk 6 met behulp van CKIA. 
Eigenschappen van de kern van de zaadcel zoals vorm, DNA-kleuring en chromatine 
structuur, werden in totale monsters en in de geselecteerde fracties beoordeeld. 
Sperma selectie volgens de ICSI criteria verhoogde de frequentie van morfologisch 
normale zaadcellen zowel in epididymale- (van 12.3%  tot 23.7%) als in geëjaculeerde 
monsters (van 17.2% tot 40.5%). In de laatste groep kon na selectie een maximum van 
55% normale kernen worden verkregen volgens CKIA criteria. De geselecteerde 
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epididymale fractie bestond bovendien uit zaadcellen met zowel hypo- als 
hypergecondenseerd chromatine (dat minder toegankelijk is voor de Feulgen 
kleuring).  
Wetende dat in geëjaculeerd sperma slecht gecondenseerd chromatine is 
gerelateerd aan een grotere gevoeligheid voor schade aan het DNA (zie Hoofdstuk 
4), is in Hoofdstuk 7 onderzocht of dit ook het geval is in epididymaal sperma. De 
condensatie van het chromatine (een teken van rijpheid) verschilde tussen OA 
patiënten, terwijl voor de normale klinische parameters zoals hormoonwaarde en 
testiculaire histologie geen duidelijke verschillen aantoonbaar waren. DNA-schade 
werd in alle epididymale samples van OA patiënten aangetoond maar correleerde 
niet altijd met de mate van chromatine condensatie. In vergelijking met mannen met 
een obstructie als gevolg van een vasectomie (sterilisatie) was de frequentie van 
slecht gecondenseerde zaadcellen significant hoger bij mannen met een aangeboren 
afwezigheid van beide zaadleiders (CBAVD) en bij mannen met een OA van 
onbekende oorzaak. Deze bevinding suggereert dat de rijpheid van zaadcellen uit de 
bijbal verschilt tussen OA patiënten. Een abnormale chromatine condensatie is dus 
(gedeeltelijk) gerelateerd aan de oorzaak van de obstructie. Dit verschil in de 
kwaliteit van het zaad zou gedeeltelijk de minder goede ICSI resultaten kunnen 
verklaren van sommige OA patiënten. 
In Hoofdstuk 8 werd onderzocht of motiliteit een goed criterium was voor de 
selectie van zaadcellen zonder systematische DNA-schade (TUNEL negatief). DNA-
schade van epididymaal en geëjaculeerd zaad was bepaald in het totale zaadmonster 
en in een, volgens de huidige ICSI criteria geselecteerde fractie. Alle epididymale 
monsters hadden een hoog percentage (18.9%) beschadigde cellen (TUNEL positief), 
terwijl in de geselecteerde motiele fracties, minder dan 1% van de cellen positief was. 
De conclusie van deze studie is dat bewegende zaadcellen een vrijwel niet-meetbare 
kans op DNA schade hebben. Dit sluit aan bij de resultaten van het onderzoeks-
model in hoofdstuk 5. Door gebruik te maken van slechts beweeglijk zaad wordt de 
kans om met ICSI beschadigde zaadcellen te injecteren verkleind. 
In Hoofdstuk 9 zijn de klinische resultaten van de ICSI procedures 
(bevruchtings-, zwangerschaps- en geboortepercentages) beschreven voor zowel 
chirurgisch verkregen zaadcellen uit de epididymis als uit de testis van OA patiënten 
in de periode van voor het moratorium. Uit 39 behandelingen bij 24 paren zijn 10 
doorgaande zwangerschappen ontstaan, een zwangerschapspercentage van 41.6% 
per paar. Samen met de resultaten van het ICSI-PESA programma dat sinds 2001 in 
ons centrum wordt uitgevoerd (deze resultaten zijn in dit proefschrift niet 
beschreven), kan geconcludeerd worden dat indien morfologisch normaal en 
bewegend epididymaal sperma wordt gebruikt, de kans op zwangerschap 
vergelijkbaar is met ICSI met geëjaculeerde zaad.  
Samenvattend zijn de belangrijkste conclusies van dit proefschrift: 1) de 
selectie van zaadcellen op basis van morfologie en motiliteit verhoogt de frequentie 
van ‘normale onbeschadigde’ zaadcellen, zowel in epididymale als in geëjaculeerde 
zaadmonsters; 2) de condensatie van het chromatine in humaan sperma vertoont een 
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grote heterogeniteit, welke sterker is in zaadmonsters van infertiele mannen en in 
epididymaal sperma van mannen met een obstructieve azoospermie; 3) het feit dat 
sperma wordt gevonden bij een PESA procedure bij een man met een klinische 
verdenking op een OA, duidt op een volledige spermatogenese; 4) wanneer ICSI 
wordt uitgevoerd met morfologische normale en bewegende epididymale zaadcellen 
kunnen bij partners van mannen met obstructieve azoospermie hoge bevruchtings- 
en zwangerschapspercentages worden behaald.  
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El factor masculino es el responsable de la esterilidad en aproximadamente el 
50% de las parejas sin hijos, mientras que la ausencia total de espermatozoides en el 
semen (azoospermia) tiene una incidencia del 5% entre hombres infértiles.  A su vez, 
las obstrucciones en el tracto eferente se calculan entre el 30 al 40% de los casos de 
azoospermia. Actualmente este tipo de infertilidad masculina se puede tratar con la 
técnica del ICSI (inyección intra citoplásmica del espermatozoide) con espermas de 
origen testicular o del epidídimo. De allí la importancia de determinar si la calidad 
de los espermas epididimales, para uso en la reproducción humana, es comparable a 
la de los espermas del eyaculado: las células en estas muestras pueden ser tanto 
inmaduras, como maduras o pos-maduras (avejentadas). Esta cuestión generó entre 
los profesionales de la reproducción en los Países Bajos una gran preocupación con 
respecto a la seguridad de este tipo de reproducción, llevando a la cesación de este 
tipo de práctica (moratoria), hasta disponer de mayores conocimientos al respecto. 
Los resultados presentados en esta tesis proveen una mejor comprensión respecto a 
la calidad del espermatozoide epididimal obtenido por la técnica de PESA 
(aspiración percútanea de los espermatozoides del epidídimo). También este trabajo 
evalúa aquellos parámetros de selección espermática comúnmente usados con el 
método de ICSI,  como los son  la morfología y la motilidad del espermatozoide. Los 
estudios presentados en esta tesis se agrupan en 3 secciones: 1) caracterización de los 
pacientes con azoospermia obstructiva (AO); 2) estudios pre-clínicos: evaluación de 
métodos y técnicas para el estudio del espermatozoide humano y 3) estudios clínicos: 
determinación de la calidad de los espermatozoides epididimales de pacientes con 
azoospermia obstructiva. Finalmente se presentan los resultados obtenidos (antes de 
la moratoria) usando espermatozoides no-eyaculados para el ICSI. 
En la Introducción General (Capítulo 1) se presenta una compilación de la 
incidencia y clasificación de la azoospermia. Además se describe el proceso de 
producción del espermatozoide (espermatogénesis), las características nucleares del 
espermatozoide, la maduración y la fisiología del transporte. También se describe la 
situación holandesa con respecto al uso de espermatozoides no- eyaculados y los 
resultados clínicos  internacionales de esta práctica del ICSI. 
En el Capítulo 2 se presentan las características y cuadro clínico de pacientes 
afectados de azoospermia obstructiva. Se evalúa el valor pronóstico de los 
parámetros clínicos usados en rutina (FSH, LH, inhibin B y el volumen testicular)  
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para determinar el grado de espermatogénesis (usando el puntaje de Johnsen 
[Johnsen score]) y la obtención de espermas con la técnica de PESA. La presentación 
clínica de las distintas etiologías de la obstrucción se evaluó con respecto a la 
histología testicular y la obtención de espermatozoides con la técnica de PESA. 
Aunque la presentación clínica de la azoospermia obstructiva es muy variada, la 
presencia de espermatozoides epididimales es el parámetro más preciso para 
predecir una espermatogénesis completa (Johnsen score ≥8; sensibilidad del 93% y 
especificidad del 94%). Como consecuencia de este resultado, en la actualidad en 
nuestro centro la técnica de PESA se usa para el diagnóstico la azoospermia 
obstructiva.  
Es de gran importancia en reproducción el determinar la calidad del DNA 
nuclear. En la segunda parte de esta tesis (Capítulos 3, 4 y 5) se validan las técnicas y 
metodología de estudio del núcleo con espermatozoides eyaculados.     
Las características externas del núcleo espermático (por ejemplo: la forma, tamaño, 
etc.) se evaluaron con una tinción específica del DNA (Feulgen), en combinación con 
el método del análisis computarizado del núcleo (computerized karyometric image 
analysis, CKIA, Capítulo 3). En total son ocho los parámetros adecuados para la 
descripción y análisis del núcleo. La variabilidad del método de CKIA para 
identificar diferencias morfológicas en las muestras de un mismo paciente es del 5%. 
Los coeficientes de confiabilidad de estos ocho parámetros son mayores del 70%. De 
allí que con el método de CKIA se puede obtener una descripción objetiva del núcleo 
del espermatozoide humano, con altos coeficientes de reproducibilidad. Este método 
es una nueva herramienta en la evaluación de la calidad del espermatozoide 
humano. 
El DNA en el núcleo del esperma esta altamente condensado en una 
estructura que se llama cromatina. El núcleo espermatozoide humano se caracteriza 
por la gran heterogeneidad en la condensación cromatínica, no sólo entre muestras 
diferentes sino también en cada muestra. Una baja condensación de la cromatina 
presenta una mayor susceptibilidad para el daño en el DNA. En el Capítulo 4 se 
evaluó el grado de condensación cromatínica  combinando fluorocromos con 
diferentes propiedades de tinción. Así se evaluó si la condensación anormal de la 
cromatina es generada por una baja protaminación (falla en el reemplazo de 
histonas) o por falla en la condensación en el epidídimo. Se separaron distintas 
fracciones de espermatozoides según el nivel de fluorescencia. Estas fracciones 
celulares se evaluaron con técnica de TdT-UTP end-nick labelling (TUNEL, detecta 
daño al DNA) y con anticuerpos monoclonales contra la doble cadena del DNA 
(monoclonal antibody #36, mAb#36). Las fracciones celulares con más alto contenido 
de protaminas presentan también tienen una cromatina más condensada y con 
menor daño en el DNA. Usando el anticuerpo mAb#36 se observaron  diferentes 
patrones de fluorescencia en el núcleo: uno se basa en la intensidad de la señal, el 
otro en la señal en el contorno celular y el último en la presencia de una banda no-
fluorescente en la base nuclear. Las proporciones de uno u tipo de estructura varia 
según la fracción  celular analizada. Nuestros resultados demuestran que la 
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diferenciación (maduración) de los espermatozoides es más susceptible a error en 
hombres infértiles, caracterizado por la gran heterogeneidad en la calidad de los 
espermatozoides. La caracterización de los espermatozoides con el anticuerpo 
mAb#36 presenta un nuevo criterio en la evaluación de la calidad del 
espermatozoide, ya que revela estructuras internas del núcleo además de la 
morfología externa. 
El daño del DNA en espermatozoides eyaculados se estudió en un modelo in 
Vitro (Capítulo 5). Se usaron dos sistemas inductores de daño al DNA en núcleos 
somáticos (los radicales libres [reactive oxygene species, ROS] y los rayos gamma) 
para producir daño al DNA de los espermatozoides. El daño al DNA se evaluó con el 
test de TUNEL y los daños de membrana con Annexin-V y propidium iodide (PI). La 
motilidad de los espermatozoides se evaluó después de exponer las muestras a ROS 
o rayos gamma, relacionándolos a los cambios en membrana y al daño del DNA. 
Usando el sistema de ROS, los primeros cambios observados en los espermatozoides 
fueron la disminución de la motilidad y daño al nivel de membrana. La motilidad de 
los espermatozoides es el primer parámetro afectado antes de poder detectar 
cualquier cambio al nivel nuclear. Inmediatamente después de la aplicación de los 
rayos, no se observó ningún cambio al nivel de membrana o núcleo. La  incubación 
las células por tiempos mayores a una hora resultó en un aumento del test de TUNEL 
(de 10.8% a un 47.2%, P = 0.03) y una disminución de la motilidad. Después de 
incubar las muestras por 24 horas, se observó que en la fracción de espermatozoides 
motiles el porcentaje de células positivas con el test de TUNEL fue solo del 0.5%. Esta 
observación sugiere que la motilidad es un marcador relevante en la selección de 
espermatozoides para el ICSI.   
Las técnicas usadas en la segunda parte de la tesis fueron aplicadas en la 
tercera sección para la evaluación de los espermatozoides del epidídimo. La novedad 
estos trabajos es que, la evaluación de la calidad espermática se realizó en una 
fracción celular previamente seleccionada: morfología normal bajo un aumento del 
400x y motilidad, tal como se hace con el método de ICSI. 
La evaluación de la morfología como parámetro de  selección en la 
identificación de espermatozoides normales en muestras epididimales se evaluó con 
el método de CKIA (Capítulo 6). Las características externas de los espermatozoides 
del epidídimo tales como la forma, la coloración del DNA y la textura de la 
cromatina nuclear se evaluó tanto en las muestras originales como también en la 
fracción seleccionada de células con el criterio del ICSI. La selección de 
espermatozoides en estas condiciones aumenta la frecuencia de gametos normales en 
las muestras del epidídimo (del 12.3% al 23.7%) y en los eyaculados (del 17.2% al 
40.5%). Sin embargo, no mas del 55% de los espermatozoides seleccionados fueron 
clasificados como normales con el método de CKIA. Además, en las fracciones de 
espermatozoides del epidídimo se observó una gran variación en la condensación y 
textura de la cromatina, hecho que sugiere que las muestras del epidídimo presentan 
una mezcla de  espermatozoides con signos de  hipo- e hipercondensación. 
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Basándonos en el conocimiento que los núcleos poco condensados de los 
espermatozoides eyaculados tienen una mayor susceptibilidad para daño del DNA 
(ver capitulo 4), se estudió si este mismo fenómeno se presenta en espermatozoides 
epididimales (Capítulo 7). También aquí se considera si el grado de condensación de 
la cromatina (maduración) se relaciona a la etiología de la obstrucción. Si bien la 
histología testicular y los niveles hormonales de los pacientes con azoospermia 
obstructiva evaluados en este estudio no presentaron diferencias, los niveles de 
condensación de la cromatina difieren entre pacientes. Todas las muestras 
epididimales presentaron altos grados de daño en el DNA, mientras que la 
frecuencia de células con baja condensación era significativamente mas alta en los 
pacientes con el síndrome de la ausencia bilateral de los vasos deferentes (CBAVD) u 
otras causas desconocidas de obstrucción que en las de las muestras de pacientes 
vasectomizados. Estos resultados sugieren que, en casos de azoospermia obstructiva, 
el grado de condensación de la cromatina nuclear (maduración) depende en cierto 
grado de la etiología de la obstrucción. 
Otro parámetro usado en la selección espermatozoides para el ICSI es la 
motilidad. En el Capítulo 8 el daño del DNA de espermatozoides eyaculados y del 
epidídimo se estudió con el test de TUNEL en las muestras nativas y en la fracción 
motil seleccionada con el criterio del ICSI. Las muestras nativas del epidídimo 
contienen un alto porcentaje de células con daño al DNA (18.9% TUNEL positivo). 
Sin embargo, en la fracción motil menos del 1% de éstos resultaron positivos con el 
test de TUNEL. Por lo tanto se concluyó que la selección de espermas motiles 
disminuye el riesgo de inyectar espermatozoides dañados con el ICSI. 
Los resultados clínicos del ICSI con espermatozoides del epidídimo o 
testiculares (fertilización, embarazo y nacimientos) obtenidos en el período antes de 
la moratoria se presentan en el Capítulo 9. De los 39 tratamientos de ICSI con 
espermatozoides de origen testicular o del epidídimo (24 parejas), se obtuvieron 10 
embarazos, una frecuencia de embarazos de 41.6% por pareja en casos de pacientes 
con azoospermia obstructiva. Junto a los resultados conseguidos en el programa de 
ICSI-PESA después de enero del 2001 (estos resultados no han sido descriptos aquí), 
se concluyó que el porcentaje de embarazos obtenidos con espermatozoides no-
eyaculados en caso de azoospermia obstructiva es comparable a los resultados de 
ICSI con muestras eyaculadas.  
En resumen, las conclusiones principales de esta tesis son: 1) la selección de 
gametos usando como referencia la motilidad y la morfología incrementa la 
frecuencia de espermatozoides normales tanto en las muestras eyaculadas como en 
las epididimales; 2) la gran heterogeneidad en la cromatina nuclear presente en los 
espermatozoides humanos se incrementa aún más en muestras de pacientes infértiles 
o azoospérmicos; 3) la presencia de espermatozoides en el epidídimo (PESA positivo) 
es indicativa de una espermatogénesis completa; y 4) se puede obtener un alto 
porcentaje de fertilización y embarazos cuando espermatozoides motiles y de 
morfología normal se seleccionan para la inyección con la técnica del ICSI. 
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